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ABSTRACf 
Recent observations suggest a link between the pineal gland and the 
opioid system. Possible areas of interaction between the pineal 
gland and the opioidergic system in Wistar rats were investigated . 
The effect of opioids on the pineal gland in organ culture was 
monitored. Neither morphine, methadone nor the opioid antagonist 
naloxone was found to affect [14C]-serotonin metabolism by the 
pineal gland in vitro. 
Both the pineal gland and the opioid system are influenced by 
exposure to stressful stimuli. Morphine and melatonin had 
protective effects on stress-induced gastric lesions. The ability 
of melatonin to inhibit lesion formation was found not to be 
exerted via an opioidergic mechanism . Evidence has been obtained 
for a possible modulation of the stress response by the pineal 
gland . 
The opioid drugs are the most potent analgesic agents available. A 
possible interaction between the opioid system and the pineal gland 
in the modulation of the response to noxious stimuli was 
investigated. An intact pineal gland was found to be necessary for 
the manifestation of the nocturnally increased response of rats to 
noxious stimuli. 
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CHAYfERONE 
LITERATURE REVIEW 
1 The Pineal Gland 
History 
The human pineal gland was first discovered in 325-280 Be by a 
famous anatomist, Herophilos. He described it as being a 'tap' 
regulating the stream of the 'pneuma' from the third to the fourth 
ventricle (Ariens Kappers,1979) . Galen (130 - 300 A.D) termed the 
pineal gland 'soma konoeides' because of its pine cone shape in 
man. 
Rene Descartes' (1596 - 1650) concept of the pineal gland being the 
'seat of the soul' came at a time when philosophers and scientists 
had a keen interest in attempting to localize the soul. 
In the second half of the 19th century, interest in pineal anatomy, 
histology and embryology grew as a result of the availability of 
more refined staining and sectioning techniques. 
Studnicka (1905) described many of the cell types of the pineal 
gland which today are known to be present in the pineal organ of 
lower vertebrates. 
Heubner (1898) first described a boy suffering from precocious 
puberty showing a pinealoma - and suggestions were made that the 
pineal gland could act to normally inhibit premature development of 
the reproductive system in infancy by an action on the 
hypothalamus. 
An important study undertaken by Borgman described the anatomy, 
histology and cytology of the pineal organ in various animal 
species (Ariens Kappers, 1981). 
In 1954, Kitay and Altschule (1954) edited a book on pineal 
physiology and suggested future lines of research in this field. 
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Considerable advances in pineal research have been made since then, 
and interest in this field is still gaining impetus. 
Anatomy 
Although the pineal gland was discovered and described before most 
other endocrine glands in the body, its function has remained 
unknown until recently. 
The pineal gland originates in the brain of the developing embryo, 
but it loses direct nerve connection with the brain soon after 
birth (Axelrod, 1974). It is found outside the blood brain barrier 
between the two cerebral hemispheres of the brain and weighs 
approximately 100 mg in man and 1mg in rats. Postnatally, the 
pineal gland of the rat enlarges rapidly. Volumetric data indicates 
that depending on the strain, the pineal gland continues to enlarge 
until the the rat is 8.5 to 12 weeks old (Reiter, 1981). The 
superior saggital sinus and the transverse sinus cover the pineal 
gland, which is superficially located just below the skull. 
The pineal gland of mammals displays much variation in size, 
location, and form. 
Blood supply 
The major blood supply to the pineal gland is provided by branches 
of the posterior choroidal arteries (Gladstone and Wakely, 1940). 
The arteries branch into the capsule of the pineal gland before 
they penetrate the parenchyma. In most mammals, the pineal glands 
are abundantly supplied with capillaries. 
Hodde (1979) found that the pineal gland receives 2 - 6 arterial 
branches from posterior cerebral arteries. The capillary network 
forms vessels, which enter the septae, or merely run through the 
pineal tissue to the capsule. 
The pineal gland has 12 - 16 superficial collecting veins (Hodde, 
1979) which drain via the distal end of the great cerebral vein, 
into the superior saggital sinus in rodents. 
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A profuse blood supply reaches the pineal gland at a rate of flow 
of 4 mll mini g - surpassed only by the kidney (Reiter, 1981). This 
blood supply is greater at night than during the day (Quay, 1972; 
Rollag, 1978). 
Innervation 
The pineal gland is innervated mainly by noradrenaline (NA) 
containing postganglionic sympathetic neurons, the cell bodies of 
which are found in the superior cervical ganglia (SCG) (Kappers, 
1981). These nerve fibres reach the pineal gland along the internal 
carotid plexus. On nearing the pineal gland, the nerve fibres 
eventually form one or two discrete nerves called the nervii 
conarii (Kappers, 1981). They penetrate the pineal capsule at the 
apex of the gland, and ramify among the pinealocytes, ending 
between the parenchymal cells, especially in the pericapillary 
spaces (Romijn, 1973; Matsushima and Reiter, 1977). 
The bulk of the NA wi thin the pineal gland is confined to the 
sympathetic nerve terminals (Matsushima et ai, 1981). The 
neurotransmitter is primarily released during darkness resulting in 
a stimulation of indole production within the pineal gland (Morgan 
etal,1976). 
Reports have suggested that the pineal gland may also be innervated 
by fibres having their cell bodies in other areas of the CNS. 
Kappers (1960) showed that abbe rent commisural fibres of the 
habenular commisure often form hairpin loops in the pineal stalk or 
in the deep part of the pineal. Reiter (1982) has suggested that 
the axons of these cell bodies may pass into the vicinity of the 
habenular nucleus on their way up the pineal stalk. 
Dafney (1980) 
pineal body 
hypothalamic, 
suggestive of 
has demonstrated short latency responses in the 
of the rat following amygdalic, ventromedial 
olfactory, acoustic and photic stimulation 
neural connections between the pineal gland and 
neural structures in the brain of the rat. The transport of photic 
information via the habenular commisure to the pineal body is 
faster than that via the suprachiasmatic nucleus (SCN). 
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The pinealocyte 
The pineal gland consists mainly of interstitial cells and 
pinealocytes which are the recepto-sensory components (Juillard and 
Coll i n, 1980) . The biochemistry and function of the pinealocyte 
likens it to the APUD cell type series (Leong and Matthews, 1979) 
enabling the pineal to participate in the diffuse neuroendocrine 
system (Matthews and Leong, 1981) . The pinealocyte has also been 
described as a paraneuron (Ueck and Wake, 1979) . 
Biochemistry 
Klein and Moore (1979) described the neuronal pathway from the eye 
to the pineal gland. Photic stimuli sensed by the retina is sent as 
a neurally coded message by the optic nerve via the retino-
hypothalamic tract to the SCN. From here, the information is sent 
via the spinal chord to the SCG, with the postsynaptic NA-ergic 
nerves synapsing in the pineal gland . The terminals of these fibres 
do no t form true synapses with the pinealocytes, but end freely in 
the parenchyma. 
The NA released from these fibres at night acts on highly specific 
receptors (Klein and Weller, 1970) of the ~1 subgroup (Backstrom, 
1977) . 
The enzymatic capacity of pineal homogenates to convert adenosine 
triphospate (ATP) to cyclic AMP (cAMP) was ·an important finding for 
the understanding of pineal biochemistry. This reaction requires 
the enzyme adenylate cyclase . Unstimulated (basal) levels of the 
enzyme have been shown to undergo diurnal variations in the pineal 
gland (Weiss, 1971) 
Stimulation of the ~-rec eptor thus activates adenylate cyclase with 
a resultant increase in cAMP production (Klein etal, 1978). 
The post-synapti c ~-receptor is linked to adenyl cyclase - but it 
ha s been observed that not all of the effects of ~-receptor 
stimulation are mediated exclusively by cAMP. Hyperpolarisation of 
the pinealocyte membrane due to the activation of the ~-receptor 
changes the ion physiology in the pinealocyte , possibly independent 
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of cAMP (Parfitt el ai, 1975) . It has been suggested that both 
hyperpolarisation and increases in cAMP are necessary for the 
complete manifestation of the i3-stimulatory effects in the pineal 
(Parfitt el ai, 1975) and Ca2+ ions have been shown to be 
essential for such activity (Zatz and Romero, 1978). 
The amino acid taurine is found in high concentrations in the 
pineal gland when compared to other parts of the brain (Cra bai el 
ai, 1974) and is located almost entirely in the pinealocyte. 
Stimulation of the i3-receptor leads to a release of taurine 
possibly via hyperpolarisaUon (Wheler and Klein, 1980) and cAMP 
(Wheler el ai, 1979). Klein el al (1981) have suggested that 
taurine might act as an extracellular feedback messenger, 
modulating the amoumt of NA released in response to tonic neural 
stimulation. 
The sensitivity of the i31-adrenergic receptor in the pineal gland 
varies. Various manipulations including light exposure, treatment 
with reserpine, and superior cervical ganglionectomy have been 
reported to induce supersensitvity of the pineal i31-adrenergic 
receptor (Reiter, 1981). Conversely, after 12 hrs of exposure to 
darkness (Romero el ai, 1975) or either acute (Kebabian el ai, 1975) or 
chronic (Moyer el ai, 1980) exposure to i3-adrenergic agonists 
reduces receptor sensitivity. 
At the onset of the dark phase, these receptors exhibit 
supersensitivity, probably due to the decreased NA release during 
the light phase (Romero and Axelrod, 1974). Gonzales-Brito el al 
(1988) demonstrated an increase in i3-receptor binding in the first 
half of the dark phase in hamsters, with peak binding around the 
mid-dark period and an abrupt decrease in binding one hour after 
lights on. 
B-receptor stimulation causes a decrease in the number of receptors 
and in the concentration of hormone sensitive adenyl cyclase, 
suggesting that receptor sensitivity is dependent, at least to a 
certain extent, on the sensitivity of adenyl cyclase to stimulation 
(Kebabian elal, 1975) 
Gonzales-Brito el al (1988) concluded that intrinsic mechanisms of up 
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and down regulation of pineal ~-adrenergic receptors operate during 
a 24 hr LD cycle resulting in a circadian variation in 
pinealocyte NA output (Browenstein and Axelrod, 1974). 
SNAT 
The adrenergic-cAMP mechanism described above regulates the 
activity of the pineal enzyme Serotonin-N-Acetyl-Transferase (SNAT) 
- the induction of which has been suggested to occur via two routes 
transcription and enhancement of post-transcription events 
(translation) . 
Actinomycin D (inhibits transcription) and cycloheximide (inhibits 
translation) block the isoprenaline-stimulated or dark phase-
induced increase in SNAT activity (Romero el ai, 1975). A lag 
period prior to an increase in SNAT activity occurs after treatment 
with these drugs, possibly due to a lack of mRNA necessary for SNAT 
induction (Zatz el ai, 1976). These findings thus suggest that' both 
new RNA and protein are required for the synthesis of SNAT. 
cAMP stimulates the synthesis of the specific new macromolecules -
RNA and protein - required for the stimulation of SNAT and also 
stabilizes the enzyme and keeps it in an active state (Klein el ai, 
1970) . 
The activity of this enzyme undergoes large daily changes, with 30-
100 fold increases having been noted in the dark phase (Axelrod, 
1974). This enzyme is located mainly in the cytoplasm (Deguchi and 
Axelrod, 1972) and acts to transfer an acetyl group from the 
cofactor Acetyl Coenzyme A (CoA) to acceptor amines. It is 
responsible for the formation of N-Acetyl Serotonin (NAS) in the 
melatonin biosynthetic pathway. 
The nocturnal induction of SNAT is dependent on increased pineal 
cAMP levels and the capacity of the intracellular mechanisms to 
respond to this increase (Romero and Axelrod, 1975). 
Maintenance of the elevated nocturnal activity of SNAT requires the 
continuous activation of the ~-adrenergic receptor by NA - this is 
suggested by the rapid (Half-time = 3 minutes) decrease in SNAT 
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activity on exposure to light or ~-receptor blockade (Deguchi and 
Axelrod, 1972) . 
The activity of SNAT is also very sensitive to drug manipulations 
affecting ~-receptor adenylate cyclase-coupled regulating 
mechanisms. Agents such as isoprenaline, pargyline (MAO inhibitor), 
cocaine (NA reuptake blocker) increase SNAT activity (Deguchi and 
Axelrod, 1972). 
Pre-synaptic a-adrenergic receptors have been characterized in the 
pineal gland In vivo and in vitro experiments have shown that 
stimulation of these receptors leads to an accumulation of cGMP 
(Vanacek et ai, 1986), as well as a potentiation of the stimulating 
effects of isoprenaline on SNAT activity (Klein et ai, 1983) and 
cAMP production (Vanacek et ai, 1985). Administration of the a1-
adrenergic antagonist prazosin inhibits the nighttime increase in 
melatonin release (Sugden etai, 1985a). 
Mobilization of Calcium (Ca2+) via the stimulation of the inositol 
lipid signalling pathway is reported to be necessary for 
a-adrenergic regulation of pineal activity (Exton, 1985). 
It was suggested that NA released from the pineal sympathetic nerve 
endings may act on both ~- and a-adrenergic receptors, with the 
effect on a-adrenergic receptors leading to a decrease in ~­
adrenergic receptor sensitivity (Klein et ai, 1981). Gonzales-Brito et 
ai, (1988), however, reported that a homologous (agonist-specific) 
mechanism of ~-adrenergic receptor desensitization operates within 
the pineal gland. Thus, the NA acting on post-synaptic ~-adrenergic 
receptors potentiates ~-receptor stimulation induced increases in 
SNAT activity without modifying the sensitivity of the ~-adrenergic 
receptor to the neurotransmitter (NA). 
Recent studies have suggested that prostaglandin (PG) stimulation 
of SNAT may represent yet another mechanism for regulating 
melatonin production by the pineal gland (Ritta et ai , 1981). It has 
been observed that a-adrenergic receptor stimulation of rat pineal 
explants results in PGE2 release (Cardinali and Vacas, 1987). PG 
synthesis inhibitors block the nocturnal rise in pineal SNAT , and 
PGE2 (in vitro) increases pineal SNAT activity, cAMP levels and 
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melatonin release (Cardinali and Vacas, 1987) . 
SNAT activity is also sensitive to stressful stimuli (Vaughan et ai, 
1978), possibly brought about due to the release of catecholamines 
from sympathetic nerve endings, and the adrenal medulla. 
HIOMT 
Hydroxy - indole-O-methyl transferase (HIOMT) was initially thought 
to be unique to the pineal gland (Axelrod et ai, 1965) - however, 
it has since been localized in other areas, including the retina, 
Harderian gland, intestine and also enterochromaffin cells (Reiter, 
1981) . 
Axelrod and Weissbach (1961) first purified HIOMT from bovine 
pineal glands. This enzyme transfers methyl groups from the 
cofactor S-adenosyl methionine to acceptor molecules (5-
hydroxyindoles) Reiter, 1981 . In the pineal gland, HIOMT 
catalyzes the conversion of NAS to melatonin. The activity of the 
enzyme is possibly regulated in vivo by two mechanisms: a) Light -
modulates neural stimulation (Klein and Moore, 1979); and b) 
circulating steroids (Preslock, 1977). 
Although early reports suggested daily changes in enzyme activity, 
these findings were not reproducible. However, during exposure to 
constant darkness, a gradual increase in HIOMT activity occurs, and 
conversely, exposure to constant light results in a gradual 
reduction of HIOMT activity (Wurtman et ai, 1963). It is now 
conceded that if HIOMT activity does vary throughout the 24 hr 
period, the rhythm is of very low magnitude (Klein, 1981) . 
Gonadal steroids (e.g. oestradiol) have been reported to increase 
pineal HIOMT activity by 80 - 90% using nM concentrations in an 
organ culture system (Reiter, 1981). Oestradiol, testosterone and 
progesterone show a biphasic dose-dependent stimulation of HIOMT 
activity (Daya, 1982) . 
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Fig 1.1: Diagram representing some of the subcellular mechanisms 
underlying neuroendocrine-transducing events in the 
mammalian pineal. TP: tryptophan; HTP: 5-
hydroxy tryptophan; 5HT : serotonin; NAS : N-
acetylserotonin; HTOH : 5-hydroxytryptophol; HlAA: 5-
hydroxyindoleacetic acid; MTOH: 5-methoxytryptophol; 
MlAA: 5-methoxyindloeacetic acid. 
Adapted from Cardlna 1 i el ai , 1982. 
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Melatonin 
In 1917, McCord and Allen observed a lightening of the skin of 
amphibians fed with bovine pineal extracts. Lerner el al (1958) 
first isolated and identified the pineal substance responsible for 
this effect, and ca lled it melatonin (5-methoxy-N-acetyl 
tryptamine) . 
Of all the pineal substances studied, melatonin is probably the 
most investigated substance, The importance of the pineal gland and 
melatonin as possible neuroendocrine modulators becomes apparent on 
studying their various physiological effects. 
The generalized stimulation of the pineal gland at night results in 
a great increase in the concentration of melatonin within the 
gland. As far as can be determined, melatonin is not stored within 
the pineal gland in any appreciable quantity. Shortly after being 
synthesized, it is released into the circulation (Kennaway m 
al,1977; Rollag el ai, 1977). In some cases, melatonin may even be 
released into the CSF (Reppert el ai, 1978) - and CSF and blood 
levels of melatonin follow those of the pineal gland. 
Wetterberg el al (1981) have observed that circulating levels of 
melatonin during the night are higher than those during the day in 
humans. 
After being secreted into the blood, melatonin is loosely bound to 
plasma albumin, passes through the liver where it is rapidly 
conjugated with glucuronide (5%) and sulphate (70 - 80%) by hepatic 
microsomes, and the metabolites are then excreted in the urine 
(Reiter, 1981a). One of the metabolites in the urine 6-
hydroxyme1atonin sulphate - is sometimes measured to monitor pineal 
melatonin production, and may serve to provide a simple, rapid and 
non-invasive technique of assessing melatonin levels in clinical 
situations (Aldhous and Arendt, 1988). This technique would not, 
however, be able to pick up rapid changes of short duration. 
Many potential functions of the pineal gland and melatonin have 
been suggested . Possibly, the most extensively documented effects 
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of the pineal gland are those on the reproductive system. The first 
convincing data that the pineal gland was an organ of internal 
secretion came from the work of Reiter and colleagues (review, 
1981a), who observed an involutior- of the gonads and accessory sex 
organs of both male and female hamsters on exposure to constant 
light. This effect was reversed by pinealectomy. 
Other findings showed that melatonin is capable of suppressing 
reproduction (Cardinali el ai, 1974) - and this effect requires an 
intact pineal gland (Reiter elal, 1976). 
The growth of the ovarian interstitium is dependent on ample 
luteinizing hormone (LH) secretion from the anterior pituitary 
gland. LH and follicle stimulating hormone (FSH) exhibit a daily 
afternoon surge in light restricted female hamsters (Bridges and 
Goldman, 1975). It has been suggested that the pineal gland 
participates in linking this LH hormone surge to the photoperiod 
(Walker el ai, 1982). 
A melatonin free pineal extract was also observed to exert an anti-
gonadotropic effect (Damian el ai, 1981) which raises the possibility 
that factors other than the methoxyindoles e.g. pteridines and 
pterins might also exert this effect (Ebe1s, 1979). Other pineal 
factors, such as 5-methoxy tryptophol and 5-methoxytryptamine 
(McIsaac el ai, 1964) also exert antigonadotropic effects. even in 
the absence of an intact pineal gland (Pevet elal, 1981). 
The pineal gland has also been implicated as a target organ for 
androgens (Sem el ai, 1981) suggesting a pineal gonadal feedback 
mechanism. 
The anti-gonadal effects of melatonin have been well reported, and 
excellent reviews may be consulted for a more detailed perspective 
(Minneman and Wurtman, 1976; Reiter, 1981b). 
Many other functions for melatonin and the pineal gland have been 
indicated in isolated reports. It has been suggested that melatonin 
affects melanin synthesis (Weatherhead and Logan, 1981), may serve 
a neuromodulatory role in the salivary glands (Bubenik, 1981), and 
may affect sperm motility in human semen (van Vuuren el ai, 1988). 
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Abnormal rhythms of melatonin have been found in 47 disease states 
(Birau, 1981). 
The CNS has also been implicated as a site of action of melatonin 
It has been suggested that melatonin assists the entry into sleep 
and perhaps maintains undisturbed sleep throughout the night 
(Armstrong elal, 1982). 
Many reports suggest that the pineal gland may be involved in the 
modulation of epileptic seizures - with melatonin being the pineal 
anti-convulsant principle (Peterson el ai, 1981), exerting its action 
possibly by reducing the ability of excited (epileptic) neurons to 
maintain activity, and/or via an indirect alteration of the EEG by 
an action on the hypothalamus (Pang elm, 1976). 
Anton Tay el al (1971) noted an increase of REM sleep, and a slowing 
down of the EEG rhythm in patients treated with melatonin. An 
increase in the convulsive threshold was also noted in epileptic 
patients, and an improvement in the clinical picture of 
Parkinsonian patients was observed. 
A feedback mechanism between the pineal gland and the hypothalamo-
hypophyseal axis has been suggested (Karasek, 1979) with retinal 
melatonin also possibly affecting the hypothalamus (Grota el ai, 
1982). Evidence has been presented that melatonin may act on 
neurons in the preoptic and the anterior hypothalamic areas of the 
hypothalamus (Reiter, 1982a). Recently, English and Arendt (1988) 
characterized melatonin binding sites in the rat hypothalamus using 
[l~Il-Iodomelatonin . Melatonin may also influence GABA and 5HT 
concentrations of the hypothalamus and the midbrain (Reiter, 
1982a) . 
Zisapel (1988) has observed specific melatonin binding sites in the 
rodent brain; with the presence of a diurnal variation in the 
hypothalamus, medulla, pons and the hippocampus. The ability to 
characterize melatonin binding sites in various brain areas will 
facilitate the understanding of the nature of the neuroendocrine 
effects of melatonin. 
Vacas and Cardinali (1980) demonstrated specific, high affinity 
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binding of melatonin to crude membrane preparations from bovine 
pineal glands, suggesting that melatonin may have an action on the 
pineal gland. 
It has been sugges ted that melatonin may exert some of its effects 
via a cAMP mediated mechanism (Brown and Niles, 1982) by indirectly 
influencing NA and DA sensitive adenylate cyclases in the brain, or 
by an action on its own receptor sites. Also, a direct action of 
melatonin at peripheral target organs has been proposed . 
Convincing evidence for a role of the pineal gland in the control 
of thyroid function has been provided by Vriend and Reiter (1977). 
They have suggested that the pineal gland is capable of depressing 
both total plasma thyroxine concentrations as well as the free-
active form of thyroxine. Pinealectomy was observed to increase 
Iodine accumulation in the thyroid gland (Csaba and Nagy, 1974). 
Furthermore, the pineal gland has been suggested to influenc'e the 
spread and growth of malignant tumours (Tapp, 1980). Patients with 
breast cancer have particularly large pineal glands (Tapp, 1980). 
In studies conducted on female rats, melatonin has emerged as a 
particularly important anti-neoplastic agent, especially with 
respect to the growth of breast cancer. Lissoni el al (1988) have 
suggested that an increase in plasma melatonin concentrations can 
be used as a predictor of the objective response of cancer patients 
to chemotherapy. These investigators have also suggested that the 
antineoplastic effect of cytotoxic drugs may require the 
participation of the pineal gland. 
Melatonin has also been implicated in immune regulation. 
Interleukin-2 cells inhibit pineal melatonin production in vitro 
(Esposti el ai, 1988a) and melatonin may stimulate Natural Killer 
cell activity in humans and enhance humoral and cellular immune 
responses in mice (Fraschini elal, 1988). 
Extracts of the pineal gland are being used for the treatment of 
psychosis and schizophrenia (Young and Silman, 1982). Melatonin 
levels in the plasma correlate with mood - low in depression, high 
in mania, and scattered levels being observed in bipolar manic 
depression. 
Fig 1.2: 
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Although melatonin is the most investigated substance, it is unwise 
to assume that it is the only pineal factor with physiological 
consequences. Many othec known or yet undiscovered pineal 
substances may prove to have roles equally as, or perhaps even more 
important than, melatonin. 
To exhaustively review the vast literature available on the pineal 
gland would exceed the scope of this study. Newly discovered 
possible physiological functions for the pineal gland and its 
factors are constantly being suggested. Indeed, . pineal research is 
a dynamic field of study. 
2 The Opioid System 
Overview 
The opium alkaloids are the structural prototypes of the modern 
potent analgesic agents. Opium is obtained from the milky exudate 
of the unripe seeds and capsule of the opium poppy - Papaver somniferum 
- now grown legally and illegally in many parts of the world. 
Originally, opium was native to the Middle East and was used by the 
Assyrians to promote sleep. It was transported to the Far East 
(China) by the Arabs, and was used by the Chinese for dysentry. 
They later began to smoke the crude extract of the poppy. Chinese 
immigrants introduced opium to the West, and it was accepted by 
physicians as a useful remedy for pain. Addiction remained mild 
when smoking and eating opium became popular because the tarry 
extract decomposed thermally and was not well absorbed through the 
GIT. However, severe cases of addiction were noted, especially 
after the invention of the first hypodermic syringe (quill and 
bladder) enabling the intravenous (iv) administration of opium. 
One of the opium alkaloids, morphine, was later extracted . It was 
observed not only to relieve pain, but also to produce a general 
feeling of well being, promote sleep and reduce anxiety (review, 
DeStevens, 1965). However, it had several disadvantages, producing 
respira tory depression, bradycardia, dependence, constipation and 
hypotension - and with repeated use, tolerance to certain of its 
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side effects. 
The search then began for a potent analgesic agent without the 
side-effects of morphine - especially without the the ability to 
produce dependence. Extensive research introduced the 
phenylpiperidene and methadone congeners which were originally 
believed to be non-dependence producing drugs. These chemically 
synthesized drugs, however, were later found to have addictive 
potential. 
The development of potent agonist-antagonist analgesics with low 
addiction potential resulted in part by accident and in part by 
design. In an attempt to develop a drug without the respiratory 
depressant actions of morphine, and possibly devoid of its 
addiction potential as well, Hart and McCawley (cited in Toro and 
Way, 1983) stumbled across a compound with antagonist properties to 
morphine. Replacing the piperidene-N-methyl group of the morphine 
compound with an allyl group gave rise to nalorphine. Lasagna and 
Beecher (1954) carried out a series of experiments to find a 
morphine-nalorphine combination that would maintain the analgesic 
properties of morphine and minimize its other side effects. A major 
breakthrough was made when, in the course of their work, they 
demonstrated that this opiate antagonist produces analgesic effects 
in man. 
Although drug addiction studies confirmed that it would be unlikely 
to produce dependence in man (Wilker et ai, 1953), nalorphine 
displayed psychotomimetic effects (including dysphoria) - (Isbell, 
1956) that precluded its use as an analgesic. 
This discovery, however, resulted in a search for other agonist 
antagonists that would cause pain relief without causing dysphoria. 
This led to the discovery of naloxone, a relatively pure antagonist 
compound, devoid of analgesic activity. Other agonist-antagonists 
having analgesic activity were later discovered. These include 
pentazocine, butorphanol, nalbuphine and buprenorphine (Toro and 
Way, 1983) all of which are now used clinically. 
Beckett and Casy (1954) later proposed a model for an endogenous 
opioid receptor. The opioid receptor was later pharmacologically 
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(Kosterlitz and Waterfield, 1975) and chemically (Pert and Snyder, 
1973) characterized using bioassays and ligand binding studies. 
The characterization of the receptor led to the suggestion that an 
endogenous morphine-like substance should exist (Hughes, 1974) 
and an exciting race to isolate such a ligand began. 
Hughes(1975) and Terenius and Wahlstrom (1975) showed. that a brain 
extract displayed opioid-like activity in bioassays using the mouse 
vas deferens. Met- and leu-enkephalin were purified (Hughes, 1975) 
later followed by the discovery of ~-endorphin (Li and Chung, 
1976). 
These discoveries led to great advances being made in opioid 
pharmacology, some of which will be discussed below. 
Characterization of the opioid receptor 
The chemical characterization of the opioid receptor in 1973 led to 
a better understanding of the mechanisms of action of the opioid 
compounds (Snyder etal, 1973). 
Morphine is well suited for use as a receptor probe because of its 
rigid structure and the fact that its structure must describe at 
least a part of the morphology of the opioid receptor (Thorpe, 
1984) . 
In the 1980' s, pharmacologists began to recognize the structural 
characteristics shared by the potent narcotics (review, Thorpe, 
1984) . These included: 1) a tertiary nitrogen; 2) a quarternary 
carbon, separated from the basic nitrogen by an ethylene (-CH2-CH2 ) 
chain and attached to a phenyl group; and 3) the presence of a 
ketone (e.g. methadone) or a hydroxyl (e.g. morphine) group. 
It has been suggested that the receptor site contains the amino 
acids tyrosine and phenylalanine. The following model for the 
receptor site has been proposed : 
1) The receptor consists of two aromatic binding sites and one 
anionic site (for the binding of the basic nitrogen). 
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2) One of the receptor subsites called the T site binds 
hydroxylated rings (e.g . morphine) preferentially. The second 
aromatic subsite - the P site - binds non-hydroxylated rings (e.g . 
pethidine) but may also bind other groups (e . g . allyl, 
cyclopropyl) . 
3) A steric hump exists and serves to possibly elevate the nitrogen 
from its anionic site . 
This is based on the operational model suggested by Beckett and 
Casy (1954), and although oversimplified, it facilitated the design 
of new compounds and explanations of opioid action. 
Two major approaches are used to characterize the binding of 
opioids to the recognition (receptor) site . Competitive 
displacement assays are used to investigate the binding properties 
of the opioid, followed by saturation analysis to determine the 
maximum binding capacity of the different binding sites (Paterson el 
ai, 1983) . 
Pharmacological characterization is also necessary to analyze the 
effects induced by interaction of the opioid receptor with the 
receptor site . A number of assays can be used to measure some of 
these effects, the most Common being that using the mouse vas 
deferens, the guinea pig ileum, and the vas deferens of the rat and 
the rabbit (Paterson elal, 1983). 
Ligand binding to the opioid receptor has been shown to be 
stereoselective (Goldstein el ai , 1971) and sensitive to pH, ionic 
strength and temperature (Fisher and Medzihradsky, 1981). 
Studies on the chemical nature of the opioid receptor have shown 
that it consists of both protein and lipids (Toro and Way, 1983). 
Cerebroside sulphate (Loh el ai, 1978), phosphatidyl serine (Abood ef 
ai, 1975), and phosphatidyl insitol (Haregawa el ai, 1981) are the 
lipids associated with the receptor . Not much is presently known 
about the nature of the protein moiety involved in opioid receptor 
activity . 
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Multiple Opioid Receptors 
The multiplicity of the opioid receptors seem to match the 
complexity of the endogenous opioid ligands. Initially a single 
opioid receptor interacting with morphine was recognized. The most 
significant discovery that facilitated the conceptualization of 
multiple opioid receptors was the development of the narcotic 
antagonists. These antagonists became powerful tools for studying 
the specificity and mode of action of opioid action. The 
observation that nalorphine antagonized the analgesic effect of 
morphine as well as exerted an analgesic effect itself (Lasagna and 
Beecher, 1954), suggested the existence of another receptor for the 
mediation of nalorphine's effect. In order to explain the diverse 
actions of the opioids, it was necessary to postulate that either 
one receptor existed with more than one conformation, or that there 
were several types of receptors. 
Martin el at (1976) did a series of experiments on dogs with chronic 
spinal transections and therefrom postulated the existence of 
multiple opioid receptors. The basic types defined by these 
investigators are: 
The mu receptor 
The kappa receptor 
The sigma receptor 
Mediates classic morphine-like effects 
such as analgesia, and is found abundantly 
in the guinea pig ileum and pain 
modulating brain regions. 
so named for the effects of 
ketocyclazocine, and is thought to mediate 
opioid effects atypical of morphine e.g. 
hallucinations and dysphoria . Localized in 
the deep layers of the cerebral cortex and 
found abundantly in rabbit vas deferens 
to which SKF-10047 binds, producing a 
general activation of the eNS 
(tachycardia, tachypnoea, mania) . Naloxone 
insensitive - may not be a typical opioid 
receptor 
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Two other receptor types have also been postulated (Rodgers and 
Cooper, 1988): 
The delta receptor 
The epsilon receptor 
Found in the CNS, displays great affinity 
for the enkephalins. Also found abundantly 
in the mouse vas deferens 
for ~-endorphin - has been characterized 
in the mouse vas deferens (Schulz et ai, 
1979). Although ~-endorphin binds to the 
CNS (Akil etal, 1980), an epsilon receptor 
has not been described here. 
Subtypes of these receptors may possibly exist (Pasternak et ai, 
1986) . 
Another argument favouring the existence of multiple opioid 
receptors is based on the experimental work done on cross-tolerance 
between various opioid compounds. Using the guinea pig ileum, 
Yoshimura et a/ (1982) were able to discriminate between various 
opioid agonists. They observed that ilea chronically treated with 
morphine exhibited complete cross-tolerance to ~-endorphin, 
moderate cross-tolerance to enkephalins and no cross 
dynorphin. Tolerance developing to a given opioid 
tolerance to 
(in this case 
morphine) activating one class of receptors primarily will exhibit 
cross tolerance to other agonists acting on the same receptor type 
(in this case ~-endorphin, and to a lesser extent enkephalin) but 
not to those acting at a different receptor type (dynorphin) . 
Behavioural studies (schedule controlled behaviour - Harris, 1980), 
drug discrimination (Teal and Holtzman, 1980) and locomotor 
activity studies (Iwamoto et ai, 1981) have also provided evidence 
for the existence of receptor subtypes. 
Evidence for a biochemical basis to support the existence of 
multiple opioid receptors has also been provided. Binding studies 
have shown that there may be more than one recognition site for 
opioid compounds (Smith and Loh, 1981; Lord et ai, 1977), however, 
these studies do not indicate whether such sites are associated 
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with active or silent receptors. More research is necessary to 
correlate the activation of the binding site with 'specific' 
pharmacological effects. 
Mechanism of Action of Op\oids 
Many hypotheses have been advanced to explain the mode of action of 
the opioids . Several neurotransmitters have been implicated in 
opioid action. These include Ach. 5HT. DA. NA. GABA and Substance P 
(Chapman ann Way . 1980). 
It could thus be proposed that a primary mechanism of action common 
to all these naturally occurring ligands may be involved in the 
opioid mechanism of action. Second messengers such as Ca2 +, cGMP, 
and cAMP have been suggested to be responsible for the transmission 
of opioid information to initiate or inhibit cellular processes. 
Calcium 
The neuronal Ca2+ concentration has been suggested to be critical 
for opioid action. Intracisternal administration of Ca2+ 
antagonizes morphine induced analgesia when tested on both the hot 
plate or in response to electrical stimulation (West and Miller. 
1983). Lowering the Ca2+ level in the neuron (by intracisternal 
administration of EDTA . oxalate. citrate) enhances and may even 
mimic opioid action. 
Morphine administration also reduces Ca2+ content in synaptosomes 
of brain homogenate by approximately 30% after acute treatment 
possibly by inhibiting Ca2+ uptake and binding. The converse is 
found after chronic opioid treatment, where an increase in 
synaptosomal Ca2+ is observed. localized mainly in the vesicular 
fractions of the synaptosome . 
Lanthanum blocks Ca2+ effects in many systems (Weiss. 1974). and 
displays naloxone sensitive analgesia in mice (West and Miller. 
1983) . This cation (La3+) also reduces naloxone precipitated 
jumping in morphine dependent mice (Harris. 1975). and a possible 
cross tolerance between morphine and lanthanum has been described . 
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The opioids are suggested to reduce 
membranes possibly by inhibiting the 
CaZ+ binding to synaptic 
interaction of Caz+ with 
certain phospholipids (thus for e.g., altering serine incorporation 
into phosphatidylserine) - (West and Miller, 1983) . 
High Caz+ concentrations in the neuron possibly inhibit morphine's 
effect by hyperpolarisation of the synaptic plasma membrane with a 
resultant reduction in the effect of morphine on transmitter 
release (Szerb, 1980) 
Cyclic AMP 
In 1974, Collier and Roy reported that morphine and morphine-like 
drugs inhibit the stimulation by PGE of cAMP formation in rats 
brain homogenate, without affecting basal (unstimulated) levels. 
These investigators suggested that the inhibition of cAMP may 
represent a mechanism whereby morphine-like drugs exert their 
analgesic and other effects. 
Ho et al (1973) observed that intravenous (iv) or intraventricular 
administration of cAMP antagonizes morphine analgesia in tolerant 
and non-tolerant animals. Administration of cAMP or PDE inhibitors 
increases naloxone precipated opioid withdrawal jumping (Collier 
and Francis, 1975). 
Law et al (1981) observed that a number of opioids inhibit basal 
adenylate cyclase activity in the striatum. 
These findings suggested a role for cAMP in opioid 
neurotransmission. 
CyclicGMP 
Reports have indicated that opioid agents may increase cGMP levels 
in the striatum and in cultured cells (Racagni et ai, 1976; 
Minneman and Iversen, 1977) and in the plasma after icv 
administration (of morphine to mice) (Muraki et ai, 1982) . 
Dibutyryl cGMP has been reported to have analgesic effects in mice 
(Vocci etal, 1978). 
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Tolerance and Dependence 
Criteria for tolerance and dependence are set out in table 1. 
Tolerance is generally agreed to be a lessened response to a drug 
after its continued application. Dependence is more difficult to 
define , but it includes behavioural disturbances induced by 
withdrawal of certain drugs after their continued application . 
TABLE 1: Criteria for tolerance and dependence 
Tolerance 
Dependence 
1. Decreased response to the same dose of 
drug occurs. 
2. Increase in the dose of drug to yield the 
same response is required . 
3. Lessened response to the drug occurs after 
continued exposure. 
1 . 'Spontaneous' behavioural disturbance occurs 
when the drug is removed . This effect is 
suppressed by replacing the drug. 
2 . The specific antagonist of the drug displays 
an increased potency. 
3 . Administration of the specific antagonist 
precipitates the behavioural disturbance (1) 
Adapted and modified from Coll ier. 1981a and 1981b . 
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The opioids are drugs par excellence for illustrating the phenomenon of 
to l erance and dependence . Both in vitro (guinea pig ileum) and in vivo 
(self administration by animals) can be used to display these 
effects (Iversen and Iversen, 1975), and in vivo and in vitro 
techniques of dependence induction have many similarities (table 
2) . 
TABLE 2: Similar characteristics of dependence displayed in in 
vivo and in vitro studies 
1) Dependence is only manifested after a period of continued 
exposure to the opioid . 
2) Dependence is accompanied by tolerance to the acute 
effects of the opioid . 
3) Opioid withdrawal results in disturbances that can be 
suppressed by retreatment with the opioid . 
4) A similar disturbance can be elicited by treatment with an 
opioid antagonist. 
5) A specific as well as stereospecific opioid receptor is 
activated to produce opioid dependence 
Adapted from Collier elal. 1981a 
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The exact mechanisms of opioid tolerance and dependence have not 
been discovered . Two hypotheses have enjoyed much research, and 
these will be discussed below. 
The Ca2 + Hypothesis 
It has been suggested that the nociceptive state is regulated by 
the Ca2+ level within the neuron (West and Miller, 1983) with 
opioids having a primary action of lowering these levels. 
The lowering of these neuronal Ca2+ levels after acute 
administration is counterbalanced by a homeostatic mechanism which 
tends to reverse this effect. This process is cumulative, so that 
with chronic opioid administration there is a gradual accumulation 
of intraneuronal Ca2+, establishing a new elevated steady state for 
Ca2+. Lowering of this steady state becomes more difficult but 
maintenance of this steady state requires the opioid (dependence). 
An abstinence syndrome would then reflect sequestered Ca2+ release 
(normally inhibited by the opioid) or a supersensitive state due to 
the absence of the opioid. 
This hypothesis has been forwarded by Chapman and Way, (1980); Way 
and Rezvani, (1980); West and Miller, (1983). 
The cAMP Hypothesis 
Most of the data supporting a role for cAMP in opioid tolerance and 
dependence mechanisms have been undertaken in vitro using cultured 
hybrid neuroblastoma x glioma cells. The opioid receptors 
characterized on these cell lines are of the rr-type. 
Sharma et al (1975) reported that the addition of morphine to 
cultured cells results in a rapid inhibition of adenylate cyclase 
activity with a resultant decrease in cAMP. As the cells are 
incubated for longer periods with the opioid, a gradual return to 
the normal cAMP level occurs. Changes in enzyme (adenylate cyclase) 
activity parallel those of the cAMP levels, and this stage is 
likened to tolerance. A late compensatory increase of adenylate 
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cyclase activity occurs. Challenge with naltrexone or abrupt 
withdrawal of the opioid at this point generates high levels of 
cAMP - possibly reflecting dependence. With sufficient deprivation 
of the opioid, the cAMP levels and adenylate cyclase activity 
return to normal. 
The actual physiological significance of alterations in cAMP levels 
in opioid tolerance and dependence is not clear. 
A Unitary Hypothesis? 
It has been suggested that the Ca2+ and cAMP hypotheses may be 
related in some causal way. 
Reports have suggested that calmodulin (Ca2+-dependent regulatory 
protein) stimulates brain adenylate cyclase activity (Lynch et ai, 
1977) - suggesting that the reduced Ca2+ uptake induced by opioids 
could directly inhibit adenylate cyclase . 
The Endogenous Opioid System 
Opioid peptides are those 'naturally occurring peptides with 
opioid-like biological properties' (Morley, 1983) - the effects of 
which can be reversed by opioid antagonists. 
Five main groups of endogenous opioid peptides are characterized 
(adapted from Morley, 1983): 
1) The two pentapetides derived from pro-enkephalin A : -
methionine- and leucine-enkephalin . 
2) Peptides arising from enkephalin precursors these include 
[Met]-enkephalinyl-Arg-Phe and peptide E from adrenal pro-
enkephalin; and dynorphin, a-neo-endorphin and rimorphin arising 
from other pro-enkephalins. 
3) [:I-endorphin as well as related a-, ~, and a- endorphins 
arising from pro-opiomelanocortin. 
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4) Pronase resistant peptides e.g. ~-casomorphin 5 and 7 (found in 
bovine milk) and anodynin (found in blood). 
5) Other peptides - Opioid-like properties of these peptides do not 
arise from direct interaction with opioid receptors e.g. 
kyotorphin. 
The Enkepbalins 
The first opioipeptins to be discovered were the pentapeptides met-
and leu- enkephalin (Hughes. 1975). The first four amino acids of 
these peptides are similar in sequence (Try-Gly-Gly-Phe) and they 
differ only in the terminal carboxy amino acid residue. one being 
methionine and the other leucine . 
These enkephalins are derived from pro-enkephalins in the brain 
(Beaumont et al. 1982) and in the adrenal glands (Schultzberg ' et al. 
1978). Although met-enkephalin is contained in the terminal 
sequence of ~-endorphin. it cannot be derived from this endorphin. 
Enkephalins have a short half life in the body and can be degraded 
by a variety of peptidases (Hughes. 1975). In the guinea pig ileum. 
these enkephalins are about 3 times less potent than morphine. but 
60 to 80 times more potent than morphine in the mouse vas deferens. 
Enkephalinase inhibitors such as thiorphan have been synthesized -
and protect the enkephalins from degradation in vitro. as well as 
produce analgesia in vivo probably due to the inhibition of 
enkephalin degradation (Roques et al. 1980). Synthetic enkephalin 
analogues have also been developed. some of which are relatively 
resistant to enzymatic degradation and exhibit strong analgesic 
properties (Morley. 1980a; Pert eta~ 1976) . 
A few long enkephalinergic fibres do exist. however. these peptides 
are generally found primarily in interneurons with short axons 
(Frederickson. 1977). and immunoflourescence techniques have been 
used to localize them in the brain stem nuclei. periaqueductal 
grey, substantia nigra, medial lemniscus, hypothalamic nuclei 
(globus pallidus. nucleus accumbens) and the substantia gelatinosa 
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of the spinal chord (Atweh and Kuhar, 1983). 
Peripherally, they have been localized in the colon, myenteric 
plexus, adrenal glands, various autonomic nerves, the retina t the 
cochlea, and the peripheral ganglia (Toro and Way, 1983) . The 
physiological significance of this peripheral location is unknown . 
Evidence has been provided to suggest that catecholamines and the 
enkephalins may be stored in the same chromaffin vesicles in the 
adrenal glands and may be co-released on stimulation (Wilson el ai, 
1980) . 
Binding assays have localized the enkephalins to synaptosomal 
fractions characterisic of neurotransmitter substances 
(Frederickson, 1977) . The enkephalins probably act at postsynaptic 
sites making axo-dendritic or axo-somatic synapses on single 
neurons (Duggan, 1983) and their effects can be antagonized by 
naloxone (Frederickson and Morris, 1976) . 
The enkephalins elicit analgesic responses in mice (tail flick and 
hot-plate) - and a good correlation exists between the ability of 
analogues of enkephalin to produce physical dependence and their 
analgesic activity (Morley, 1983). 
Administration of enkephalins near the bodies of neurons in the 
dorsal horn of the spinal chord results in a naloxone reversible 
depression of cell firing (Duggan, 1983). This inhibitory action of 
the enkephalins could reduce the response to both noxious and non-
noxious inputs. 
A simple hypothesis has been advanced to describe the postsynaptic 
mode of action of the enkephalins. It suggests that the enkephalins 
are inhibitory transmitters, and the main inhibitory effect of the 
enkephalins is not on the excited neurons, but instead, on 
tonically active adjacent inhibitory interneurons (Duggan, 1983). 
Considerable processing of sensory information occurs within the 
retina and the olfactory bulb. The enkephalins act to increase the 
firing of the input neurons in these areas through a block of 
inhibition (Nicoll, 1980) . 
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Enkephalins have also been suggested to cause an excitatory effect 
on pyramidal cells when administered iontophoretically near 
hippocampal cells (Nicoll, 1980) . Most of the evidence on this 
effect favours disinhibition as being responsible for the 
excitation of the hippocampal cells (Duggan, 1983). Although these 
excitatory effects are said to resemble epileptiform spiking of 
neuronal activity, no evidence has been forwarded to link it to 
human epilepsy. Recent evidence has been forwarded suggesting that 
these endogenous pep tides may actually function to spontaneously 
arrest seizures (Tortella, 1988) . 
The functional and physiological significance of enkephalinergic 
action remains to be determined . It would appear that these 
peptides have a wider role in the body than just the control of 
nociception. 
The Endorphins 
In most cases, endogenous transmitters or hormones were discovered 
before their receptors were characterized (review; Offermeier and 
Van Rooyen, 1984), but this was not so for the endogenous opioid 
ligands . The opioid receptor was characterised in 1954 (Beckett and 
Casy) followed many years later by the discovery of the endogenous 
opioid ligands (Hughes, 1975; Li and Chung, 1975) . 
~-endorphin is a 31 amino acid peptide fragment of ~-lipotropin (Li 
and Chung, 1975) . It is derived via selective degradation of ~­
lipotropin, which also contains the sequence of ACTH and part of 
MSH (Toro and Way, 1983) . Immunohistochemical and biochemical 
techniques have localized ~-endorphin in the arcuate nucleus of the 
hypothalamus and certain limbic structures (Watkins and Akil, 1981) 
and also in the anterior pituitary lobe. 
~-endorphin exists in conjunction with ACTH and both may be 
concommitantly released (Guilleman et ai, 1977). This endorphin is 
also more resistant to enzymatic degradation than the enkephalins, 
and in most cases is more potent than these peptides (Delitala et 
ai, 1984). 
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Possible roles for the endorphins 
An explosion of research into the possible physiological functions 
of the endogenous opioids followed their discovery, and 
investigation in this field is still gaining impetus. Literature on 
possible roles for the endorphins increases at a rapid rate, and 
various excellent reviews are available on this subject (Morley et 
ai, 1983; Rodgers and Cooper, 1988; Clement- Jones and Rees, 1982) . 
Food intake 
Until comparatively recently, the pharmacology of food intake was 
largely concerned with "anorectic drugs" such as amphetamine, 
fenfluramine and other phenylethylamine derivatives. The endorphins 
however, slowly stepped onto the scene. 
Early work revealed that naloxone reduced food intake in prior food 
deprived rats, possibly due to a blockade of the endogenous opioid 
system and food-deprivation resulted in a decrease in hypothalamic 
l3-endorphin concentrations (Gambert et ai, 1980) . It was also 
observed that the pituitary glands of obese mice and rats contained 
more l3-endorphin than those of lean littermates (Gambert et al 
1980) . This led to speculation that the release of excess endorphin 
might be responsible for overeating in obese animals. 
Injection of naloxone into the hypothalamic nuclei and the globus 
pallidus results in a reduction in the feeding response (Gosnell et 
ai, 1986), suggesting a possible modulation of the feeding response 
by the opioid system at this level . 
Naloxone may also reduce feeding in humans . Atkinson (1984) 
reported that naloxone (15 mg) reduced food intake in 8 out of 14 
obese humans, but did not affect food intake in 5 out of 5 lean 
humans . 
Drinking and Water Balance 
Maickel et al (1977) first observed that naloxone and nal trexone 
reduced the ingestion of water by thirsty rats. This antidipsogenic 
31 
effect of the opioid antagonists was speculated to be mediated 
through specific opioid receptors, although no clear-cut data is 
available to point to one opioid receptor as opposed to another 
being responsible for this effect. 
It is known that morphine has antidiuretic effects, and recent 
evidence implicates ~-endorphin in this reportedly ~-receptor 
mediated opioid action (Rodgers and Cooper, 1988). 
Although an exact 
elucidated, it has 
mechanism for 
been suggested 
this action has 
tha t the opioids 
not been 
function to 
facilitate mechanisms that minimize water loss. 
Sexual Behaviour 
Male heroin addicts commonly show symptoms of sexual dysfunction 
(Cushman, 1981) and morphine abstinence syndrome is associated with 
erection, spontaneous ejaculation and orgasm (Cushman and Dole, 
1973). 
Most studies on the role of the endorphins in sexual behaviour has 
been carried out on male rats, however, some investigations have 
been carried out on females. 
Administration of ~-endorphin (1 ~g intraventricularly) results in 
an inhibition of mounting behaviour in rats, with a resultant 
reduction in the number of intromissions (Meyerson and Terenius, 
1977). This inhibitory effect of the opioid on copulatory behaviour 
is prevented by the opioid antagonist naltrexone . Higher doses of 
endorphin (6 ~g) caused a complete cessation of copulatory 
behaviour in rats. 
The occurrence of lordosis (concave back flexion, neck extension 
and lateral tail deviation) is considered to be 
degree of sexual receptivity in 
Intracerebroventricular (icv) administration 
related to the 
female rats . 
of ~-endorphin 
suppresses lordosis in rats, probably via an action on ~-opioid 
receptors (Sirinathsinghji, 1984). 
Systemic administration of naloxone was observed to increase 
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copulatory behaviour in otherwise sexually inactive male rats 
(Gessa et ai, 1979) probably suggesting that sexual impotence in 
rats may in part be due to endorphinergic hyperactivity in the CNS. 
These findings are important in that possible therapeutic value 
might be obtained from the use of opioid agonists and antagonists 
to modulate sexual hyperactivity or impotence in man. 
Social Interaction and Attachment 
The young of many mammalian species call persistently when 
separated from their mothers. Centrally administered a-, ~-, and 1-
endorphins were observed to reduce the calling of chicks, with ~­
endorphin having the most potent effect, suggesting that this 
opioid influences separation-induced distress (Benton and Brain, 
1988) . 
The young mammal also has a strong urge to frolic with its 
littermates, and naloxone decreases this playful activity (Beatty 
and Costello, 1982). 
Social isolation is known to decrease opioid receptor populations 
in many brain regions (Benton and Brain, 1988) . Group housed rats 
show an increased tendency to jump and suffer from diarrhoea on 
precipitation of the morphine withdrawal syndrome with naloxone 
when compared to rats housed in isolation. 
A predominant characteristsic of autistic children is a failure to 
seek company . High brain opioid activity has been suggested to be 
responsible for this effect (Panskepp, 1979). 
Imbalances in the opioid system may thus be suggested to be 
responsible for some emotional disorders . 
Learning and Memory 
Central administration of ~-endorphin was found to impair 
performance in rats tested in assays for memory. Also, this peptide 
impairs the development of shock-induced fighting in rats and 
slowed down the extinction of the pole jumping avoidance response 
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(Benton and Brain, 1988). 
Endogenous release of ~-endorphin also occurs when rats are exposed 
to a novel environment, but no such increase occurs on subsequent 
exposure to the same environment. Stein and Belluzi (1978) 
suggested that activation of the opioid system after a learning 
procedure may facilitate memory consolidation. 
Exploration and Activity 
Katz (1980) reported that the Straub tail response (typical sign of 
opioid activation) could be elicited by a variety of environmental 
manipulations including stress and exploration. The Straub tail 
response occurred in conjunction with exploratory activity and was 
not present during normal locomotor activity. This effect was 
reduced by naloxone. 
Pharmacological blockade of opioid receptors (with naloxone) 
interferes with the initial expression of exploratory activity. 
Grevert and Goldstein (1977) observed that naloxone (10 mg/kg) 
increases the latency for mice to enter a novel dark environment 
significantly, suggesting an opioid-exploratory activity link. 
Naloxone (0.5 - 2 mg/kg) decreased motor activity in some autistic 
children, as well as improved their clinical status - suggesting, 
once again, a role for the endogenous opioid system in some aspect 
of autism. 
Hormones 
The endogenous opioid peptides are possibly involved in 
neuroendocrine function. ~-endorphin administered icv to rats 
stimulates growth hormone (GH) and prolactin release (Schmauss and 
Emrich, 1988) and naloxone decreases plasma levels of these 
hormones (Grandison and Guidotti, 1977). 
In man, naloxone was observed to significantly elevate serum 
cortisol, ACTH, LH and follicle stimulating hormone, with no effect 
on basal GH and prolactin levels. 
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Activation of different receptor subtypes have been suggested to be 
involved in the opioid-modulated regulation of pituitary hormone 
release. 
Shock and Trauma 
Plasma j3-endorphin levels are increased significantly after shock 
and may probably contribute to shock-induced hypotension. This 
effect can be reversed by naloxone (Toro and Way, 1983) 
A role for the opioids in modulating microcirculation in hamsters 
has been suggested (Akil, 1984) . The beneficial action of naloxone 
is possibly due to the blockade of the opioid peptide-induced 
circulatory vasodilation, thus allowing the blood pressure to 
increase. 
Opioid antagonists could thus play a beneficial role in the 
clinical management of shock . 
ANALGESIA 
The opioid drugs and their analogues are perhaps the most potent 
analgesic agents yet discovered. The conservatism in our search for 
newer analgesic agents is made more obvious by the fact that the 
synthetic opioid analgetics still exhibit a spectrum of 
pharmacological and clinical actions quite similar to that of 
morphine, of which the most unwanted side-effects (tolerance , 
dependence, addiction liability) still prevail . The agonist-
antagonist synthetic agents ( eg buprenorphine) have found some 
clinical use, but are still not the optimum agents for pain 
relief. 
This could, perhaps, be due to a lack of knowledge on the exact 
nature of the pain controlling mechanisms. Much has been discovered 
regarding the nature of the pain controlling mechanisms since the 
discovery of the endogenous opioid peptides, but still , the 
knowledge obtained thus far is incomplete. 
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Various experimental assays have been designed in laboratories to 
measure the analgesic activity of drugs (see table 3) . These 
methods have enjoyed different degrees of popularity, depending on 
the type of compound being assayed for analgesic activity, and in 
some cases the cost effectiveness of the design. 
TABLE 3 DESCRIPTION OF VARIOUS ANALGESIC ASSAYS 
Assay 
Rat tail flick 
Mous e tai l flick 
Rat tail immersion 
Rat hot plate 
Mouse writhing 
Rat air writhing 
Guinea pig EDTA test 
Mouse tail clamp 
Rat inflamed paw 
Rabbit tooth pulp 
Monkey shock titration 
Rat shock titration 
Dog Bradykinin 
Mouse Ultrasonic 
Adapted from Lednicer. 1982 
Stimulus 
Thermal 
Thermal 
Thermal 
Thermal 
Response 
Chemical irritation 
Physical irritation 
Chemical irritation 
Mechanical pressure 
Mechanical pressure 
Electrical 
Electrical 
Electrical 
Pain mediator 
Ultrasonic 
SP - spi nal reflex. eM - complex motor, V • vocalization, LP • lever press 
SP 
SP 
SP 
CM 
CM 
CM 
V 
CM 
CM 
CM 
LP 
V 
V +CM 
CM 
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Historically, two main theories existed to explain the sensation of 
pain: the specific theory and the intensive theory (Lednicer , 
1982) . 
SPECIFIC THEORY 
Pain is transmitted from peripheral 
pain receptors to a pain centre in 
the brain 
v 
Pain is a separate sensory modality 
INTENSIVE THEORY 
Pain results from an over-
stimulation of other 
sensory modalities such 
as touch, sight and sound 
v 
Pain is a sensation 
attributed to a central 
summa tion of sensory ·input 
Melzack and Wall (1965) later proposed a new theory in an attempt 
to unify these two theories - the gate control theory. 
Very, simply, this theory suggests that pain impulses are conveyed 
by specific groups of nerve fibres. The activity of these fibres 
are modified by other fibres conveying non-noxious impulses until a 
critical level of stimulus intensity is reached. At this point the 
noxious stimuli are projected rostrally, and pain is perceived . 
This theory thus allows for peripheral specificity, central 
summation and psychological alteration of the pain experience. 
Peripheral Pain Pathways 
Pain sensitive receptors, termed nociceptors, appear as free nerve 
endings in the periphery . Small diameter slow conducting (AB) and 
unmyelinated (C) fibres that can be stimulated by thermal, chemical 
and/or mechanical cutaneous stimulation are found peripherally. Not 
all AB and C fibres are nociceptive in nature (deStevens 1965, 
Lednicer, 1982). 
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AS fibre activation produces a sharp rapid pain sensation, whereas 
C fibre activation evokes a dull, chronic pain - described by some 
investigators as a Jirstpain and a second pain . 
It has also been observed that stimulation of large diameter pain 
fibres (All and A(3) also evokes pain sensation in man (Willer et ai, 
1980) and this has been suggested to be responsible for the 
persistence of pain in certain diseases . 
Spinal Pain Pathways 
The first site of synapse of the peripheral pain perceiving neurons 
is the dorsal horn of the spinal chord, the general anatomy and 
physiology of which have been described and are still accepted 
(Rexed, 1954; Wall, 1967). The dorsal horn has been differentiated 
into six distinct laminae on a functional basis (Wall, 1967). 
The substantia gelatinosa (SG) in laminae 11 contains many neurons. 
Substance P, enkephalin, dynorphin, cholesystokinin, and 
neurotensin are some of the peptides found in these neurons (Gibson 
et ai, 1981; Hunt et ai, 1981), as well as a large population of GABA-
ergic neurons which may possibly control the primary afferent 
, 
fibres presynaptically (Basbaum etal, 1981) . 
Substance P (SP), the most suitable candidate for neurotransmission 
for primary afferent nociceptive fibres, is found in high 
concentrations in the superficial laminae of the dorsal horn 
(Takahashi and Otsuka, 1975). 
Opioid analgesics have been observed to produce analgesia as well 
as inhibit noxious dorsal horn neuronal activity in normal as well 
as spinalized animals (LeBars et ai, 1975). This spinal modulation of 
the analgesic response by the opioid drugs (figl .3) has been 
proposed as a presynaptic inhibitory process in which small 
interneurons containing enkephalins inhibit both the activity and 
release of SP from the small diameter afferent fibres (Jessel and 
Iverson, 1977). 
ASCENDING 
PAIN IMPULSES 
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ENK SP 
NOXIOUS 
INPUT 
Fig 1.3: Presynaptic inhibition of Substance P (SP) containing 
primary afferents by enkephalinergic (ENK) 
interneurons. 
Proposed by Jessel and Iversen. (1977) . 
Ascending Pain Pathways 
The most prominent pathway via which noxious information travels to 
the supraspinal pain perceiving areas is the spinothalamic tract, 
which in higher animals consists of the neospinothalamic tract and 
the paleo spinothalamic tract (see fig1.4). 
The neospinothalamic tract consists primarily of rapidly conducting 
myelinated fibres. These fibres first synapse with cell bodies in 
the thalamus (Mehler, 1969) . 
The paleospinothalamic tract follows a similar pathway, but 
synapses at various levels of the brain stem reticular core and 
innervates diffuse supraspinal structures (Mehler, 1969) 
Other ascending pathways including the spinoreticular tract, the 
dorsal columns, the spinocervical tract and the propriospinal tract 
have also been suggested to play partial or supporting roles in 
conveying noxious information to higher centres in the eNS 
(Lednicer, 1982). 
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Supraspinal Pain Pathways 
Most of the neospinothalamic, spinocervical and postsynaptic dorsal 
column fibres terminate in the ventrobasal thalamus, which relays 
information to the somatosensory cortex (Lednicer, 1982) . 
The posterior thalamus also acts as a nociceptive relay station, 
and electrical stimulation of this area produces pain in humans 
(Hassler and Riechert, 1959). 
The nociceptive information received by the medial thalamus (MT) 
arises mainly from the paleospinothalamic tract , and lesions in the 
area of the MT have been used to alleviate pain in man (Lednicer, 
1982 ) . 
The brain stem reticular formation is densely innervated by 
spinoreticular and paleo spinothalamic fibres and has efferent 
connections to the thalamus. The nucleus reticularis 
gigantocellularis is excited by and responds to noxious somatic 
stimuli (Mohrland and Gebhart, 1980) . Enkephalinergic terminals and 
opioid receptor binding sites have been identified in the 
mesencephalic reticular formation (Atweh and Kuhar, 1977) providing 
good evidence that opioid-induced analgesia may partly arise from a 
possible supraspinal inhibition of noxious stimuli . 
Endogenous opioid peptides and opioid receptor binding sites have 
also been identified in the cerebral cortex (Pert and Snyder, 
1983). Although it has been suggested that the somatosensory cortex 
is unlikely to be a pain modulating centre (Lednicer, 1982), it 
could very well be involved in integrating noxious information with 
other somatosensory information. 
Descending Pain Pathways 
The first region to be implicated in the modulation of pain was the 
periaqueductal gray (PAG) (Reynolds , 1969), yet its intrinsic 
circuitry is still largely unknown. 
Focal stimulation of the PAG produces profound analgesia in many 
VB 
MT 
PO 
.4 o· 
NST PST 
.. 
Fig 1.4: The two divisions of the spinothalamic tract: the 
neospinothalamic tract (NST) and the paleospinothalamic 
tract (PST). MDRF : medullary reticular formation, MRF: 
mesencephalic reticular formation, po: posterior 
thalamus, MT: medial thalamus, VB: ventrobasal thalamus . 
Adapted from Lednicer, 1982. 
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species, including man (Hosobuchi, 1979). In order to initiate 
descending pain control mechanisms, excitation of the PAG output 
neuron is required (Basbaum and Fields, 1984). Nicoll et aI (1980) 
have have suggested that opiate actions inhibit target neuron 
activity, and it could thus be suggested that these drugs do not 
act directly on the PAG output neuron. However, a vast number of 
enkephalinergic neurons have been observed presynaptic to dendrites 
in the PAG (Moss and Basbaum, 1983), and the analgesia produced by 
activation of the output neuron could be attributed to an 
inhibition of inhibitory interneurons by this or other opioid 
peptides . 
The PAG efferrent fibres project to the nucleus raphe magnus (NRM), 
the axonal fibres of which project to the dorsal horn of the spinal 
chord via the dorsolateral funiculus (Basbaum and Fields, 1984). 
Many peptidergic neurons have been demonstrated in the NRM, 
including enkephalin, somatostatin, and substance P neurons 
(Basbaum and Fields, 1984). Two putative neurotransmitters can 
possibly co-exist in the same neuron (Hokfelt et at 1980) and in the 
NRM serotonin and SP coexist in the raphespinal neurons, suggesting 
that SP may act as a neuromodulator. A reduction of the serotonin 
tone in the NRM or the PAG leads to an inhibition of the analgesic 
effects of stimulation in these areas, suggested by the ability of 
serotonin antagonists to block this stimulation produced analgesia 
(Satoh etal, 1980) . 
Microinjection of the NA cr-adrenoreceptor antagonist, phentolamine, 
into the NRM produces a methysergide (administered intrathecally) 
rev ersible hypoalgesia (Hammond et ai, 1980), suggesting the possible 
presence of a tonic NA-mediated inhibition of the 5HT neurons in 
this bulbar nucleus. 
A possible role for pain modulation by cholinergic agonists has 
been surmised by the ability of iontophoresis of ACh, and injection 
of carbachol, into the NRM to produce analgesia (Basbaum and 
Fields, 1984). The role of the locus coeruleus (LC) in the 
modulation of nociception is not entirely clear . Morphi ne is known 
to inhibit LC neuronal activity (Aghajanian, 1978), suggesting that 
this inhibition may possibly accompany analgesia. 
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Thus it can be seen from the above that there are many sites within 
the eNS and the periphery at which nociceptive information may be 
modulated. 
Although it has been a matter of controversy, evidence is 
accumulating that the neurotransmitter at the supraspinal site of 
synapse for ascending pain fibres is the undecapeptide Substance P 
(Jessel et ai, 1979). It could thus be assumed that inhibition of the 
neurotransmitter function of Substance P would yield analgesic 
effects. In fact, capsaicin, a pungent compound derived from red 
pepper. causes a long-lasting depletion of SP with a resultant 
analgesia (Yaksh et ai, 1979). This compound is, however, toxic to 
sensory nerves (Nagy et ai, 1980) and is thus not therapeutically 
useful. In this regard it has been speculated that less potent 
Substance P depletors or the development of SP receptor blockers 
may yield important clinical advances especially in the treatment 
of chronic pain . 
Although the exact neural and neurochemical mechanisms of the pain 
pathway have not been fully elucidated , our knowledge and 
understanding of the physiology of pain modulation has increased 
significantly since the time when Melzack and Wall (1965) proposed 
the gate control theory of pain. One important observation of this theory 
however, was the presage that descending modulatory controls over 
the activity of spinal chord pain transmission neurons existed. 
Several endogenous systems may possibly modulate nociceptive input 
(Basbaum and Fields, 1984; Mayer and Price, 1976; Watkins and 
Mayer, 1982) and neurotransmitters and hormones involved in the 
neuronal circuitries underlying analgesic mechanisms are being 
elucidated. These endogenous systems may be activated by many 
environmental stimuli with varying degrees of complexity. 
Since the initial description by Reynolds (1969) of the phenomenon 
of stimulation produced analgesia, a wide variety of environmental 
factors have been found to elicit analgesia in rodents (Table 4). 
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TABLE 4: DESCRIPTION OF VARIOUS ENVIRONMENTAL FACTORS ELICITING 
ANALGESIA IN RODENTS 
Brain stimulation 
2-Deoxy-D-glucose 
Copulation (males) 
Food deprivation 
Social conflict 
rlStress U odours 
Heat exposure 
Body pinch 
Insulin 
Novelty 
Irradiation 
Predation 
Tail pinch 
Tail pressure 
Adapted from Rodgers and Randall. 1988 
Centrifugal rotation 
Classical Conditioning 
Electroconvulsive shock 
Restraint/ immobilization 
Vaginal stimulation 
Social isolation 
Centrifugal rotation 
Different environmental manipulations can selectively activate 
opiate as well as non-opiate analgesia systems (Watkins and Meyer. 
1982). A complex picture of at least four endogenous pain 
inhibitory systems (doubly dissociated on neural/hormonal and 
opiate/nonopiate dimensions) is beginning to emerge and the diverse 
analgesia producing environmental stimuli can be categorised into 
these inhibitory systems (see table 5). The opioid - sensitive forms 
of stress-induced analgesia can be differentiated from the non-
opioid forms depending on certain factors . These include cross-
tolerance to morphine, antagonism by naloxone, and determination of 
opioid peptide release after stress exposure . 
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TABLE 5 : STIMULI ACfIVATING ENDOGENOUS PAIN INHIBITORY SYSTEMS 
Neural-opioid 
Brief front paw shock 
Conditioning to footshock 
Systemic morphine 
Intracerebral morphine 
Intrathecal morphine 
Neural non-opioid 
Brief hind paw shock 
Brief four paw shock 
2-Deoxy-D-glucose 
Unknown opioid 
Transcutaneous nerve stimulation 
(TNS) - low frequency, high 
intensity 
Modified from Watk ins and Mayer (1982) 
Hormonal oplold 
Acupuncture 
Prolonged shock to all 
four paws. 
Immobiliza tion 
Hormonal non-onioid 
Cold water swims 
Insulin 
Unknown non-opioid 
TNS - high frequency, low 
intensity 
Hypnosis 
The pituitary-adrenal axis plays an important role in the adaptive 
response to stress (Selye, 1974). Terman et ai , (1984) observed 
that hypophysectomy attenuates only the opioid form of stress -
induced analgesia. Removal of the pituitary gland, however, also 
compromises the activity of the adrenal glands - which are known to 
secrete enkephalin-like peptides in response to stress . Terman et 
ai , (1984) noted that adrenalectomy too blocked only the opioid 
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form of stress-induced analgesia, probably due to the loss of the 
enkephalin-like peptides from the adrenal medulla. 
One of the most commonly used stressors, restraint, involves both 
somatic and emotional components and is also associated with 
analgesic mechanisms . The technique involves painlessly forcing an 
animal into a defined posture, so making it very difficult for the 
animal to perform normal body and limb movements . 
Altered levels of p-endorphin immunoreactivity in the brain, blood 
and pituitary gland and opioid-like alterations in animal behaviour 
after exposure to restraint immobilization suggests that this 
process activates the endogenous opioid system (Porro and Carli, 
1988) . 
Rats restrained in a plexiglass chamber show a significant 
analgesia on the hot plate 30 minutes later (Amir and Amit, 1978) 
possibly mediated by endogenous opioids. Pretreatment with 
naltrexone (1 mg/kg bw) before immobilization is able to prevent 
the onset of immobilization-stress-induced analgesia (Kelly and 
Franklin, 1985). Vaswani et al (1988) have observed changes in 
opioid peptide levels in the CNS and the plasma, suggesting an 
activation of this system in cold swim stress . In human beings, it 
was observed that cold stress (submerging foot in ice cold water 
for as long as it was bearable) significantly increased the pain 
threshold to an aversive electric shock (Jungkunz aal, 1983). 
Bhatacharya et al (1978) observed a time-related (1 4 hrs) 
inc rease in tail flick latencies in completely immobilized rats, 
and showed that serotonin and prostaglandins might also mediate 
this effect . Kelly and Franklin (1985) observed that pre-loading a 
rat with valine or tyrosine (and thus inhibiting tryptophan uptake 
across the blood brain barrier) reduces immobilization-induced 
analgesia, suggesting that serotonin is involved in this mechanism. 
The muscarinic antagonist, scopolamine, reduces only the opioid 
form of analgesia, whereas methylscopolamine (peripherally active) 
has no such effect (Terman et ai, 1984) further implicating an 
interaction between the central cholinergic and opioid systems in 
intermittent footshock-induced analgesia. 
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The cerebral renin- angiotensin 
innnobiliza tion-induced analgesia 
system has 
(Haulica 
been implicated 
el al,1986) and 
in 
is 
suggested to be mediated by the release of endogenous opioids and, 
possibly, pineal gland activation. Food-deprived mice innnobilized 
for 15 minutes show a stress-induced increase in salt intake, and 
this effect is reversed by naloxone (0.01 mg, 1 mg, and 0.1mg/kg 
bw) in a dose dependent manner (Kuta el ai, 1984). These 
investigators suggest that stressors activating the endogenous 
opioid system lead to an increase in salt intake. 
A variety of stressful stimuli are known to activate noradrenergic 
neurons in many brain regions (hypothalamus, amygdala and thalamus) 
in animals (Tanaka et ai, 1983). Endogenous opioid peptides are also 
released in these regions, which are closely related to 
emotionality. Tanaka et al (1983) have observed that morphine (6mg/kg 
bw sc) attenuates stress induced increases in NA release in these 
brain regions in rats. They also observed (1988) that naloxone 
5mg/kg bw sc) enhances stress induced increases in NA in the early 
periods of innnobilization stress. They suggest that this is due to 
a blockade of endogenous opioid receptors by naloxone thus 
preventing the activity of endogenous opioid peptides released on 
exposure to stress (Porro and Carli, 1988). 
Using in vivo autoradiography, it was observed that significant 
alterations in opioid levels in the brain occurred in stressful 
conditions, suggesting a release of the endogenous opioids (Seeger 
et ai, 1984) Also, it was found that opioid receptors exist on NA-
containing nerve terminals (Llorens el ai, 1978) and that 
stimulation of these opioid receptors results in an inhibition of 
NA release (Arbilla and Langer, 1978) . Abercrombie and Jacobs 
(1988) have observed a stress-induced increase in the noradrenergic 
activity of locus coeruleus neurons in cats, and this effect was 
potentiated by naloxone (1mg/kg bw iv) administration. This dose of 
naloxone also increased signs of distress in restrained cats. 
Immobilization has been reported to selectively alter DA synthesis 
and release in certain brain regions (DeSouza and Van Loon, 1986). 
Repeated innnobilization enhances apomorphine-induced stereotyped 
behaviour in mice, possibly due to a stress induced modification of 
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sensitivity of DA-ergic activity. 
Acute restraint stress has been observed to increase ACh release, 
as well as enhance high affinity choline uptake in the hippocampus 
and the frontal cortex (Gilad et ai, 1983). 
Serotonin turnover, manifested by 5-HlAA levels, as well as 
tryptophan levels in the brain, are increased after acute 
immobilization (Curzon et ai, 1972). This effect is abolished with 
repeated immobilization (Kennet dal, 1985). 
Tonic immobility (TI) is another manifestation of exposure to 
restraint stress, and can be induced by a short period of restraint 
in the supine and inverted position (Porro and Carli, 1988). 
Analgesia is known to occur during TI . Morphine potentiates the 
duration of TI, and this effect can be abolished by naloxone 
(Peters and Hughes, 1978) . Stress is also known to facilitate 
opioid-induced catalepsy in the rat (Katz, 1980). 
Serotonin may modulate the mechanisms involved in the control of 
the duration of TI (Farabollini et ai, 1984) and conflicting 
evidence exists for a role for ACh. Pineal melatonin has also been 
observed to increase the duration of tonic immobility in chickens 
at low doses (0.4 mg/kg) - (Hennig et ai, 1980a). Administration of 
methysergide completely abolishes this effect on melatonin. These 
investigators (1980b) suggest that melatonin exerts this effect by 
a direct action on serotoninergic mechanisms in the CNS, and that 
methysergide acts to reduce the duration of tonic immobility by 
inhibiting the conversion of 5HT to its metabolites, one of which 
is melatonin. 
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STRESS 
Restraint and/or immobilization has been used for many years to 
investigate physiological, pathological and pharmacological effects 
of stress. Scientists from a wide variety of disciplines study the 
stress syndrome and its implications for human health and disease. 
The very diversity of the topic of stress becomes evident in the 
difficulty of finding an apt definition for it. The term stress was 
first used in the field of physics describing strain, force or 
pressure applied to a system. It was first used as a medically-
related term by Selye, who noticed that a wide range of physical 
ailments had common symptoms; such as muscular weakness, body pain, 
elevated blood pressure and a lethargic attitude (Selye, 1974). He 
called this the 'syndrome of just being sick.' 
He defined stress as the 'non-specific response of the body to any 
demand made upon it' and this definition includes a physical as 
well as a psychological component. 
For any stimulus to evoke a stress response, it must first be 
received by the sensory receptors of the parasympathetic nervous 
system (PNS). These receptors then send impulses toward the brain, 
and once in the CNS they diverge from the main ascending pathways 
to the neocortex where an interpretive analysis of the stimulus is 
undertaken. These interpretations are then transferred to the 
limbic system (Everly and Rosenfeld, 1981).If they are perceived as 
aversive, or challenging, emotional and physiological arousal will 
result. 
The pituitary and adrenal glands are important in the physiological 
responses to stress. In acute stress situations, the adrenal 
glands provide a protective action, and adrenalectomy increases the 
severity of the response to stress (Brodie and Hanson, 1960; Selye; 
1946). Stressful stimuli activate sensory centres in the brain, and 
via mediation by the hypothalamus, ACTH is released by the 
pituitary into the bloodstream. The adrenal glands respond to the 
stress-induced release of ACTH by secreting corticosteroids. These 
hormones then mobilize energy stores, and make high energy glucose 
available to the body to combat the stress. 
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The General Adaptation Syndrome (GAS) has been described by Se l ye 
(1946). It is a triphasic phenomenon, the first of which is the 
alarm phase in which the body is exposed to the stressor and 
responds by activating its defense mechanisms . The pituitary-
adrenal axis is activated as the body attempts to combat the shock 
of the stressor . This is followed by the stage of resistance , in 
which the body tries to maintain a homeostatic balance in the 
presence of the stressor . A stage is reached when all the ' adaptive 
energy" is depleted, and the body enters the stage of exhaustion 
(Schaffer 1982). 
The stress response may result from the activation of one or more 
of the following mechanisms : 
1) Neural innervation via SNS or PNS 
2) Fight or flight response 
3) GAS 
These mechanisms are described in fig (1.5) . 
Chronic elicitation of the stress response can result in end organ 
dysfunctions and pathologies that can manifest themselves as 
structural changes in the end organ tissues. Various stress-related 
disorders are known to occur in man . The precise nature and 
mechanism/ s of the human stress reponse have yet to be defined 
conclusively. 
Various end organs may be affected by psychophysiological arousal, 
depending on (according to Lachman, 1982) : 
1) Predisposition of the organ due to genetic factors. 
2) The intensity and duration of involvement of the organ in 
response to arousal in these conditions 
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Some of the most commonly encountered stress-related diseases are: 
1) GIT disorders ego peptic ulcer and ulcerative colitis . The 
pathogenesis of stress ulceration seems to involve a combination of 
emotional and genetic factors, however, the specific causal 
mechanisms involved in peptic ulceration are not clearly known. 
2) Respiratory disorders such as allergy are aggravated by 
stressful situations. Hyperventilation is also a manifestation of 
acute stress. Periodic bursts of hyperventilation that are not 
diagnosed at an early stage, later present as various vague 
symptoms including nausea I aches and pains. vomiting, and chest 
pains (Everly and Rosenfeld, 1981). 
3) Cardiovascular disorders such as hypertension and migraine are 
potentiated by stress. The cardiovascular system is thought to be 
the prime target end-organ for stress. 
4) Tension headaches and lower back pain these are common 
symptoms of stress-related musculoskeletal disorders - and occur as 
a result of prolonged contraction of the muscles of the back, and 
the head and neck area. 
5) Skin disorders such as acne, eczema, urticaria and psoriasis are 
common stress-related disorders. 
6) Thymus involution and 1ymphopaenia have also been associated 
with stress. 
7) Various psyhco10gical disturbances have been associated with 
chronic stress, the most common of which is anxiety. 
The desire for instant relief from various ailments often leads man 
to a pharmacological solution. Various pharmacological agents are 
used to treat the pathological conditions related to stress . These 
treatments are reserved for chronic elicitations of the stress 
response . The drugs used include: 
. 1) The barbiturates, in small doses, to counter restlessness and 
agitation. 
2) The benzodiazepines 
inhibition and isolation. 
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to counter stress-related anxiety, 
3) Antihistamines are sometimes used for their sedative side-
effects to counter stress-induced insomnia. 
4) ~-adrenergic receptor blockers - to counter peripheral autonomic 
symptoms. These drugs are not officially appproved for this 
particular use. 
5) Tricyclic antidepressants - for stress-related depression. 
6) Phenothiazines - for individuals in whom anxiety forms part of a 
more hyperactive, distractible, and disorganized picture. 
Pharmacological treatment can also be used to treat other 
manifestations of the stress response, eg analgesics for lower back 
pain and tension headache, and antacids for gastric ulcers. 
The obvious solution would be to actually treat the cause of the 
stress before it reaches pathological proportions. Relaxation 
techniques, meditation, breathing exercises and neuromuscular 
relaxation exercises are useful techniques that can be used 
clinically. Recommendations about dietary requirements are also 
important. 
A holistic approach to the treatment of stress is perhaps the best 
clinical solution, so as to ensure psychological as well as 
physiological therapy. 
Gastric ulceration is a very common manifestation of exposure to 
excessive stress (Kleiman et ai, 1988). Acute gastric lesions occur 
in patients with severe burns, intracranial lesions, myocardial 
infarctions, and after surgery (Rhodes, 1972; Kleiman etal, 1988). 
Stress (restraint, immobilization) is a simple, rapid, effective, 
non-surgical means of inducing gastric erosions in the experimental 
animal (Brodie and Hanson, 1960). When subjected to abnormally high 
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physiological demands, acute superficial inflammatory lesions may 
occur in the proximal (acid/pepsin) area of the stomach (Kleiman et 
m, 1988). This technique is often used by researchers in the field 
of gastrointestinal drugs to screen new compounds . 
Various restraining techniques are used to induce gastric stress 
lesions. These include wrapping the animal in plaster of Paris, 
enclosing it in an window screen envelope, reducing the cage 
volume, and using special metal tube cylinders (Pare and Glavin, 
1988) over varying time spans. 
The rapid production of experimental ulcers is facilitated by a 
pre-stress starvation period (Brodie and Hanson, 1960) and exposure 
to cold (Senay and Levine, 1967). Both stressors reduce the 
duration of restraint required to induce ulcers. 
Various physiological and biochemical changes (central and 
peripheral) occur in response to stress. These include changes in 
gastric secretion and motility, increases in heart rate and blood 
pressure (Vogel, 1987) elevated plasma corticosterone/cortisol, 
fatty acids and glucose levels (Pare and Glavin, 1988) and 
accelerated NA and DA turnover in many brain regions (Glavin et ai, 
1983). Beattie (1978) observed that cold and restraint stress 
increases the volume of urinary output (with increased K+ and urea 
excretion) and plasma urea in rats. Marked increases in 
corticosterone and thyroxine levels, and a reduction in insulin 
levels were noted, as well as leucopaenia and lowering of blood pH. 
The exact reasons for stress ulcer formation have not been 
adequately explained. Various factors contribute to the maintenance 
of the physical integrity of the gastric mucosa and protect it from 
the adverse effects of back-diffused Hydrogen ions. These include 
adequate mucosal blood flow (Hase and Moss,1973), an adherent 
mucous layer (Kleiman et ai, 1988), mucosal bicarbonate secretion 
(Kleiman et ai , 1988) and the presence of prostaglandins (Szabo and 
Szelenyi, 1987) . 
The prostaglandins (PG's) are widely distributed im mammalian 
tissue and body fluids. They have been found in, amongst other 
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areas t the kidneys, eyes, spleen, lungs t thymus t adipose tissue t 
thyroid gland, uterus, adrenal glands, and in the stomach (Curtis-
Prior, 1976). PG's have been proposed to have cytoprotective 
properties - protecting the gastric mucosa without altering gastric 
acidity, by promoting mucosal repair (Jacobsen, 1986; Curtis-Prior, 
1976). Exogenous administration of PG's protect the gastric mucosa 
of rats and humans against the effects of aspirin, ethanol and 
acidic solutions (Robert, 1979). 
The beneficial mechanism of action of the PG's in mucosal 
protection appears to be multifactorial, including increased mucous 
production, increased mucosal cell integrity (Robert, 1979) and 
increased mucosal perfusion ( Whittle, 1977) . 
The origins of gastric stress erosions can be attributed to many 
causes. The removal of mucous from the gastric mucosa is followed 
by the development of lesions, providing evidence for the 
beneficial role played by mucous in gastric cytoprotection 
(Turnberg, 1985). The integrity of the epithelial cells also plays 
a role in the resistance of the mucosa to various injurious agents 
- with rapid cell regeneration strengthening the mucosal barrier 
(Svanes et al 1982) . 
Among other possible factors is the observation that a causative 
relationship exists between the mucosal microcirculation of the 
stomach and the formation of lesions (Hase and Scarborough, 1973). 
Gastric mucosal blood flow is essential for the maintenance of the 
integri ty of the gastric mucosal barrier. It has been suggested 
that the extent of injury to the gastric mucosa is directly related 
to the severity of the ischemia (Kleiman et ai, 1988). It has been 
shown that the rat stomach generally has the same vascular 
arrangement as that of the human stomach (Arabehety et ai, 1959). 
These investigators postulated that one of the initial direct 
responses to stress was a generalized mucosal ischemia, becoming 
localized as the stress persists. Hase and Moss (1973) explained 
that this localized mucosal ischemia gives rise to early signs of 
microvascular breakage in the stomach wall. Also, the protective 
capacities of the surface epithelium and the mucous layer in the 
ischemic region could be altered, making it more vulnerable to the 
erosive action of gastric juice thus leading to the initial damage 
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of the gastric mucosal epithelium. 
These investigators (Hase and Moss, 1973) suggested that the 
microcirculatory pattern becomes 
persists, with smaller lesions 
larger lesions being surrounded 
severe haemorrhage. 
more irregular as the stress 
showing little haemorrhage, and 
by engorged mucosa and showing 
In the pathogenesis of stress ulceration, the hypersecretion of 
acid is not as important as the way in which the stomach deals with 
the back diffused hydrogen ions (Kleiman et ai, 1988). Generally. 
it is accepted that mucosal ischemia is the primary factor leading 
to gastric ulceration (Moody and Cheung, 1976; Skillman and Silen, 
1976). An efficient blood flow is essential to dispose of back-
diffused hydrogen ions - which release histamine from mast cells 
and stimulates acid and pepsin secretion. 
Antoon and Gregg (1976) found that ulcer induction in rats exposed 
to restraint and cold stress was accompanied by a marked drop in 
core temperature. They also observed that the incidence of 
ulceration could be greatly reduced by preventing hypothermia. They 
observed that when body temperature was maintained at 38°C, a 
striking reduction in gastric stress ulceration occurred. However, 
rats still developed ulcers, and it was concluded that although 
hypothermia was not a causative agent in the production of stress 
ulcers, it contributed to its formation . 
Various experiments carried out by Natelson et al (1984) provided 
further evidence to support the conclusion that hypothermia was 
correllative and not causative of gastric stress ulceration. 
Although the pathogenesis of stress ulceration is not completely 
understood, the primary factors involved in such damage to the 
gastric mucosa are localized mucosal ischemia and an elevated 
localized hydrogen ion concentration. 
In 1977, Guilleman et al noted that j3-endorphin and ACTH are 
secreted concommitantiy by the pituitary gland in conditions of 
acute stress . This stimulated much research to determine a role for 
the endogenous opioid system in stress and it has since been 
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implicated in many of the biochemical, physiological, and 
behavioural responses to stress (Adams, 1987; Rodgers and Cooper, 
1988) . Lishmanov et al (1987) have shown that a 4-hour period of 
stress in rats causes an elevation of l3-endorphin levels in the 
blood. Other hormones characteristic of the alarm phase were also 
present . They also reported that preliminary adaptation of animals 
to short term stresses led to an increase in basal l3-endorphin 
levels in the plasma . Subsequent exposure of these animals to 
stress prevented the rise in l3-endorphin and weakened other 
hormonal responses to stress . They concluded that the opioid 
peptides may have an important role to play in the adaptation to 
stress . 
Exposure to stress has been associated with increased brain levels 
of opioid peptides (Madden et ai, 1977) and with a de crease in the 
number of opioid binding sites in the brain. The latter finding 
could be due to the presence of competing endogenous ligands 
(Chance et ai, 1977) or to receptor down regulation from prolonged 
exposure of receptors to elevated levels of endogenous ligands 
(Hnatowich etal, 1986) . 
Enkephalin-like materials are also stored together with 
catecholamines in adrenal medullary chromaffin cells , and both may 
be released simultaneously in response to stress (Viveros et ai, 
1979) . 
Considerable research has been undertaken to determine the role of 
the opioid drugs in gastric stress pathology, and there are many 
conflicting reports in the literature on this topic . 
Arrigo- Reina and Ferri (1980) showed that exposure 
stressful stimuli (restraint, cold [4°C] for 5 hrs) 
production of gastric stress ulceration . This 
of rats to 
lead to the 
effect was 
exacerbated by naloxone (5mg/kg bw sc). Prior treatment of rats 
with 10 mg/kg bw morphine showed a significant inhibition of lesion 
formation . They also obs erved that FK 33-824, an enkephalin 
analogue, prevented this stress-induced gastri c damage . An 
interesting observation was the prevention of gastric damage by 
morphine methyliodide , a compound which does n ot c ros s the blood 
brain barrier, suggesting a possible peripheral action of the 
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opioids in gastric stress pathology. 
Glavin (1985) also observed that various doses of morphine 
inhibited lesion formation in rats exposed to stress. The opioid 
antagonist naloxone exacerbated lesion formation, suggesting that 
the endogenous opioid peptides released under stressful conditions 
may act to relieve the pathological effects of stress on the 
gastric mucosa. Glavin et al (1986) also observed that chronic 
treatment with naloxone augmented stress-induced gastric 
ulceration, and morphine-dependent rats stressed during spontaneous 
or naloxone precipitated withdrawal presented with severe 
ulceration as compared to controls. 
Similar protective effects of 
ulceration have been observed 
~,1988; Arrigo - Reina and Ferri, 
al,1984) . 
opioids on stress-induced gastric 
by other investigators ( Ray et 
1980; Del Tacca et ai, 1987; Ho et 
Neuropharmacological data have indicated a significant correllation 
between activity in the central nucleus of the amygdala and the 
regulation of gastric mucosal integrity in stress situations 
(Henke, 1982; 1985). Ray et al (1988) have shown that intra-
amygdalar injections of endorphins and enkephalins protect against 
stress ulceration and this effect is antagonized by intra-amygdalar 
administra tion of naloxone. They suggest that opioidergic neurons 
in the central nucleus of the amygdala are involved in the 
regUlation of gastric mucosal integrity in stress, and that sigma 
and possibly ~-opioid receptors are important in the mediation of 
this effect. 
Conversely, other investigators have observed that opioid drugs 
exacerbate, 
1983; Del 
1980) . 
and naloxone inhibits lesion formation (Dai and Chan , 
Tacca et at, 1987; Morley et ai, 1982; Feldman et al; 
Other investigators (Canfield and Spencer , 1981) noted no effect of 
morphine or naloxone on gastric stress ulceration. 
The contradiction in the data obtained thus far may arise from 
differences in drug dose, the type of stress employed, the 
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chronicity of the stressful challenge, the route of drug 
administration, and other factors in the experimental design. 
Prima facie evidence for an involvement of the pineal gland in 
stress exists, although the precise nature of its involvement has 
yet to be elucidated. 
Although publications concerned with pineal-adrenocortical 
interactions appear infrequently, many reports support the view 
that the pineal gland possibly participates in the regulation of 
the hypothalamo-pituitary-adrenal axis (HPAA) in rats (Vaughan et 
ai, 1972; Herman and Porter, 1980; DeFronzo and Roth, 1972). 
Studies indicate that the pineal gland may possibly modulate 
adrenal steroidogenesis under normal and stress conditions. Kinson 
and colleagues (1967) suggested that the pineal gland has an 
inhibitory effect on the adrenal cortex. Dickson and Hasty (1972) 
suggested that the pineal gland secretes a substance that blocks 
the synthesis and release of ACTH at the level of the hypothalamo-
pituitary axis, exerting an inhibitory influence on the adrenal 
glands. Other investigators suggest that the pineal gland exerts a 
pituitary mediated inhibition of adrenal activity (DeFronzo and 
Roth, 1972), and others provide evidence for a possible direct 
inhibitory action of the pineal gland on the adrenals (Giordano et 
ai, 1970). 
Ogle and Kitay (1976) have suggested that the pineal gland may 
directly or indirectly affect ACTH secretion, via oestradiol. They 
concluded that the pineal gland, together with the ovaries, plays a 
role in adrenal steroidogenesis. 
In vitro studies (Porter and Heiman, 1977) show that a crude 
aqueous pineal extract inhibits the ACTH-induced release of 
corticosterone from adrenal cells in culture medium. Porter and 
Heiman proposed that the aqueous pineal extract contains some 
substance that may act directly on the adrenal glands to interfere 
by a yet unknown mechanism with ACTH mediated corticosterone 
release. They suggest that this substance is not melatonin. These 
investigators (Heiman and Porter, 1980) later observed that 
addition of increasing concentrations of ACTH to the culture media 
did not reverse the inhibitory effect of the pineal extract on 
59 
corticosterone release by the adrenal cells . The interaction of 
ACTH with its receptor is known to activate adenylate cyclase 
(Garren et 01, 1971), resulting in a cAMP mediated release of 
corticosterone from adrenal cells. Heiman and Porter (1980) showed 
that the addition of dibutyryl cAMP to the culture medium also 
stimulated corticosterone release; and the pineal extract inhibited 
this effect. They thus suggested that the active constituent of the 
crude extract does not compete with ACTH for the same receptor 
site. 
Mehdi and Sandor (1977) explored the effects of melatonin in vitro 
on the biosynthesis of corticosteroids using bovine adrenal cortex. 
They observed that melatonin significantly (33 - 63%) inhibited the 
the transformation of radiolabelled progesterone to cortisol, 
possibly by inhibiting 17- and 21-hydroxylation by adrenal 
microsomes. Kinetic studies carried out by these investigators seem 
to support a possible non-competitive inhibition by melatonin of 
17- and 21-hydroxylases in bovine adrenal glands. 
Subcutaneous and intra-hypothalamic implantation of melatonin 
results in a significant adrenal atrophy, and a reduction in plasma 
corticosterone levels in rats Motta et ai, 1968) . Blinding of 
rats (with a resultant stimulation of pineal biosynthetic activity) 
abolishes the normal plasma corticosterone levels (Jacobs, 1974) 
and this effect can be reversed by pinealectomy. Nir et 01 (1971) 
have shown that the pineal gland exerts an inhibitory influence on 
adrenocortical function in rats, and pinealectomy results in 
increased plasma corticosterone levels. These investigators suggest 
that an antagonism exists between the pineal gland and the 
adrenals . However, this evidence is contradictory, and other 
workers (Niles et ai, 1977; Gromova et ai, 1967) have observed a 
stimulatory effect of melatonin on adrenal activity . Possible 
reasons for the variation in the results between the various 
investigators could be differences in the environmental conditions 
to which the rats were subjected and the time at which the 
experiments were undertaken. 
Rivest et ai, (1979) studied the effects of the pineal gland on the 
reactivity of the adrenal cortex to stress in rabbits. The pineal 
stalk of the rabbits was sectioned (with a resultant sectioning of 
• 
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the vein of Galen}. Presumably, the adrenergic innervation via the 
nervi eonarii was left intact . Six days after the operation, the 
rabbits were subjected to cold stress (7°C) for two hours . Blood 
samples were collected through an implanted jugular cannula during 
cold exposure and for two hours thereafter, and plasma 
corticosteroid levels were continuously assayed . Exposure to cold 
resulted in an enhanced release of circulating glucocorticoids, the 
levels slowly returning to normal on return to the warmer 
environment. A greater and earlier increase in plasma corticoids 
was noted in pineal stalk-sectioned rats compared to sham-operated 
rats. These findings are interesting in that they may reflect an 
important role for pineal attachment to the diencephalon, and 
indicate that the endocrine capabilities of the pineal gland may be 
disrupted by pineal stalk interruption in the rabbit. Further 
studies on other animals might reveal a possible important role for 
an intact pineal stalk in the normal functioning of the pineal 
gland. 
Although it has generally been accepted that the role of the pineal 
gland in stress is mainly anti-stressogenic (Reiter, 1982), 
controversy surrounds the actual effects of stress on pineal gland 
biosynthetic activity. 
Exposure to stress may increase tryptophan uptake by the pineal 
gland (Singh et ai, 1979) and increase pineal adrenaline 
concentra tions (Saavedra et ai, 1982). 
During acute . stress, the 
circula tion can increase the 
catecholamines released into the 
the activity of pineal NAT in rats 
(Lynch et ai, 1973; Parfitt and Klein, 1976), suggesting a possible 
activation of melatonin synthesis in stress. Vaughan et al (1978) 
measured NAT activity in ether stressed rats, and observed a four 
fold increase in pineal NAT activity in the light phase. Lynch et al 
(1973) showed that , in rats, melatonin content and NAT activity in 
the pineal gland increase rapidly in response to physical 
immobilization and insulin induced hypoglycaemia . In humans 
however , an intravenous challenge with insulin did not alter the 
melatonin pattern (Coetzee and Theron, 1988) . Lynch et al (1973) 
also observed that destruction of the sympathetic innervation to 
the pineal gland does not abolish the effect of stress on NAT 
activity 
possible 
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and pineal melatonin content. They suggested that a 
explanation for this effect could be an action of 
circulating catecholamines released during stress on supersensitive 
pineal cells . An interesting observation made by these 
investigators was that propanolol could block the stress-induced 
increase in NAT activity, but had no effect on the increased 
melatonin concentration. It could be suggested that factors 
influencing pineal blood flow and other intracellular functions may 
impair melatonin secretion from the pineal gland . 
Parfitt and Klein (1976), however, observed only very small 
increases in stress-induced pineal NAT activity in rats and 
suggested that the pineal gland has a built in protective mechanism 
against non-trans synaptic adrenergic stimulation. They propose that 
the pineal nerve endings act as a sponge to remove catecholamines 
arising from other areas (eg adrenal glands) and the neuronal 
uptake mechanisms facilitate the maintenance of a substimulatory 
concentration of NA in the perivascular space. Thus the pineal 
gland is protected from stimulation by catecholamines released 
during stress. 
Recent work on the effect of various stressors (cold, hind leg 
saline injection) on pineal biosynthetic activity has provided 
paradoxical results. It has been observed that cold (ZOC) exposure 
during the light phase induced a slight but significant (p < 0.05) 
increase in pineal NAT activity without affecting pineal melatonin 
levels (Tannenbaum et ai, 1988). Nighttime exposure (Z hrs) to the 
same stressor caused a 50% reduction in pineal NAT activity without 
affecting melatonin content. Administration of 1.5 ml of saline 
into the hind leg of rats led to a depression in pineal melatonin 
production (Joshi et ai, 1986), this effect possibly being mediated 
by the release of corticosterone from the adrenal glands (Troiani et 
ai, 1988). These findings are in conflict with many other studies 
(Lynch et ai, 1973; Illernova, 1976; Champney el ai, 1985; Seggie el ai, 
1985; Tannenbaum et ai, 1987) suggesting an activation of pineal 
gland activity in response to stressful stimuli. Possible reasons 
for these differences in findings could be related to the timing of 
the experiments and the nature of the stressor (mild or intense). 
Forced swimming was observed to increase the release of melatonin 
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from the pineal gland. It has been suggested that this effect could 
either be a stress response, or a specific response to some aspect 
of swimming - e.g. exercise (Troiani, 1989). Exercise in itself is 
recognised as a stressor (Everly and Rosenfeld; 1981). An 
interesting study was carried out by Oosthuizen (1983) on the 
effects of physical stress (step climbing at a rate of twelve steps 
per minute for 240 minutes including rest sessions) on, amongst 
other parameters, plasma melatonin levels in mineworkers. A steady 
increase in plasma melatonin was noted until 30 minutes after 
commencing exercise. No further increase was noted after this time 
point of melatonin determination, and plasma melatonin levels 
plateaued until the end of the exercise session (240 minutes). One 
hour after the exercise session, plasma melatonin levels had 
returned to normal. Oosthuizen (1983) suggested that melatonin 
could, together with cortisol and prolactin, possibly be recognized 
as a stress hormone. 
It has been suggested that a relationship exists between the pineal 
gland and the pituitary adrenal axis in health, endocrine and 
psychiatric conditions (Wetterberg, 1983). Some patients suffering 
from Cushing's disease and depressive disorders have disturbed 
melatonin levels (Carrol, 1982). It has been proposed that low 
nocturnal melatonin levels may be a genetic trait marker for 
vulnerability to depression (Wetterberg, 1983). This investigator 
also suggested that the pineal gland may secrete a factor together 
with melatonin, inhibiting the release of co::ticotropin-releasing 
factor from the hypothalamus (see fig 1.6 ). 
It has previously been suggested that the pineal gland may be 
involved in feedback inhibition of the hypothalamo-pituitary-axis 
in stress, due to the ability of melatonin to reverse pinealectomy-
induced adrenal hypertrophy (Reiter, 1982). 
Exposure to stressful stimuli could trigger neuroendocrine and 
behavioural compensa tory mechanisms to return the body to 
normality. It could be proposed that the pineal gland reacts to 
stressful stimuli by releasing substances that facilitate the 
maintenance of a homeostatic balance in the body. ' It's generally 
accepted anti-stressogenic effect, and the previously described 
efficient uptake mechanism (Parfitt and Klein, 1976) of its 
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sympathetic neurons. are possible mechanisms whereby the pineal 
gland may maintain its integrity as a precise photoperiodic 
responding system. 
Fig 1. 6 : Possible relationship betwe en the pineal gland and the 
hypothalamic-adrenal axis. 
MELATONIN 
PINEAL GLAND + 
CRF-IF 
~.- - -
r ·-- .-
HYPOTHALAMUS L G.R.F 
J 
PITUITARY GLAND IACTH I 
~ 
ADRENAL GLAND jCORTISOq 
Adapted from Wetterberg. (1983). 
CRF = Corticotropin releasing factor; CRF IF = corticotropin 
releasing factor inhibiting factor; 
hormone. 
ACTH = adrenocorticotropic 
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3 The Pineal Gland and The Opioid System 
The pineal gland has been the subject of many investigations for 
the past few decades, and is a useful experimental model for the 
monitoring of circadian rhythms. 
Research on the relationship between the pineal gland and the 
opioid system is a comparatively new field of s tudy, and recent 
progress in this direction suggests that a necessary balance 
between these two systems of neuromodulation could be important for 
the maintenance of psychophysical health (Reiter, 1987). 
Various investigators are now working on the possible links between 
these two systems, and it has been suggested that the pineal gland 
is necessary for opioid substances to exert some of their effects. 
To give further credence to an interaction between these two 
systems. enkephalin-like peptides (Cherdchu et ai, 1988) and 13-
endorphin-like immunoreactivity is present in the pineal gland 
(Vuolteenhao et ai , 1980) - suggesting that the pineal gland may be 
regulated in part by specific opioid peptides . 
Pineal - opioid research may be regarded to be in its stage of 
infancy, and as such, no vast scope of literature is available on 
this subject. The following review will attempt to describe some of 
the research being undertaken in this field . 
The pineal gland and melatonin can affect analgesic activity in 
rodents. Lakin et al (1981) have shown that pinealectomy abolishes 
the nocturnal increase in morphine-induced analgesia . Winters et at 
(1983 ) suggested that the diel rhythm in morphine and ketamine-
induced analgesia could be due to the diurnal rhythm in melatonin 
synthesis, and proposed that melatonin triggers the release of 
pituitary peptides . Sugden (1983) observed analgesic effects in 
mice. 
An age - dependent reduction in the nocturnal peak of serum and 
pineal melatonin has been observed in rodents (Reiter , 1987) . 
Kav a l iers et al (1983) undertook a study to determine the effects 
of ageing on t he diel rhythms of murine analgesia and to determine 
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if the pineal gland mediates these changes. They observed an age-
related decline in the rhythm of morphine analgesia in mice. and 
these effects were modulated by the pineal gland. These 
investigators suggest that age related declines in pineal activity 
could affect and disrupt various other neuroendocrine transmitter 
systems that possibly affect opioid activity. 
Substantial evidence exists for opioid involvement in feeding 
behaviour. Administration of opioids stimulate food intake in many 
animals (Rodgers and Cooper. 1988) . Kavaliers el a/ (1984) observed 
that morphine increases the nighttime ingestion of food. and this 
effect is depressed but treatments that inhibit nocturnal pineal 
gland activity (brief light pulse or benserazide (50 mg/kg) 
treatment). These findings suggest a link between the pineal gland 
and the opioid system in the modulation of feeding behaviour . 
Lowenstein el a/ (1984) observed that naloxone (10 mg/kg) reduced 
the nocturnal increase in rat pineal melatonin concentrations in 
vivo . They thus suggested that an opioid synapse modulates the 
effect of light on pineal activity. 
Kumar el a/ (1982) noted that pinealectomy eliminates the daily 
fluctuation in met-enkephalin levels in the preoptic area of the 
hypothalamus. Using electrophysiological techniques. Dafny and 
Burks (1976) noted that morphine affects the amplitude of sensory-
evoked potentials in the pineal body and several brain nuclei. 
These investigators suggested that morphine may interact with 
neuronal 5HT associated with sympathetic nerves innervating the 
pineal gland (Bertler el a/ .1964) or at other neural sites 
interacting with the pineal gland . They also suggested (Burks and 
Dafny . 1977) that this influence of morphine on the pineal body 
could influence pineal melatonin. and thereby exert effects on the 
hypothalamus . These investigators are thus of the opinion that the 
pineal gland may determine some of the actions of morphine on the 
hypothalamus . 
Esposti el a/ (1988) have suggested that an important relationshi p 
could possibly exist between the pineal gland and the opioid system 
in the modulation of several psycho-neuroendocrine functions. 
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Melatonin is reported to influence several neurotransmitters, 
including enhancement of brain 5HT and GABA content (Anton Tay et 
ai, 1970) and an inhibition of DA release (Zisapel and Laudon, 
1982). Esposti et al (1988) undertook an investigation to determine 
whether melatonin influences the activity of the opioid system. 
Melatonin and naloxone were administered to healthy volunteers and 
serum levels of GH and LH were measured. The results showed that 
naloxone induces an increase in LH secretion, and this effect is 
reversed by melatonin administration. Also, melatonin stimulated GH 
secretion, and naloxone completely inhibited this effect. Naloxone 
administered alone had no effect on GH release. These observations 
suggest that melatonin's endocrine stimulating action on GH 
secretion requires opioid modulation; and that this pineal hor.mone 
may be involved in the opioid modulation of gonadotropin release. 
It could therefore be proposed that some of the actions of 
melatonin may require at least in part an interaction of the opioid 
system, and also, it is likely that the opioid peptides require a 
participation of the pineal gland through a modulation of melatonin 
release to manifest some of their actions. 
Lissoni et al (1986) demonstrated an increase in melatonin levels 
after administration of FK 33-854 - a met-enkephalin analogue - to 
heal thy, normal human subjects. Naloxone partially blocked this 
stimulatory effect on melatonin secretion . These investigators also 
noted that melatonin administration (0.2 mg/kg bw at 14hOO) induces 
a significant decrease in plasma ~-endorphin levels. They thus 
suggested that a feedback mechanism with a stimulatory action of 
the opioids on the pineal gland, and an inhibitory effect of the 
pineal gland on the opioid system could possibly exist. 
In vitro studies however, have suggested that melatonin may have a 
stimulatory effect on opioid peptide release from anterior 
pituitary cells (Abou-Samra etal, 1985) . 
Work done in the laboratories of Fraschini et aI (cited in Reiter, 
1987) on heroin drug addicts showed that a "street dose" of heroin 
(0 . 5 g iv) induced a significant decrease in melatonin serum 
levels, whereas a remarkable increase in serum melatonin levels was 
noted after the administration of naloxone (0.4 mg iv) to these 
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addicts. Administration of methadone (10mg iv) to these naloxone 
treated addicts gradually brought melatonin levels back to normal 
serum values. 
In normal healthy patients, methadone (10 mg iv) had no significant 
effect on melatonin serum levels, however, a significant decrease 
was noted in addict patients. To the contrary, it was found that 
another opioid, FK 33-854 (0 . 3 mg/50 ml infusion) provoked an 
increase in melatonin levels in healthy patients, having no effect 
at all on addict patients. 
These investigators then examined the effects of melatonin as 
maintenance therapy Groups of patients who had been drug addicts 
for 4 - 5 years and were being maintained on approximately 2.5 
g/day "street" heroin, were injected either with naloxone (0.4 mg 
iv) or an intramusclar dose of melatonin (40 mg) prior to naloxone 
administration at 9hOO (two groups) and 15hOO (another two groups). 
Melatonin did not seem to block the naloxone-induced abstinence 
syndrome at either time point in heroin addicts . 
It was thus concluded that chronic administration of opioid 
substances may in some way induce changes in pineal function, and 
thus alter a possible equilibrium existing between these two 
systems. The clinical usefulness of melatonin therapy for opioid 
drug addicts requires further research. 
Reports have indicated that both the pineal gland (Maestroni et m, 
1987; Jankovich et ai, 1970) and the opioid system (Fischer and 
Falke, 1984) may regulate cell proliferation and immune responses; 
and both systems are involved in the control of tumor growth 
(Buswell, 1975; Lewis et ai, 1983). Esposti et al (1988) carried 
out studies on groups of patients suffering from early or advanced 
cancer in order to investigate the relationship between the pineal 
gland and the opioid system in human neoplasms. They observed that 
metastatic patients 
ratios than that 
difference in this 
had significantly lower fl-endorphin:melatonin 
observed in normal patients. However, no 
ratio was observed in controls and cancer 
patients having no metastatic lesions. 
They also observed (1988a) that melatonin levels in healthy human 
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beings were increased after FK 33-854 administration (0.3 mg/20 ml 
iv infusion. In patients with cancer, however, FK 33-854 induced 
increases in serum melatonin were noted in only 4 cases. while 5 
cancer patients showed no change in melatonin levels and another 4 
patients showed decreased melatonin levels. 
They thus suggest that an altered pineal-opioid relationship might 
prevail in patients with cancer , and suggest that these alterations 
could represent a risk factor for the development of metastases in 
cancer patients. It would therefore appear that a balanced 
relationship between the pineal gland and the, opioid system could 
possibly result in some anti-neoplastic activity; and that a 
correlation exists between an altered pineal-opioid relationship 
and the clinical course of cancer . 
Maestroni and colleagues (1987) have proposed that lymphocyte 
products act as messengers to the eNS, due to the ability of 
antigens to induce rapid hormonal responses early after injection 
into mice. They observed that the circadian release of melatonin by 
the pineal gland modulates immune reactivity; and that exogenous 
melatonin(lO mg/kg) had a powerful immunoaugmenting effect in mice . 
Furthermore, these investigators also observed that melatonin (2 
mg/kg bw) fully antagonized the immunosuppressive effects of 
corticosterone and partially antagonized that of cyclophosphamide 
in mice. 
Opioid receptors have been localized on leukocytes, and opioid 
peptides may possibly modulate immune functions (Fischer and Falke, 
1984). With the proposed functional link between the opioid system 
and the pineal gland (Reiter, 1987) in mind, Maestroni el at (1987) 
investigated the effects of melatonin on the immune system in mice 
treated with naltrexone (7 mg/kg bw). They observed that the opioid 
antagonist had no effect on the primary antigen response (in this 
case sheep red blood cells were used) when administered alone, but 
induced a complete antagonism of melatonin's immuno-augmenting 
effect . This suggested that melatonin influences humoral and 
cellular immune responses by activating the endogenous opioid 
system; and that no naltrexone-sensitive, opioidergic tone normally 
controls antibody production. 
\ 
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These findings are of importance if one notes that low levels of 
melatonin have been associated with affective disorders, in which 
an increased incidence of infection, autoimmunity and cancer has 
been reported (Maestroni, 1977). 
Also, adrenal corticosteroids have been reported to mediate the 
negative influences exerted by stress on the immune system. During 
stress, opioid peptides are secreted concomitantly with 
Adrenocorticotopic Hormone (Guilleman et ai, 1977) and melatonin 
production is enhanced (Lynch etal, 1977). 
These findings support a connection between the pineal gland and 
the neuroendocrine mechanisms mediating the effects of stress. 
Maestroni et al (1988) observed that the exogenous administration 
of melatonin (20 mg/kg sc for 4 days) counteracts the effects of 
stress on thymus weight. Naltrexone (1 mg/kg) administered 
simultaneously, antagonized this response. These investigators thus 
concluded that melatonin may have the physiological rol.e of 
restoring the ability of an "exhausted" opioid system to co-
ordinate the stress response . 
From the foregoing discussion, it would seem apparent that a 
relationship could exist between the pineal gland and the opioid 
system. This study was thus undertaken to observe the effects of 
the opioid agents on the pineal gland in vitro, and to observe if a 
possible relationship exists between the pineal gland and the 
opioid system in the modulation of the stress response and 
nociception. 
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CHAPTER'IWO 
PINEAL ORGAN CULTURE STUDIES 
2.1 INTRODUCTION 
The mammalian pineal gland is highly vascularized, and, second 
only to the kidney, is the most richly perfused organ. Various 
drugs are capable of affecting pineal indole synthesis and 
metabolism, and ideally, a technique is required that is sensitive 
enough to determine the normal functioning of the gland, as well 
as to detect changes in activity upon drug manipulations in vitro. 
The organ culture system is one such technique. This technique 
originated in the laboratories of Strangeways and Fell in 1926, 
and has been adapted and modified to facilitate keeping an organ, 
or parts of an organ, alive in vitro, (Trowell, 1959) as well as 
preventing growth and redifferentiation of cells. 
Many researchers have successfully developed organ culture 
techniques for the pineal gland . (Chan and Ebadi ,1981; Wainright 
and Wainright, 1981, A1phs et ai, 1980, Rowe and Parr, 1979, Klein 
and Notides, 1969, Axelrod et ai, 1969, Shein and Wurtman, 1969). 
The viability of rat pineal glands can be maintained for up to 6 
days if they are incubated at 37°C in a suitably aerated culture 
medium (Klein, 1969). 
Most techniques involve incubation of the pineal gland in the 
presence of a radioactive precursor (tryptophan, 5 hydroxy 
tryptophan or serotonin) in a suitable culture medium. The pineal 
gland takes up the radioactive precursor, incorporates it as part 
of its normal biosynthetic pathway, synthesizes radioactive 
metabolites and releases them into the culture medium. The 
metabolites are then separated 
other methods, bi-dimensiona1 
liquid scinti11ometry. 
and quantitated using, amongst 
thin layer chromatography and 
The following sections will describe the organ culture system 
used, the separation of indo1es using bi-dimensional thin layer 
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chromatography, the measurement of the radioactive [14C) serotonin 
metabolites formed, and the use of the system to determine the 
effects of drug manipulations. 
2.2 MATERIALS AND METHODS 
2.2.1 Chemical. and Reagents 
BGJb medium (Fitton- Jackson modification) was obtained from Gibco 
Europe. Radioactive 5-Hydroxy[ side-chain-2-14C) tryptamine 
creatinine sulphate, (specific activity 57mCi/mmol) was purchased 
from Amersham International, Weir Organisation, South Africa. The 
antibiotics benzyl penicillin and streptomycin were purchased from 
Hoechst S .A., and amphoterecin B from Squibb Laboratories, South 
Africa. All the standard indoleamines, melatonin, NAS and hydroxy 
and methoxy tryptophols were purchased from Sigma Chemical Co., 
USA. 
Aluminium backed thin layer chromatography plates (60F254 coated 
with silica gel 0.2mm) were purchased from Merck. 
2.2.2 Animals 
Inbred male rats of the Wistar strain were used in all 
experiments. Female rats were not 
because of the variation in [14C) 
included in the experiments 
serotonin metabolism noted in 
female rats in different stages of the estrus cycle (Daya, 1976). 
The male rats weighed between 200-300g at the time of sacrifice. 
They were housed four or five per cage in a well ventilated room 
with an automatically regulated lighting cycle of LD l2 : 12.(lights 
on 6hOO-18hOO) Rats were allowed access to a standard diet and 
wa t e r ad libitum. 
Rats were killed by neck fracture and then decapitated. A blade of 
a sharp pair of scissors was inserted into the foramen magnum and 
the skull was cut laterally on both sides to the area just behind 
the orbit. A clean forceps was inserted into this incision and the 
skull and adhering brain was lifted and folded back. The brain was 
gently peeled away from the dura and the skull, exposing the 
pineal gland. The small pearl-white structure was often found 
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adhering to the skull . Rarely, when this did not occur, the pineal 
gland could be found in the groove between the cerebral 
hemispheres, anterior and cephalic to the colliculi . A curved 
forceps was then inserted into this groove , and the pineal gland 
easily removed. Once perfected , the entire process took no longer 
than 30 seconds . 
2.23 Organ Culture 
The pineal glands were rapidly removed 
Adhering tissue was removed and the pineal 
was excised . The glands were individually 
after 
stalk, 
placed 
decapitation . 
if present , 
in sterile 
culture tubes containing 52 ~l culture medium. The culture medium 
used was a Fitton-Jackson modification of the BGJb medium (see 
table 2.1 for list of contents and composition) supplemented 
with the following antibiotics: Benzyl penicillin 0.06mg/ml, 
Streptomycin sulphate o . lmg/ml, and Amphoterecin B 2.5 ug/ml. An 
8ul aliquot of the precursor subtrate (side, chain-2- [14C) 
serotonin creatinine sulphate, specific activity 57mCi/mmol) was 
added to each tube. The pineal glands floated freely in this 
medium . The tubes were aerated with carbogen (95% C02/5% 02) 
until satura ted, and then tightly sealed with parafilm. The 
pineal glands were then incubated in the dark at 37°C in a 
Forma-Scientifica 3028 incubator for va.rying lengths of time as 
required for the experiment being carried out. Blanks containing 
no tissue w~re simultaneously incubated. 
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Table 2.1: COMPOSITION OF THE FITTON-JACKSON MODIFICATION OF THE 
BGJb MEDIUM USED FOR PINEAL GLAND ORGAN CULTURE STUDIES. 
CONTENTS 
Amino Acids 
L-Alanine 
L-Arginine 
L-Aspartic Acid 
L-Cysteine HCl 
Glycine 
L-Histidine 
L-Isoleucine 
L-Leucine 
L-Lysine HCl 
L-Methionine 
L-Phenylalanine 
L-Proline 
L-Serine 
L-Threonine 
L-Tryptophane 
DL-Valine 
Vitamins 
a-tocopherol phosphate 
Ascorbic Acid 
Biotin 
Calcium pantothenate 
Choline Chloride 
Folic Acid 
Inositol 
Nicotinamide 
Para-aminobenzoic acid 
Pyridoxal Phosphate 
Riboflavin 
Thiamine HCl 
CONCENTRATION IN mg{L 
250.00 
175.00 
150.00 
90.00 
800 . 00 
150.00 
30.00 
50 . 00 
240.00 
50.00 
50.00 
400.00 
200.00 
75.00 
40.00 
65.00 
1.00 
50.00 
0.20 
0.20 
50.00 
0.20 
0.20 
20.00 
2.00 
0 . 20 
0 . 20 
0.40 
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Vitamin B2 
Inorganic salts 
Dihydroden sodium ortho phosphate 
Magnesium Sulphate.7H20 
Potassium Chloride 
Potassium dihydrogen phosphate 
Sodium Bicarbonate 
Sodium Chloride 
Other Components 
Calcium Lactate 
Glucose 
Phenol Red 
Sodium Acetate 
Supplements 
Benzyl Penicillin 
Streptomycin Sulphate 
Amphoterecin B 
2.2.4 Bi·dimensionsionallLC Analysis of Pineal Indoles 
0.04 
90 . 00 
200.00 
400 . 00 
160.00 
3 500.00 
5 300.00 
555 . 00 
10 000.00 
20.00 
50.00 
200 mg/L 
100 units/ml 
2.5 fLg/ml 
After the necessary incubation time, the incubation was 
terminated by removing the pineal gland from the culture medium. 
A 10 fLl aliquot of the culture medium was spotted onto a TLC 
plate (silica gel 60FZ54' 10x10 cm, Merck). A 10 fLl solution of 
non-radioactive pineal indole standards (see figure 2.1) was 
then spotted on top of the culture medium spot, and these served 
to localise the various radioactive spots after development . To 
make up the standard solution, lmg of each of the 8 standard 
indoles used was dissolved in 5ml of absolute ethanol, resulting 
in a final concentration of 2ug/10ul of each standard . Earlier 
methods suggested the addition of ascorbic acid into the 
standard solution to protect those substances sensitive to 
oxidation from metabolic breakdown (Klein and Notides, 1969; 
Daya, 1976). However, ascorbic acid is known to catalyse 
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aromatic hydroxylation (Udenfriend el a~ 1954), and its protective 
capacity in this regard is questionable. When stored in an amber 
vial at _20°C, no degradation of the standard solution was 
noticeable 3 months after preparation. Thus the antioxidant was not 
used in this study . A gentle steady stream of nitrogen was always 
used to dry the spots, to prevent atmospheric degradation of the 
metabolites. The spots were always less than 0.5cm in diameter. 
A bi-dimensional system was then used to develop the plates. The 
plates were first placed in a thin layer chromatography tank at 
room temperature in chloroform:methanol:glacial acetic acid 
(97:3:1), and the solvent front was allowed to run 9cm up the 
plate. The plate was then removed, quickly dried under nitrogen,and 
returned to the same developing tank and run in the same direction 
again. After drying under nitrogen, the plate was developed in 
ethyl acetate at right angles to the first run. The solvent front 
was allowed to run 7cm up the plate. The plate was then dried under 
nitrogen. Once developed, the plates could not be stored, and 
exposure to air was kept at a minimum to prevent oxidation of the 
sensitive indoles. 
The plates were then sprayed with Van Urk's reagent (lg of 4-
dimethylaminobenzaldehyde dissolved in 50ml of 25% hydrochloric 
acid, to which 50ml ethanol is added) so as to visualize the 
spots. The entire procedure took approximately two hours. Test 
plates were always run prior to spotting so as to ensure that 
the system was working well. 
The spots were then marked, and carefully cut off the aluminium 
backed TLC plates. They were immediately placed in a 
scintillation vial containing 1ml of absolute ethanol to 
solubilise the indoles. After I ' hour, 3ml of scintillation 
cocktail (Beckman) was added to each vial. The vials were 
vortexed for 20 seconds each, and placed in a Beckman LS 3150 T 
scintillation counter . The radioactivity in dpm's was counted 
for 5 minutes per vial . The ESCR (external standard channel 
ratio) was used establish the quenching curve. 
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Fig 2.1: Illustration of a chromatogram after indole seperation 
using bi-dimensional thin layer chromatography. 
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2.2.5 Statistical Analysis of Results 
All data 
variance 
was statistically analyzed using 
followed by Scheffe's test 
oneway analysis of 
for multiple range 
comparisons, or the Students-I-test. Results are expressed as 
means ± SEM. 
2.3 RESULTS 
The solvent system used for the separation of the indoles 
(chloroform:methanol:acetic acid, 7:3:1 followed ethyl acetate) 
was found to be very efficient. 
After the plate had been developed twice in the first · solvent, 
all the standards were not separated from each other. Melatonin 
and 5- MIAA appeared as a single spot, as was also observed 
(under u . v. light) for NAS and 5-HTOH. Development in the second 
solvent separated these compounds (see fig 2 . 1) . Good separation 
of the metabolites was obtained in all cases . The original 
starting spot gave the highest counts, because serotonin and 
methoxytryptamine did not migrate from this position (see Figure 
2 . 1). 
2.4 DISCUSSION 
The TLC method described here has been used in our laboratory 
previously (Daya, 1976; Skene, 1985), and is the original method 
developed by Klein and Notides (1969). Other workers have 
attempted to use various other solvent systems (Skene,1985; 
Morton,1982 , ), and the above method has been found to give good 
separation of all the standards (Daya, 1976; Skene,1985) . In 
view of its relative success, this method was thus adopted for 
use in all future experiments. 
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2.5 ADAPTABILIlY OF THIS ORGAN CULTURE SYSTEM FOR USE WITH OTHER 
TISSUE OR GLANDS PRODUCING MELATONIN. 
2.5.1 Introduction 
The pineal gland is not the only site of melatonin synthesis in 
the body. Immunohistochemical techniques have been used to 
localise other nonpineal sites of melatonin synthesis (Bubenik et 
ai, 1977). Thus far, these studies support the localization of 
melatonin in the intestine, retina and the Harderian gland 
(Bubenik etal, 1977). 
2.5.1.1 The Retina 
The isolated retina has been suggested as a model of the eNS 
(Nowak, 1988) and could thus serve as a useful tool for tissue 
experimentation. All the major neurotransmitters found in the 
brain and the spinal chord have also been found in the retina, 
with the exception of NA (Banting, 1976). 
The features that make the retina an attractive model for in vitro 
experimentation include 
1) Ease of dissection: The retina is localised 
extracranially, and is strong enough to remain intact throughout 
the dissecton procedure. 
2) Viability: The retina maintains nearly all of its 
physiological activity for several hours after dissection. It 
receives its nutrients by diffusion from capillary networks on 
either surface. 
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3) Drug treatments: These can be introduced directly 
onto the intact retinal cells in vitro. 
Nowak (1976) has 
applications used 
explained 
for studying 
that various pharmacological 
synaptic mechanisms in brain 
tissue may be applied to retina equally well. This is due to the 
similarity between the retinal and brain neurotransmitter 
systems, eg the dopaminergic, cholinergic, GABA-ergic, 
serotoninergic and glycinergic systems. 
Cardinali and Rosner, (1971), were the first investigators to 
localize the enzyme HIOMT in the retina of the rat, and thus 
provided the initial evidence that melatonin was produced by the 
retina of mammals. They suggested that further investigations 
were necessary to determine the significance of the biosynthesis 
of melatonin by the retina . 
Dubocovich (1983) observed that melatonin potently inhibited the 
stimulated release of dopamine from the retina, possibly acting 
via specific melatonin receptors. It has thus been suggested 
that the retina could also be used as a model tissue for 
investigations into the nature of melatonin receptors, as well 
as to test for specific melatonin antagonists . 
2.5.1.2 The Harderian Gland 
The exact function of the Harderian gland in mammals has yet to 
be determined. 
The Harderian gland is one of the extrapineal sites of melatonin 
synthesis (Cardinali and Wurtman, 1972), and is thought to 
contribute to the plasma concentrations of melatonin observed in 
certain pinealectomized animals . 
NAS is the 
and 
immediate precursor of melatonin within 
in the Harderian 
is highly limited 
the pineal 
gland. The gland, is 
localisation of 
It is found in 
also 
the 
synthesized 
enzyme HIOMT 
high concentrations in the pineal 
in mammals. 
gland and in 
substantially lower concentrations in the retina I intestine and 
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Harderian gland (Reiter, 1981). 
2.5.2 Experiments 
The organ culture system described in this section is a reliable 
method to use for the incubation of pineal glands so as to keep 
them viable for long periods. 
Experiments were undertaken to evaluate the organ culture system 
described here, for its ability to keep other melatonin-
synthesizing tissue viable. 
2.5.3 Materials and Methods 
2.5.3 . 1 Bovine retina 
Bovine eyes were removed from sockets and were transported in a 
buffered solution on ice from the local abbatoir to the 
labora tory. Retinas were then carefully removed from the eyeball 
and stripped of all adhering tissue . Pieces of retina were 
weighed, and then individually transferred to culture tubes 
containing the incubation medium as previously described 
(section 2 . 2.3). 
The incubation medium was then gassed with carbogen (95% CO2 , 5% 
02) and the culture tubes tightly sealed. The retinas floated 
freely in the incubation medium, which was then incubated for 8 
hrs as previously described (section 2.2.3). 
The incubation was terminated by removing the retina from the 
culture tube. A 10 ILl aliquot of culture medium was then spotted 
onto a TLC plate and assayed as previously described (section 
2 . 2.4) . 
2.5 . 3.2 Harderian glands 
The Harderian gland is found in the cavity just below the lower 
eyelid in the rat (see fig 2 . 2) . Initially, localization of the 
Harderian gland proved difficult . Once localised, it was easily 
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removed by slitting the sides of the eye, inserting a forceps 
into the lower cavity, and drawing the gland out on the forceps. 
The pieces were weighed, and individually transferred to 
culture tubes containing the incubation medium (see section 
2 . 2.2) . 
The Harderian glands were then treated as previously described 
(Section 2.2 . 3) . After an 8 hr incubation time, the reaction was 
s topped by removing the pineal gland , and the cul ture medium (10 
~l) was assayed as described earlier (Section 2.2.4). 
In all the experiments described here, blanks containing no 
tissue were simultaneously incubated. 
2.5.4 Results 
The following table (2.2) expresses the results obtained 
indicating that the bovine retina is capable of producing 14C_ 
melatonin from M[Cl-serotonin in the culture medium. 
TABLE22 INDOLE PRODUCTION BY BOVINE RETINA 
NAS 1146 . 56 ± 332.73 
MEL 313 . 03 ± 50 . 70 
HIAA 11802.20 ± 1987 . 83 
HTOH 1188 . 04 ± 551.12 
MIAA + MTOH 250 . 03 ± 25.83 
All results are expressed as total 14C-serotonin metabolised in 
dpm'sl 10 ~l incubation mediuml retinal 8hr incubation. (means ± 
SEM) 
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The Harderian 
the uptake of 
The following 
experiment. 
gland of the rat also synthesized melatonin via 
radioactive 14C-serotonin from the culture medium. 
table describes the results obtained from this 
TABLE 23 INDOLE PRODUCTION BY THE HARDERIAN GLAND IN VITRO 
NAS 
MEL 
HIM 
HTOH 
MIAA + MTOH 
All results are 
dpm's / 10 .... 1 
(means ± SEM) 
expressed as total 
culture medium/ mg 
2.170.55 ± 336.73 
309.01 ± 50.74 
10807.10 ± 1987.83 
1188.04 ± 551.12. 
2.50.03 ± 25.83 
14C-serotonin metabolised in 
wet tissue/S hr incubation . 
The levels of indoles produced from the 14C-serotonin in the 
culture medium were much lower than those produced by the pineal 
gland (see table 2..4) . 
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2.55 Discussion 
The results obtained from these experiments verify previous 
reports indicating the existence of extra-pineal sites of 
melatonin production. 
The results showing a presence of melatonin in the bovine retina 
indicate that this tissue has the ability to produce melatonin in 
situ. It is therefore possible to suggest that this tissue has the 
ability to synthesize melatonin rather than obtaining it from 
the circulating pool of melatonin (in plasma) originating from 
the pineal gland. The Harderian gland was also shown to produce 
melatonin via the same pathway. 
The organ culture system used in our laboratory was thus found 
to be adequate for the measurement of indole production at sites 
other than the pineal gland. The indole levels measured in the 
pineal gland were, however, much higher than those measured in 
the retina or the Harderian gland (See table 2 . 4). 
The ease of dissection and the ability to adequately stimulate 
the melatonin biosynthetic pathway in the pineal gland, as well 
as the high levels of indoles produced by the pineal gland in 
organ culture (see table 2.4), indicated that the pineal gland was 
the most suitable melatonin-synthesizing system to be investigated. 
Fig 2.2: Diagram showing a rat Harderian Gland. 
rat 
, 
Salivary 'Gland 
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2.6 EXPERIMENTS 
2.6.1 EXPERIMENT 1 : ANALYSIS OF THE [14CJ INDOLE LEVELS IN THE PINEAL 
GLAND AND THE CULTURE MEDIUM. 
2.6.1.1 Introduction 
The pineal gland releases its hormone melatonin on production, 
possibly indicating that it is unable to store the melatonin 
produced. Thus, the amount of radioactive metabolites in the 
culture medium of a pineal organ culture system would 
necessarily have to be greater than that within the pineal gland 
itself. 
Some investigators have assayed the culture medium, (Daya,1976, 
Morton,1982) while others have assayed a mixture of culture medium 
and pineal homogenate, (Balemans et ai, 1979) or pineal homogenate 
only (Voisin eta~ 1983). 
This experiment was thus undertaken to compare the levels of the 
pineal [14C] indoles present in the pineal gland itself with 
those present in the culture medium after an 8 hour incubation 
time. 
2.6.1.2 Materials and Methods 
Pineal glands (n ~ 4) were removed and cultured as previously 
described. (Sections 2.2.1 and 2.2 . 2) After incubation, (24 
hrs), a 10 fl.l aliquot of culture medium was removed from each 
tube, spotted onto a TLC plate and treated as described. 
(Section 2 . 2.4) 
The pineal glands were removed and homogenised individually in 
60 fl.l of culture medium. A 10 fl.l aliquot of the cuI ture medium 
was spotted onto a TLC plate and separated and quantitated as 
above. (Section 2.2.4) 
2.6.1.3 Results 
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The results obtained from this experiment are shown in table 
2.4 . Analysis of these results shows that most Of the indoles 
formed from the uptake of [14C 1 serotonin are released into the 
culture medium . with very little being present in the pineal 
gland itself . 
Table 2.4 COMPARISON OF THE INDOLE LEVELS IN THE CULTURE MEDIUM 
AND THE PINEAL GLAND AFTER A 24 HR INCUBATION PERIOD . 
CULTURE MEDIUM PINEAL GLAND 
NAS 4421. 42 ± 795 . 19 194 . 01 ± 7.009 
MEL 2296.53 ± 415.77 216.01 ± 35.27 
HIM 18743.6 ± 5468.17 3720 . 29 ± 226 . 46 
HTOH 5042 . 55 ± 1239.31 1781.49 ± 82 . 06 
MIM 100.24 ± 6 . 10 19.24 ± 7.89 
MTOH 57.80 ± 3.15 7.01 ± 5.66 
All results are expressed as Total 14C-serotonin metabolised in 
dpm' s / 10 fl.l culture medium/pineal gland /24hr incubation (means 
± SEM . ) 
2.6.1.4 Discussion 
The results show that most of the radioactive indoles that a r e 
synthesized by the pineal gland are released into the culture 
medium. Using a solvent extrac t ion method . Wurtman et a~ observed 
that the concentration of radioactive indoles remaining in the 
pineal gland after a 48hr incubation time was 
negligible. indica ting that almost all of the compounds formed by 
the pineal gland are released into the culture medium during 
incubation. This was supported by Klein and Rowe (1970). who 
observ ed that 95 % of the melatonin synthesised by the pineal 
gland after 24 hrs incubation in organ culture is released into 
the culture medium . 
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In all the experiments carried out in this study, the culture 
medium was analysed for its contents of [14Cl-indoles produced by 
the pineal gland. 
2.6.2 EXPERIMENT 2: THE EFFECf OF ISOPRENALINE ON PINEAL GLAND 
INDOLE PRODUCTION IN ORGAN CULTURE. 
2.6.2.1 Introduction 
The pineal gland is innervated by postganglionic sympathetic 
neurons arising from the superior cervical ganglia, releasing NA 
in the dark phase which activates the 131 adrenergic receptors. 
Stimulation of the 13 receptor in turn activates adenylate 
cyclase, and via cyclic-AMP induces SNAT, thus activating the 
melatonin biosynthetic pathway (Axelrod, 1974). 
The pineal gland thus is invariably susceptible to the actions 
of other 131 adrenergic receptor agonists, eg isoprenaline. 
Wurtman et at (1968) have shown that the exposure of rat pineal 
glands to NA in organ culture causes a significant increase in 
melatonin production. 
The following experiment was carried out to determine the 
concentration of isoprenaline at which the pineal gland is able 
to maximally stimulate melatonin production. 
2.6.2.2 Materials and Methods 
Rats were killed by neck fracture and then decapitated. Pineal 
glands (n ~ 4) were removed as previously 
2.2.2). 
described (section 
Pineal glands were then incubated for 8 hours in culture medium 
containing 1 f)M, 10 f)M, and 100 f)M (-)-isoprenaline HC1 (Sigma) 
and treated as before (section 2.2.3). After incubation, pineal 
glands were removed and 10 flol aliquots of culture medium were 
analysed as previously described (section 2.2.4). 
2.6.2.3 Results 
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Figure 2.2 describes the results obt·ained from the above 
experiment . After an 8 hour incubation period in the presence of 
I-isoprenaline HCl, an increase in the amount of N-acetylated 
products formed was noted. This increase was not 
different to control values when the pineal 
significantly 
glands were 
incuba ted in the presence of 1 flM isoprenaline. However, 
incubation in 10 flM and 100 flM of the ~-adrenergic agonist led 
to a significant increase in the total amount of NAS + melatonin 
formed when compared to control values . Maximal stimulation was 
noted at the 10 flM concentration, this increase not being 
significantly different to that at the 100 flM concentration of 
isoprenaline. 
2.6.2.4 Discussion 
Adrenergic ~-receptor agonists such as isoprenaline are known to 
increase the synthesis of pineal NAS and melatonin, (Axelrod et aI, 
1969), principally by stimulating cyclic AMP production via the 
activation of adenylate cyclase (Axelrod, 1974). In a 24 hour 
profile on the effect of isoprenaline on [14C )-serotonin 
metabolism by the pineal gland in organ culture, Banoo et a/ 
(1987) noted significant stimulation of melatonin and NAS 
production by the pineal gland within 4 hrs of incubation, at a 
concentration of 10 flM isoprenaline. 
These workers also observed that after l6hrs of incubation, NAS 
and melatonin production were approximately 10-fold greater in 
isoprenaline treated pineals (10 flM) than in untreated controls . 
Figure 2 . 2 shows maxima l stimulation of pineal NAS and melatonin 
production when incubated in the presence of 10 flM isoprenaline. 
This confirms that 10 flM is the optimum concentration of 
isoprenaline in which to incubate the pineal glands so as to 
achieve maximal stimulation of pineal NAS and melatonin 
production. 
Although 
1987) • 
an 8 hour incubation period is not optimal (Banoo et aI, 
significant (6-fold) stimulation of methoxyindole 
production is observed after this time. 
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THE EFFECT OF ISOPRENALINE ON PINEAL 
GLANDS IN ORGAN CULTURE 
6 
* 5 
* 
4 
3 
2 
1 
0 
CONTROL ISO 1 ISO 10 ISO 100 
Isoprenaline (10-5 M and 10-4 Mlaccelerates the 
production of [14Cl_NAS and [14Cl-melatonin from [ 14C_ 
serotonin by the pineal gland in vitro. 
n - 5, P < 0.05 
* - significantly different to control 
. ,. 
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The lack of further increases in methoxyindole production above the 
10 !J.M concentration of isoprenaline is probably due to the fact 
that the 10 !J.M concentration is sufficient to stimulate the 131-
adrenergic receptors maximally, and addition of more agonist (as in 
the 100 !J.M concentration) will not further stimulate the pineal 
gland to produce more N-acetylated products. 
In all subsequent studies where stimulation of pineal indole 
production was necessary t 10 ~ isoprenaline was therefore added 
to the culture medium, and incubation time was usually kept to 8 
hours. 
2.6.3 EXPERIMENT 3 : THE EFFECT OF MORPHINE AND METHADONE ON PINEAL 
GLAND INDOLE METABOLISM IN VITRO. 
2.6.3.1 Introduction 
The pineal gland is implicated in the modulation of at least 
some of the actions of the opiates (Reiter, 1987). Dafny and 
Burks (1977), using electrophysiological studies, suggested that 
the pineal gland may be involved in the determination of the 
action of morphine on the hypothalamus. 
Recent reports also suggest that opioid substances are involved 
in the modulation of melatonin release by the pineal gland. In a 
clinical study on the relationship between the pineal gland and 
the opioid system, Lissoni et al (1986) showed that administration 
of FK 33-824, a met enkephalin analogue, resulted in an increase 
of circulating melatonin levels. Lakin et al (1981) have suggested 
that the pineal gland modulates the enhanced nocturnal analgesia 
seen in mice after 
administration has also 
activity 
doses of 
increase 
of SNAT (Za tz 
morphine (1-3 
plasma melatonin 
of an acti va tion of the 
treatment 
been found 
with 
to 
morphine. 
reduce the 
Morphine 
nocturnal 
and Browenstein, 1979) in rats. Small 
mg/kg bw ip) have been observed to 
concentrations in the rat, suggestive 
melatonin biosynthetic pathway in the 
pineal gland (Esposti etal, 1984) . 
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The mechanism of this action has yet to be elucidated. It is 
known that the development of tolerance and dependence to 
morphine in the rat is associated with a concomitant 
acceleration of serotonin synthesis in the brain (Way et ai, 
(1968)). Theoretically, a direct or indirect action of morphine 
on serotonin synthesis could be postulated. Morphine could 
modify the activity of tryptophan hydroxylase and aromatic 1-
amino acid decarboxylase, which transform tryptophan to 
serotonin (direct), or (indirectly) alter the physiological 
activity or excitability of serotonin containing neurons. 
Tryptophan hydroxylase and aromatic I-amino acid decarboxylase 
(enzymes catalyzing serotonin synthesis) are found in the pineal 
gland of the rat, and do not appear to differ from these same 
enzymes in the brain (Shein et ai, 1970). Thus if morphine affects 
serotonin metabolism in the pineal gland, it could also affect 
the production of other pineal substances. 
The following experiments were carried out in order to determine 
whether the opiates were (in any way) capable of modifying the 
production of indoles by the pineal gland in vitro. 
2.6.3.2 Materials and Methods 
Male rats were killed by neck fracture, and pineal glands (n=5) 
were removed as previously described (section 2.2.2), and 
incubated in culture medium containing 10 f1,M morphine HCl, 10 f1,M 
methadone HCl, or culture medium only, for 8 hours. The 
incubation was terminated by removing the pineal glands from the 
culture medium, and an aliquot of the culture medium was 
analyzed as previously described (section 2 . 2.4). 
2.6.3.3 Results 
The results obtained from this experiment indicate that the 
opiates have no effect on [14C) serotonin metabolism by the 
pineal gland in vitro, after an 8 hour incubation period. 
The indoleamine concentrations do not differ 
between the treatment and the control groups. (See 
2.8) 
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EFFECT OF OPIATES ON NAS PRODUCTION IN 
PINEAL GLANDS IN ORGAN CULTURE 
T 
, 
CONTROL MORPHINE METHADONE 
The amount of [ 14C )-NAS released into the 
culture medium by the pineal gland after an 8 hr 
incubation t i me in the presence of opioids is not 
significantly different to that of the control . 
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EFFECT OF OPIATES ON MEL PRODUCTION IN 
PINEAL GLANDS IN ORGAN CULTURE 
-
T 
-r 
CONTROL MORPHINE METHADONE 
The amount of [14C J -MEL released into the 
culture medium by the pineal gland after an 8 hr 
incubation time in the presence of opioids is not 
significantly different to that of the control. 
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EFFECT OF OPIATES ON HIAA PRODUCTION IN 
PINEAL GLANDS IN ORGAN CULTURE 
r 
T 
, 
CONTROL MORPHINE METHADONE 
The amount of [ 14C]_ HIAA released into the 
culture medium by the pineal gland af t er an 8 hr 
incubation time in the presence of opioids is not 
significantly different to that of the control . 
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EFFECT OF OPIATES ON HTOH PRODUCTION IN 
PINEAL GLANDS IN ORGAN CULTURE 
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CONTROL MORPHINE METHADONE 
The amount of [14Cl-HTOH released into the 
culture medium by the pineal gland after an 8 hr 
incubation time in the presence of opioids is not 
significantly different to that of the control. 
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EFFECT OF OPIATES ON MIAA PRODUCTION IN 
PINEAL GLANDS IN ORGAN CULTURE 
~ 
T 
, 
CONTROL MORPHINE METHADONE 
The amount of e4C ]-HlAA released into the 
culture medium by the pineal gland after an 8 hr 
incubation time in the presence of opioids is not 
significantly different to that of the control . 
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EFFECT OF OPIATES ON MTOH PRODUCTION IN 
PINEAL GLANDS IN ORGAN CULTURE 
.. 
T I 
T 
. 1 
CONTROL MORPHINE METHADONE 
The amount of [14Cl-MTOH re"leased into the 
culture medium by the pineal gland after an 8 hr 
incubation time in the presence of apioids is not 
significantly different to that of the control . 
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2.6.3.4 Discnssion 
The results obtained are indicative of a lack of any direct 
effect of morphine and methadone on [14CJ-serotonin metabolism in 
the pineal gland in vitro. 
These results suggest that if the opiates modify the action of 
the pineal gland by altering the production of any of the pineal 
indoles , this effect is unlikely to be a direct one. 
These results are supported by the work of Shein et at (1970), who 
have provided evidence indicating that morphine (lO..5M and 104 M) 
does not affect the in vitro synthesis of 14C-melatonin by the 
pineal gland . They have also shown that the synthesis of 14C_ 
serotonin and 14C-protein from 14C-tryptophan is not affected by 
opiate treatment in vitro. 
Fevre-Montange et al (1984) observed that the peptide Des - Tyr-Il-
endorphin does affect the content of melatonin in the pineal 
gland in vitro , also indicative of the absence of a direct effect of 
the endorphin on pineal melatonin production. 
These results also rule out the possibility that t he opiates exert a 
post-synaptic effect on [14CJ-serotonin metabolism by the pineal 
gland in vitro. 
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2.6.4 EXPERIMENT 4: A 24 HOUR TIME PROFILE ON THE EFFECT OF OPIATES 
ON 14[C] SEROTONIN METABOLISM BY THE 
PINEAL GLAND IN ORGAN CULTURE. 
2.6.4.1 Introduction 
An organ culture 
when incubated 
system can 
at 37"C 
medium (Klein, 1969). 
remain viable for up to 
in a suitably aerated 
six days 
culture 
The results of the previous experiment (exp 3) indicated that 10 
~ Morphine HCl did not affect pineal gland indole synthesis 
after an 8 hour incubation period. 
This experiment was thus carried out to determine whether the 
opiates would induce changes in 14C-serotonin metabolism during 
an incubation period exceeding 8 hours. 
2.6.4.2 Materials and Methods 
Male rats (200-250g) were killed by neck fracture between 10hOO 
and llhOO. Pineal glands (n=5) were rapidly removed as 
previously described (section 2.2.2) . They were then incubated 
separately (as described in section 2.2.3) in culture medium 
containing 10 ~ morphine HCl or 10 ~ methadone, or in culture 
medium only (control group). An additional tube containing the 
complete incubation mixture without the pineal gland was also 
incubated at the same time and was used to replenish culture 
tubes after sampling. The morphine HCl solution was freshly made 
up in culture medium on the day of experimentation. 
Samples of culture medium (10 fLl) were removed at t 4hrs, 
8hrs, 12hrs, and 24hrs from each tube. Each tube was immediately 
replenished with 10 fLl culture medium from the additional tube . 
The aliquots of culture medium were then separated and analysed 
as previously described (section 2 . 2 . 4). 
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2.6.4.2 Results 
The following set of figures (fig 2 . 9 and fig 2 . 10) describes the 
results obtained from this experiment . For the sake of clarity, the 
standard errors of the mean have not been included . 
The results clearly indicate that morphine and methadone have no 
direct effect on pineal gland indole metabolism over a 24 hr 
time period. None of the indoles 
morphine or methadone showed any 
levels to that of the control group. 
2.6.4.3 Discussion 
assayed in the presence 
significant difference 
of 
in 
The results obtained in this experiment verify those of 
experiment 3. 
From these results, it could also be concluded that morphine and 
methadone do not directly mOdify the synthesis or the activity 
of the enzymes regulating melatonin synthesis eg SNAT in vitro . This 
is manifested by the inability of these opioids to modify 
melatonin production in vitro as seen from the above experiment. 
2.6.5 EXPERIMENT 5: THE EFFECT OF OPIATES ON ISOPRENALINE 
STIMULATION OF PINEAL GLANDS IN ORGAN 
CULTURE. 
2.6.5.1 Introduction 
The post-ganglionic sympathetic neurons innervating the pineal 
gland release the neurotransmitter noradrenaline onto the pineal 
~l-adrenergic receptor, stimulating the production of melatonin. 
The addition of the synthetic ~-adrenergic agonist isoprenaline 
to pineal glands in organ culture is known to accelerate indole 
production (see section 2.5.2), via stimulation of the pineal ~­
receptor followed by an activation of cAMP (Axelrod, 1974) . 
Ul 
Fig 2.9: 
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24 HR PROFILE ON THE EFFECT OF 
OPIATES ON MEL PRODUCTION BY THE 
PINEAL GLAND IN ORGAN CULTURE 
o.25r--------------i 
0.1 
0.05 
0L----L--~----J---~16~~2~0~~2~4~~28 
o 4 8 12 
- CONTROL -+- MORPHINE -li(- METHADONE 
Pineal glands were incubated in an organ culture system 
in the presence or absence of opioids, and the culture medium was 
assayed a t various time intervals for indole production . The 
opioids do not significantly alter the levels of [HCl-MEL formed 
from 14C-serotonin by the pineal gland. 
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24 HR PROFILE ON THE EFFECT OF 
OPIATES ON NAS PRODUCTION BY THE 
PINEAL GLAND IN ORGAN CULTURE 
0 4 8 12 16 20 24 28 
- CONTROL -+- MORPHINE ""*" METHADONE 
Pineal glands were incubated in an organ culture system 
in the presence or absence of opioids, and the culture medium was 
assayed at various time intervals for indole production. The 
opioids do not significantly alter the levels of [ 14Cl-NAS formed 
from 14C-serotonin by the pineal gland . 
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Opiates may modulate the activity of adenylate cyclase in the brain 
(Collier and Roy, 1974) . It has been observed that the opiates 
inhibit dopamine-stimulated cAMP levels in the striatum and the 
whole brain (Minneman, 1977; Wilkening el ai, 1976; Motonatsu el ai, 
1977; Havemann and Kuschinsky, 1978) as well as NA-stimulated cAMP 
levels in the cortex and the cerebellum (Tsang elal, 1978). 
Opioid peptides can pre-synaptically modulate the release of 
neurotransmitters (Barker el ai, 1978) . Arbilla and Langer (1978) 
have shown that opioid agonists inhibit NA release. 
The following experiment was undertaken to examine whether the 
concomitant addition of morphine and methadone to the culture 
medium would modify the response of the pineal gland to 
isoprenaline. 
2.6.5.2 Materials and methods 
Male wistar rats were killed by neck fracture and the pineal 
glands were removed as previously described . (Section 2.2.2) 
The pineal glands (n~5) were then individually incubated in 
cuI ture medium only, culture medium containing 10 !lM (-)-
isoprenaline, or culture medium containing 10 !lM I-isoprenaline 
plus morphine HCI (10 !lM) or methadone HCl (10 !lM) and incubated 
for 8 hours as previously described (section 2.2.3). 
2.6.53 Results 
As was previously observed, isoprenaline (10 !lM) accelerated 
pineal gland indole production. (Total dpm's NAS + MEL 
formed/pineal gland 1168.29 ± 134.33 (control) and 4818 . 10 ± 
358.44 (isoprenaline stimulated) ]. 
The results obtained from this experiment indicate that neither 
morphine nor methadone modifies the response of the pineal gland 
to isoprenaline . 
each group do 
table 2 . 5). 
The levels of the various indoles produced in 
not differ significantly from each other (see 
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TABLE 2.5 THE EFFECT OF THE OPIATES ON ISOPRENALINE STIMULATED 
PINEAL GLANDS IN ORGAN CULTURE. 
% TOTAL Me-SEROTONIN METABOLIZED/10 ~l CULTURE 
MEDIUM/PINEAL GLAND 
CONTROL MORPHINE METHADONE 
NAS 2.21 ± 0.31 1.97 ± 0 . 19 2.90 ± 1.13 
MEL 2 . 42 ± 0.02 2.60 ± 0.32 1. 75 ± 0 . 25 
HIAA 17.88 ± 0.89 20.19 ± 2.74 14.79 ± 2.04 
HTOH 11.17 ± 2.74 11.51 ± 1.10 7.78 ± 0.71 
MIAA 0.12 ± 0 . 09 0.17 ± 0 . 04 0.15 ± 0.02 
MTOH 0.33 ± 0.006 0.38 ± 0.07 0.54 ± 0.22 
*NS not significantly different to controls. 
NS 
NS 
NS 
NS 
NS 
NS 
Pineal glands were incubated in the presence of isoprenaline only, 
or with the concomitant addition of morphine (10 ~) or methadone 
(10 ~) for 8 hours . Results are expressed as (means ± SEM). 
2.6.5.4 Discussion 
The results obtained in this experiment are supported by the 
work of Shein et ai, (1970). These investigators observed that 
morphine did not modify the NA-induced stimulation of 14[C)_ 
melatonin synthesis, and also had no effect on the incorporation 
of 14[C)-tryptophan into 14[C)_protein. 
The data obtained once again provide evidence for a lack of a 
direct effect of the opiates on the pineal gland. 
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2.6.6 EXPERIMENT 6 : THE EFFECT OF NALOXONE ON PINEAL GLAND INDOLE 
PRODUCTION IN ORGAN CULTURE. 
2.6.6.1 Introduction 
Lowenstein el ai, (1984) carried out experiments to investigate 
the effects of opioid antagonists on the pineal gland . They 
observed that s. c. administration of 10mg/kg bw naloxone to rats 
resulted in a reduction of the nocturnal peak of melatonin in 
the pineal gland . 
Esposti el ai, (1988b) showed a dose dependent increase in 
melatonin production after administration of 1, 1.5 and 2 mg/kg bw 
morphine to rats at 4.00 pm. This effect was blocked by 
pretreatment (15 minutes) with lmg/kg bw naloxone . 
The following experiments were carried out to observe whether 
the effect of naloxone on pineal gland indole production was 
mediated via a direct mechanism, suggesting an intrinsic opioid 
effect in the pineal gland . 
2.6.6.2 Materials and Methods 
Naloxone HCl (Sigma) was freshly prepared in culture medium on the 
day of the experiment. 
2 . 6 . 6 . 2(a) Rats were killed by neck fracture and pineal glands 
removed as previously described (section ·2.2.2) . and 
individually incubated in culture medium only, or in culture 
medium containing 10 ~ naloxone and incubated for 8 hrs as 
previously described (section 2.2 . 3) . 
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2.6.6.2(b) Pineal glands were incubated in culture medium only, 
cuI ture medium containing 10 fll1 I-isoprenaline, or culture 
medium containing 10 fll1 I-isoprenaline as well as 10 fll1 naloxone 
for 8 hours as previously described (section 2.2.3) . 
After incubation, 10 ",1 aliquots of culture medium were removed 
and separated and quantitated as previously described (Section 
2.2.4). 
2.6.6.3 Results 
The results indicate that naloxone has no effect on indole 
production by the pineal gland. The levels of all the indoles 
assayed in this experiment do not differ significantly between 
the treatment groups (fig 2.12 and fig 2 . 13) . Isoprenaline 
stimulation of pineal indole production was observed in 
2.6.2.6b (see fig 2.11). However, naloxone does not modify the 
response of the pineal gland to I-isoprenaline (see table 2 . 6) . 
22.6.6.4 Discussion 
The results obtained from these experiments indicate that naloxone 
does not modify the activity of the pineal gland in vitro, as 
manifested by indole production. 
These findings are supported by the work of Lowenstein et al (1984), 
who have shown that naloxone does not modify the content of 
melatonin in the rat pineal gland in vitro. 
It has also been observed that naloxone has no effect on the 
release of pre-loaded tritiated NA from the rat pineal gland when 
release is induced using a depolarising (K+) stimulus (Lowenstein 
et ai, 1984). 
It could thus be suggested that opioid receptor blockade has no 
effect on the production of 14[ C ]-indoles from 14[ C ]-serotonin by 
the rat pineal gland in organ culture. 
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TABLE 2.6: THE EFFECT OF NALOXONE ON ISOPRENALINE STIMULATED PINEAL 
GLANDS IN ORGAN CULTURE 
NAS 
MEL 
HIAA 
HTOH 
MIAA 
MTOH 
% TOTAL Me-SEROTONIN METABOLISED {10 ~l CULTURE 
MEDIUM{ PINEAL GLAND {8HR 
CONTROL 
2.21 ± 0.31 
1.41 ± 0.02 
11.16 ± 2.74 
7 . 51 ± 0 . 89 
0.12 ± 0. 09 
0 . 3308 ± 0.006 
NALOXONE 
1.93 ± 0.48 
1.56 ± 0 . 12 
14 . 27 ± 4.708 
11. 72 ± 5 . 22 
0.18 ± 0 . 01 
0 . 34 ± 0.0576 
Pineal glands were incubated in the presence of isoprenaline (10 
~) only. or with isoprenaline and naloxone (10 ~) . 
Results show that naloxone treatment has no significant effect on 
isoprenaline treated pineal glands in organ culture . 
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EFFECT OF ISOPRENALINE STIMULATION ON 
PINEAL INDOLE PRODUCTION IN VITRO 
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Fig 2.11: Isoprenaline stimulates the production of N-acetylated 
products (NAS + MEL) from [14-C]-serotonin by the pineal gland in 
vitro. 
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Fig 2.12: Pineal glands (n = 5) were incubated in the organ 
cui ture system described in the presence or absence of 10 -5 M 
naloxone for B hours. Naloxone did not alter [ 14e ]-indole 
production significantly when compared to controls. 
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THE EFFECT OF NALOXONE ON INDOLE 
SYNTHESIS BY THE PINEAL GLAND 
IN VITRO 
HIAA HTOH 
_ CONTROL ~ NALOXONE 
Fig 2.13: Pineal glands (n ~ 5) were incubated in the organ 
culture system described in the presence or absence of 10 -5 M 
naloxone for 8 hours. Naloxone did not alter [ 14C J -indole 
production significantly when compared to controls. 
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2.6.7 EXPERIMENT 8: A 24 HOUR PROFILE ON THE EFFECT OF NALOXONE 
2.6.7.1 Introduction 
ON 14[C) SEROTONIN METABOLISM BY THE PINEAL 
GLAND IN VITRO 
The results from the previous experiment indicate that naloxone 
does not modify the response of the pineal gland to isoprenaline 
stimulation in vitro. Naloxone also failed to significantly alter 
the basal response of the pineal gland in this organ culture 
system after an 8 hr incubation period. 
This experiment was thus undertaken to examine the effects of 
naloxone on the pineal gland in organ cui ture over a 24 hr time 
period. 
2.6.7.2 Materials and Methods 
Male Wistar rats were killed by neck fracture and pineal glands 
were rapidly removed as previously described (section 2.2.2) . 
Pineal glands were then incubated individually in culture medium 
only, or in culture medium containing 10 ~ naloxone HC1. An 
additional tube containing the complete incubation mixture 
excluding a pineal gland was simultaneously incubated, and 
served to replenish the culture tubes after sampling. 
Aliquots (10 ~l) of culture medium were removed at t = 4hrs, 
8hrs, 12hrs, and 24hrs from each tube, which was immediately 
replenished with 10 ~l incubation mixture. 
The samples were then spotted onto TLC plates and separated and 
the 14C-indoles were quantitated as previously described. 
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2.6.73 Results 
The 24 hour time profile on the effect of naloxone on pineal gland 
indole production showed that naloxone had no significant effect on 
the levels of the indoles assayed in this experiment. 
No significant alteration in pineal indole levels was observed 
at any time point at which the culture medium was assayed . 
Figures 2.14 and 2.15 describe the results obtained in this 
experiment graphically. 
2.6.7.4 Discussion 
From the results obtained in this study, it can be concluded 
that naloxone does not in any way modify the production of any 
of the indoles produced by the pineal gland assayed in' this 
organ culture system. 
It would thus appear that this specific opiate antagonist does 
not have any direct effect on l4e-serotonin metabolism by the 
pineal gland in vitro . 
It could thus be concluded that any action of the opiates or the 
opiate antagonists on the pineal gland would necessarily occur 
at a pre-synaptic level, proximal to the pineal gland itself. 
?5 
H 
'" "' :>: 
"' 
'" ::> 
... 
'"' ::> 
u 
..... 
,;. 
0 
..... 
A 
A Z 
"' 
«: 
~ '"' 0 
0 
'"' '"' «:
til 
"' Z :>: H 
'" 
0.. 
'" 
'"' «:
... 
0 
E-< 
... 
112 
24 HR PROFILE ON THE EFFECT OF 
NALOXONE ON MEL PRODUCTION BY THE 
PINEAL GLAND IN ORGAN CULTURE 
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NALOXONE 
Fig 2.14: Pineal glan~s were incubated in an organ culture system 
in the presence or absence of naloxone, and the culture medium was 
assayed at various time intervals for indole production. Naloxone 
does not significantly alter the levels of [14C)_MEL formed from 
14C_serotonin by the pineal gland. 
Fig 2.15: 
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24 HR PROFILE ON THE EFFECT OF 
NALOXONE ON NAS PRODUCTION BY THE 
PINEAL GLAND IN ORGAN CULTURE 
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CONTROL + NALOXONE 
Pineal glands were incubated in an organ culture system 
in the presence or absence of naloxone, and the culture medium was 
assayed at various time intervals for indole production. Naloxone 
does not significantly alter the levels of [ 14Cl-NAS formed from 
14C-serotonin by the pineal gland. 
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2.7 Conclusion 
Many publications have suggested a role for the opioid system in 
the functioning of the pineal gland ( Zatz and Browenstein, 1979, 
Esposti et ai, 1988b, Lowenstein et ai, 1984). It has also been 
suggested that the pineal gland is necessary for at least some of 
the actions of the opioid system (Reiter, 1986). Accordingly, it 
would appear that an inter-relationship between these two systems 
does exist . 
Subcutaneous administration of small doses of morphine have been 
found to increase plasma melatonin concentrations (Esposti et ai, 
1988b) while the administration of large doses of morphine (20mg/kg 
bw ip) results in a temporary reduction of the SNAT nocturnal 
activity. 
Lowenstein et ai, 
depressed the 
(1984) found that the opioid antagonist naloxone 
nocturnal rise of melatonin in rats and thus 
suggested that at least one opioid synapse is involved in the 
conveyance of light information to pineal gland. 
These workers also found that naloxone (104 to 10-6 M) did not 
affect the in vitro synthesis of melatonin in organ culture. 
The presence of immunoreactive 
pineal glands (Vuolteenhao, 
j3-endorphin 
1980) and 
in extracts of rat 
the enkepalin-like 
immunoreactivity observed in neurons of the human pineal gland 
(Moore and Siboney, 1988) suggest that the effects of the 
opiates on the pineal gland may be exerted at both a peripheral 
and a central level. 
The experiments described in this chapter show that the opiates 
do not have a direct effect on the pineal gland in vitro. Naloxone 
also failed to significantly alter the response of the pineal 
gland as manifested by indole production in this organ culture 
system. These observations are supported by those of other 
workers (Shein et ai, 1970, Lowenstein et ai, 1984, Fevre-Montagne et 
ai, 1984). 
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The stimulatory effect of the opioids on melatonin secretion by 
the pineal gland observed by other workers (Esposti et ai, 1984, 
Lissoni et ai, 1986) could have resulted either from a direct 
effect via an action on specific opioid receptors in the pineal 
gland , or from an indirect effect on neurons afferent to the 
pineal gland itself. 
The results of this study clearly indicate a lack of a direct 
effect of the opioids and the opioid antagonist naloxone on the 
pineal gland in vitro . 
These observations would thus favour the explanation that a 
central or an indirectly-acting peripheral opioid synapse is 
involved in the manifestation of the in vivo effects of t he opioids 
on the pineal gland . 
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CHAPTER THREE 
STRESS 
3.1 INTRODUCTION 
Man and animals are constantly exposed to stressful events that can 
lead to biochemical, behavioural, physiological and/or pathological 
changes that affect their homeostasis. 
The diversity of the topic of stress is reflected in the difficulty 
of finding an adequate definition for it. Diverse conditions can be 
described as being stressful, eg pain, noise, heat, isolation, 
fear, and it would seem as if stress is merely an intensification 
of what would normally be a tolerable experience. 
The Selyean concept of stress is perhaps the most apt description. 
Dr Hans Selye defines stress as being 'the nonspecific response of 
the body to any demand made upon it.' This demand, created by the 
stressor on the body, initiates adaptive functions for 
readjustment, and for the re-establishment of normalcy (Selye, 
1974). 
The pineal gland secretes a hormone, melatonin, first identified in 
1957 by Lerner and co-workers (Lerner et ai, (1958). It has since 
been implicated in the functional activities of many organs, eg the 
brain, adrenal glands, gonads, thyroid gland and smooth muscle 
(minireview, Minneman and Wurtman, 1984). 
Many studies have shown that stressful stimuli alter pineal 
melatonin production (Lynch et ai, 1973, Tannenbaum et ai, 1988, 
Vaughan et ai, 1978). Miline (1980) proposed that the pineal gland 
exerts an inhibitory influence on the adrenal-hypothalamo-pituitary 
axis, while Romijn (review, 1978) suggested that the pineal gland 
acts as a tranquilizing organ. 
In 1977, Guilleman et al observed that in rats, l3-endorphin and ACTH 
are secreted simultaneously by the pituitary gland in conditions of 
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acute stress. This stirred much interest as to the role of the 
endorphins in stress. Many studies have since examined the role of 
opiates and opiate antagonists in stress, (Dai et ai, 1983, Ferri et al 
1983, Del Tacca et ai, 1987, Glavin et ai, 1986) and contradiction 
exists as to their exact function . 
Recently, Maestroni etal (1988) reported that the administration of 
melatonin to rats could counter the effects of acute stress on 
thymus weight. They also observed that this action of melatonin was 
exerted via an opioidergic mechanism, suggesting a link between the 
melatonin and the opioidergic system in the manifestation of thymus 
involution due to stress exposure. 
The following study was thus undertaken to examine a possible role 
for melatonin as an anti-stress hormone, and to investigate whether 
melatonin acts via an opioidergic me chanism. 
Restraint and immobilization are techniques that have been commonly 
used to induce stress in laboratory animals . One of the common 
peripheral changes indicative of exposure to stress is gastric 
ulceration. Pare and Glavin (1986) have extensively reviewed 
various restraining techniques and found that , after starving rats 
for 24 hours, prone restraint on a board, coupled with exposure to 
cold (4-7°C) for three hours, resulted in a 100% incidence of 
gastric stress ulceration . This was in accordance with the findings 
of Senay and Levine, (1967) who concluded that the combination of 
stressors (cold and restraint) acted synergistically to rapidly 
produce gastric ulceration in starved rats. 
The following sections will describe the development of the stress 
procedure used in this study, the pinealectomy technique, and its 
application to this study . 
3.2 MATERIALS AND METHODS 
3.2.1 Drugs 
Melatonin, naloxone HCl and indomethacin were purchased from Sigma 
Chemical Co., USA. Morphine HCl was obtained from Labethica, South 
Africa. Diazepam was obtained from Roche, South Africa. All drug 
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solutions were freshly prepared on the day of experimentation. 
3.2.2 Animals 
Female rats of the Wistar strain (180-250 g) housed five per cage 
were used in all experiments . Animals were maintained in an 
automatically regulated lighting cycle of LD 12:12 with lights on 
at 06hOO. They were allowed free access to a standard diet and tap 
water prior to experimentation. 
3.23 Stress 
The following method of stress induction was found to be the most 
suitable. 
3.23.1 Starvation 
Rats were deprived of food for 24 hours prior to restraint, but 
allowed access to water ad libitum. Coprophagy was prevented by 
using cages with steel grid bases, elevated from a receptacle in 
which faeces accumulated . 
3.23.2 Stress Induction 
Experiments carried out in the dark phase (three hours after lights 
off - 21hOO) were facilitated by the use of a dim photo safe red 
light source . Daytime experiments commenced three hours after 
lights on. (09hOO) 
After the starvation period, animals were lightly anaesthetized 
with ether and injected with treatment drugs or control vehicles 
(see experiments). They were then restrained in the supine 
position, ventral surface upwards, on wooden boards using adhesive 
plaster. By this time the rats had recovered from ether anaesthesia 
and were immediately transported to a cold room (4_7°C) where they 
remained for the duration of the stress procedure. After two hours, 
the rats were removed from the cold room and sacrificed by neck 
fracture . Stomachs were rapidly dissected out , cut along the 
greater curvature, rinsed in distilled water and quickly pinned 
onto polystyrene boards . 
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3.2.3.3 Examination of lesions 
Stomachs were then examined for gastric ulceration by an observer 
unaware of treatment conditions . Total length of ulceration to the 
nearest 0 . 1 mm was measured using verni er calipers. Another 
original method for measurement of the extent of gastric ulceration 
was also developed . The total stomach area as well as the areals of 
ulceration were mapped out onto graduated transparencies . The area 
of ulceration as a percentage of total ulceration in mm2 was 
calculated. Due to the variability in the sizes of the stomachs, it 
was thought that this method would give a more a ccurate description 
of the results . 
3.2.4 Oral administration of drugs 
Ora l dose syringes were made to administer drugs to rats. The 
equipment consisted of 5 ml syringes, to which a long (21 gauge) 
needle (0 . 80 x 38 mm)had been attached. The tip of the needle was 
cut away and blunted, and a small bubble was blown around this area 
with an epoxy-wood glue. After the glue had hardened, the needle 
was slightly curved so as to facilitate oral dosing. All syringes 
were tested to see if they were functioning effec tively . At the 
time of the experiment, the syringe was filled with control vehicle 
or drug suspension, and dipped in a dilute sugar solution . The rat 
was held behind the head near the area of the neck, so that its 
mouth was partly opened . The syringe was then gently inserted into 
the mouth and the rat was fed with the contents of the syringe. 
3.2.5 Pinealectomy 
3.2.5.1 Anaesthesia 
Initially, phenobarbitone (SagatalR) in a dose of 70mg/kg bw was 
used to induce anaesthesia. The use of this drug posed the 
following ser i ous problems : -
1) Failure to induce sufficient anaesthesia : This effect 
varied from day to day and from morning to afte r noon . 
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2) Long recovery times: Rats took between three to four 
hours to recover from the anaesthetic. Respiratory depression would 
also set in after the operation, and animals had to be 
resuscitated. 
Due to the lack of success and the high mortality rate, the use of 
this anaesthetic was discontinued. 
Ether anaesthesia was then attempted . Rats were placed in an ether 
saturated dessicator until they fell asleep. They were then removed 
from the dessicator and placed on the stereotaxic apparatus. An 
ether saturated cottonwool strip was placed at the tooth bar of the 
apparatus, covering the area of the nose and mouth of the rat, so 
as to maintain anaesthesia. 
The use of ether as an anaesthetic had many advantages. During 
surgery, anaesthesia could be controlled to maintain sufficient 
respiration by removing the cottonwool strip from the noSe and 
mouth area. Also , a faint pink colour of the paws and the tail of 
the rat gave a reasonable indication of good respiration. A 
cyanosis of the limbs indicated that the administration of the 
anaesthetic had to be discontinued. 
3.2.5.2 Surgery 
Previously, the pinealectomy procedure used by other workers in our 
laboratory was found to be very problematic. The method adopted was 
based on the stereotaxic clamping of the rat. A small hole was 
drilled over the pineal area, and pinealectomy was attempted; or 
else entry was gained lateral to the large sinuses (transverse and 
saggital) covering the pineal and fine tweezers were used to grip 
the pineal stalk. These operations were unsuccessful because of the 
high mortality rate of rats due to excessive bleeding, and failure 
of most rats to recover from anaesthetic (Midlane, 1974, Paton, 
personal communication). 
The method used for all pinealectomies in this study was that of 
Hoffman and Reiter (1974). A dental drill was fitted with a special 
drill bit made at Rhodes University according to the specifications 
of Hoffman and Reiter (1974). It consisted of a long shaft with 
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serrated edges. An adjustable collar fitted with Allen keys was 
attached to the shaft, and was used to vary the extent to which the 
bone of the skull could be penetrated, so as to prevent damage to 
the underlying brain tissue (see figure 3.1). 
Rats were anaesthetised with ether I and innnediately t the head of 
the animal was rigidly mounted onto the stereotaxic apparatus (see 
figure 3.2) so that it was temporarily immobilized. 
The fur around the skull region was then rapidly shaved off. A neat 
antero-posterior cut was made along the midline of the skull, from 
the area slightly behind the eyes to just beyond the base of the 
skull. Alcohol swabs were used to wipe the area clean. The 
underlying tis sue was carefully parted using a sharp scalpel, to 
prevent entanglement with the drill and the collar. 
The lambda axis, above the transverse and saggital sinuses was thus 
exposed. The drill was centered on this axis, and a disc shaped 
hole was drilled into the skull to the desired depth. The bone was 
carefully removed so as to prevent excessive bleeding. A fine 
forceps was inserted into the junction of the two sinuses, and the 
pineal gland was rapidly removed. The gland was easily discernible, 
being paler than the rest of the tissue and approximately the size 
of a pinhead. 
The invasive nature of the procedure resulted in bleeding, which 
was eased by quickly replacing the bone disc into its original 
position, and applying gentle pressure on it using an alcohol 
saturated cottonwool swab. The skin flaps were then pulled together 
and held with a forceps. The wound was then deftly sutured. 
Occasionally, shallow or gasping breathing would be noted during or 
near the end of the operation. The rat was then resuscitated using 
a small animal respirator. 
3.2.5.3 Recovery 
The rat was placed on a warm base near a thermostatically 
controlled oscillating heater . Recovery time from the anaesthetic 
ranged between ten and twenty minutes. 
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DD 
SSAS 
HS 
Fig 3.1: Diagram of the drill 
c: collar. DD: dental drill. 
complex used for pinealectomy. 
HS: hollow shaft. SSAS: 
stainless steel Allen screw. 
(a) 
Fig 3.2: Diagram of the stereotaxic apparatus used for 
pinealectomy (a) and illustration of a rat mounted on the 
stereotaxic apparatus (b). 
From Sk1nner, (1971) 
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As soon as the rats regained consciousness they were placed in 
cages in a warm environment for a few hours.Some rats would resume 
eating and drinking behaviour within 30 minutes of the operation. 
They were then housed in an animal room with an automatically 
regulated lighting cycle of LD 12 : 12 (lights on at 06hOO). They 
were allowed access to a standard diet ad libitum. The rats were 
housed individually for no less than six days after the operation, 
to prevent injury to the operated area. 
3.2.5.4 Sham operations 
Sham operations were carried out in a similar manner . After removal 
of the bone disc of the skull (see section 3.2.5 . 2 above), the 
pineal gland was lightly touched without it being displaced. The 
bone disc was replaced, the wound sutured, and the animal was 
allowed to recuperate as described above. 
Rats were used in experiments after a minimum of two weeks post-
operation. 
3.2.5.5 Confirmation of pinealectomy. 
After being used in experiments, rats were killed by neck fracture, 
decapitated, and the brains were examined to check for the absence 
of a pineal gland, so as to ensure the success of the pinealectomy. 
On two occasions, the pineal glands removed during surgery were 
incubated in the organ culture system described previously (see 
chapter 2). The culture medium was analysed to check for indole 
production, and the presence of high levels of indoles when 
compared to blank samples indicated that the organ removed was 
indeed a pineal gland. The organ culture technique is, however, 
very expensive, and as such this technique was not used to confirm 
any further pinealectomies. 
3.2.6 SNAT Assay 
3.2.6.1 Preparation of solutions 
a) Buffer Solutions 
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1) The phosphate buffer was prepared as follows: 
Solution A: 908 mg of KHzP04 was dissolved in 100 ml distilled 
water. 
Solution B: 1.19 g of NazHP04 .2HzO was dissolved in 100 ml 
distilled water . 
Solution C: 50.8 ml of solution A and 49 . 2 ml of solution B was 
mixed together to give a phosphate buffer with pH=6.8. 
2) The borate buffer was prepared as follows: 
Solution A: 620 mg of H3B03 and 746 mg of KCI was dissolved in 100 
ml distilled water. 
Solution B: 50 ml Of Solution A was then adjusted to pH 10 using a 
0 . 1 N NaOH (0.4 g in 100ml distilled water) solution. 
b) Working solution 
A working solution containing, per sample, 5 . 6 mM tryptamine HCI, 
800 ~ acetyl coA, and 40 nCi [3H] acetyl coA in a final volume of 
10 ~l 0 . 05 M chilled phosphate buffer (ph 6.8) was prepared 
immediately before the assay was undertaken. The working solution 
was kept chilled i n a vial placed on a crushed- ice bed. 
3 . 2.6.2 Assay 
The assay procedure used for the determination of SNAT activity is 
the one originally described by Deguchi and Axelrod (1972) and 
further modified by Champney, elm, (1984) . 
The principle of the assay is based on the N-acetylation of a 
substrate, tryptamine HCl, by the endogenous SNAT in the pineal 
gland. The [3H] Acetyl Coenzyme A acts as the acetyl donor, 
transferring the acetyl group to tryptamine to form the 
radiolabelled product, [3H] N-Acetyl tryptamine. The enzyme SNAT is 
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able to utilize tryptamine far more readily than the natural 
substrate 5-hydroxy-tryptamine (Morton, 1982) and tryptamine was 
thus used as the substrate in this assay. 
The radio labelled product thus formed can be extracted into an 
organic solvent, and the radioactivity measured using liquid 
scintillometry. The amount of radioactive N-acetyl tryptamine 
formed/time is then used as a measure of SNAT activity. 
Rats (n=4) were killed by neck fracture. After decapitation, the 
pineal glands were rapidly removed as previously described (Section 
2.2.2) . Removal of the pineal glands in the dark proved to be very 
difficult. After various attempts, the technique was perfected to 
ensure rapid removal of the pineal gland in the dark . The glands 
were then individually homogenized in 100 ~l chilled phosphate 
buffer (pH 6.8). 
The assay was carried out in 1500 ~l eppendorf microfuge tubes. 10 
~l of the homogenate of each pineal gland was transferred to the 
bottom of separate cold microfuge tubes (placed on an ice bed). An 
aliquot (10 ~l) of the working solution was then pipetted onto the 
side of each tube. The surface tension was adequate to keep the 
homogenate at the bottom of the tube separate from the working 
solution on the side . The tubes were tapped on the workbench, 
quickly vortexed using a rotamixer (Hook and Tucker deluxe model), 
and tapped again to ensure combination of the homogenate and the 
working solution. The tubes were then incubated for 20 minutes at 
37 C in a shaking water bath. Blank incubations were performed in 
which only the enzyme (SNAT in pineal homogenate) was omitted from 
the assay . 
The reaction was terminated by adding 100 ~l of chilled borate 
buffer (pH 10) to each tube. The radioactive [3H] NAT formed was 
then extracted into an organic solvent. 1 ml of chilled chloroform 
was added and each tube was capped tightly. The tubes were then 
shaken for 5 minutes using a Griffin flask shaker to facilitate the 
extraction of the radioactive NAT. The tubes were then centrifuged 
for 30 seconds in a microfuge. The supernatant was aspirated using 
a pasteur pipette connected to a suction flask in which the 
radioactive waste was collected. Chilled borate buffer (100 ~l) was 
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added to each tube to wash out any contamination. Once again , the 
tubes were shaken for 5 minutes as before, centrifuged for 30 
seconds and the supernatant aspirated as described above . Aliquots 
of chloroform (500 .... 1) were then transferred to separate 
scintillation vials and evaporated until completely dry . 
Beckman HP/b scintillation cocktail (3 ml) was added to each vial. 
The vials were capped tightly , vortexed for 20 seconds each, and 
the radioactivity was counted for 5 minutes per sample on a Beckman 
LS 2800 liquid scintillation counter . 
3 . 2.6.3 Calculation of SNAT activity 
The following equation was used to measure the SNAT activity/pineal 
gland/hr: 
( DPM,;,mple - DPMuland x a x b x 2 x 3 
DPMrotal 
= nmol SNAT 
pineal x hour 
where a fraction of pineal g l and assayed (1 for whole, 2 for half 
pineal,S for 1/10 th of a pineal , etc) 
b nMoles of acetyl Coenzyme A per sample (*hot + cold) 
2 factor for counting only half the chloroform used for 
extraction 
3 factor for incubating the sample for 20 minutes only. 
3.2.7 Locomotor activity 
3.2.7.1 Apparatus: 
Locomotor activity was 
photocell activity cage 
The activity of the 
recorded by an improved version of the 
(Physics Department , Rhodes University). 
animals is measured in a black- pa i nted 
aluminium box measuring 500 unn square by 200 unn high . The box 
(cage) is mounted on an 800 unn high base ; the base carries the 
sensors and associated electronics . 
Activity is monitored by re cording the interruption of beams of 
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infra red (i-r) light by the bodies of the animals. The light 
sources for the detection of locomotor activity comprise 8 high 
power (243 mW/steradian) narrow beam (4 deg. half-angle) type 
ME7124 i-r light emitting diodes situated equidistantly (100 mm 
apart) in two of the cage walls, opposite to which are placed 8 MT2 
broad band phototransistors. The i-r sources eliminate the use of 
bright visible light sources usually employed in photocell activity 
cages and which is said to provide a mildly stressful situation 
(Sampson, 1975). The cages may also be used under conditions of 
normal ambient lighting or in the dark. 
In addition to the eight i-r beams which detect locomotor activity 
the cages are also equipped with a further 6 beams below the cage 
floors to measure exploratory behaviour. These beams (3 
originating from each of 2 adjacent wa l ls) are broken if a rat 
peers through any of an array of 9 60 mm diameter holes in the cage 
floor. Such beam-breaks are detected when a tank is interrogated 
and these breaks are separately recorded as a measur·e of 
exploratory behaviour. 
The beams are so positioned that if a rat blocks a beam a rat 
moving in the vicinity will break an adjacent beam. Moreover a rat 
which obstructs a beam for an extended period is counted only once 
since the computer only records changes in the status of the beams. 
When a rat interrupts an i-r beam the voltage level at the 
collector of the phototransistor rises and this rise is detected by 
an analog voltage comparator. The comparator delivers a logic 
signal (beam intact/beam broken) to one of an array of buffers. 
These buffers may be interrogated by the data-logger computer and 
the current beam status recorded. A number of cages may share a 
common data bus and be individually interrogated by the computer. 
The data logging program first invites the user to test the cages. 
The cages carry monitor lamps to indicate the state of indiviual 
beams . The computer assists the user by providing an audible 
acknowledgement (beep) whenever a beam is broken or restored during 
testing. 
The program then asks the user for information relating to the 
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experiment (name, date, identification etc.) with the computer 
supplying default value for missing answers . Some of this 
information is used by the program; all of the information 
supplied is incorporated in the data file's 'header' record and may 
be used at a later time to identify the data-set (see figure 3.3). 
Fig 3.3: Description of a header record. 
Header,user's name,run id.,fIlt factor,fIlename,date,day,fIltperiod,nr of tanks 
Header,Razeeya,control with vehicle,a:controll.rat,890831,wednesday, 0 , 3 , 
A problem discovered while using these cages was that of 'nuisance 
counts" resulting from a rat grazing a beam and causing many rapid 
interruptions. This problem is addressed by the data-logging 
program which, if a beam is broken, can be instructed to only 
record the break if it is sustained for a certain period . The 
computer asks the user to indicate a 'Filter Factor' which is then 
multiplied by a predetermined constant to yield the required period 
for which breaks must be sustained. Typically a constant of 0,1 is 
used; a filter factor of 2 would then require that all breaks be 
sustained for 0,2 seconds before they are eligible for recording. 
Data are recorded on disk at user selectable intervals and appear 
as ASCII records of 'upper" and "lower' breaks together with the 
time at which the record was made and that identification code of 
the tank which supplied the data. 
The program may be interrupted at any time, whereupon a menu 
appears which allows the user to view the presently logged data 
records, modify various operational parameters (record length, 
filter factor), resume data logging at the next-but-one record or 
terminate the session in a variety of ways. 
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3.2.7.2 Animals 
Preliminary investigations showed that placing three rats in 
cage gave results that were within a reasonable SEM. Thus 
each 
the 
locomotor activity of three rats was used as one reading, and 18 
rats were used to give six readings (n~6). 
3.3 Results 
The results from the various stress experiments carried out in this 
study indicate that the method used produced a 100% incidence of 
gastric stress ulceration in control rats. The starved rats , 
stressed according to this procedure, all developed many clearly 
discernible, measurable ulcers in the time prescribed . 
The technique used to measure the area of ulceration as a 
percentage of the total stomach area did not produce any superior 
information to that measuring the total length of ulceration in mm 
(see figure 3.4). This method was thus used occasionally only for 
comparison to confirm results obtained with the total length of 
ulceration method of measurement. 
3.4 Discussion 
In 1936, Selye reported that exposure of rats to various 
nonspecific stressors led to the development of acute gastric 
ulcers. Initially, he observed the that tying up of a rats legs and 
wrapping them up tightly in a towel for long hours produced these 
lesions . Since then, many new and effective techniques have 
evolved, and these have been extensively reviewed (Brodie, 1971; 
Pare and Glavin, 1986). 
The technique described by Senay and Levine (1967) has been 
successfully adapted and modified for use in our laboratory. A 100% 
incidence of gastric ulceration was noted in all rats stressed, 
indicating that this is in fact a very efficient method. 
The use of ether as an anaesthetic was useful because of the ease 
of administration, lack of post-operative complications , and a good 
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Fig 3.4: COMPARISON OF THE TOTAL LENGTH OF ULCERATION METHOD. AND 
THE AREA OF ULCERATION AS A PERCENTAGE OF TOTAL AREA METHOD . OF 
ULCER MEASUREMENT 
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The area of ulceration method does not give any superior 
informa tion to the total length method of ulcer measurement. The 
latter method was adopted for use in all experiments. 
recovery rate . 
The pinealectomy 
effective. Many 
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procedure of Hoffman and Reiter was very 
rats survived the surgery, and removal of the 
pineal gland was relatively simple. 
The methods described above were thus used in all experiments. 
Although starvation in itself is a mild stressor, the term stress 
as regards the experimental work will be used to describe the cold 
and restraint-immobilization procedure. 
3.5 PRELIMINARY INVESTIGATIONS TO OPTIMIZE TIlE STRESS-INDUCTION 
PROCEDURE. 
3.5.1 Introduction 
The nature of this work called for the use of a very aversive 
technique t and as such, preliminary work was very neces sary to 
adopt a method that would reduce the exposure of the animals to the 
stressful stimuli to an absolute minimum. 
Several criteria had to be met in order to assess the validity and 
efficacy of a reasonable model of stress induction leading to 
gastric ulceration, and at the same time minimizing the exposure of 
the animals to the stressful stimuli . The criteria included : 
1) A minimization of the pre-stress starvation period, 
2) A minimal exposure to the major stressors, and 
3) The production of true ulcers . 
The following experiments were carried out in an attempt to 
optimize the stress ulcer - induction technique. 
3.5.2 Materials and Methods 
3.5 . 2 a) Rats (n~4) were starved for 12 hours and 24 hours 
respectively . They were then killed by neck fracture and stomachs 
were rapidly dissected out and examined for gastric ulcerat i on. 
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3.5 . 2 . b) Rats (n~2) were starved for 24 hours and subjected to 
the stress procedure as described in section 3.2.3 for a duration 
of 1.5, 2, 2 . 5 and 3 hours at cold temperature (4 _7°C) 
respec tively. They were then killed by neck fracture, and stomachs 
were examined for the presence of ulceration . 
3.5.3 Results 
Examination of the stomachs from experiment 3 . 5 . 2 . a showed a total 
absence of gastric lesions at both time periods. However, at t=12 
hours, the rats still had some food remaining in the stomach . 
The rats exposed to restraint-immobilization stress for two hours 
in experiment 3.5.2. b. developed many clearly recognizable, 
measurable ulcers (average total length of ulceration - 9.2mm) that 
could easily be discerned from petechiae and small surface 
erosions. The rats exposed to the major stressors for 1.5 hours 
developed few ulcers. (Average total length of ulceration = 3 : 6mm) 
Both rats tested for the 3 hour period died before the stress 
exposure time had expired . 
3.5.4 Discussion 
It is now recognized that experimental ulcers are more reliably 
produced if the gut of the animal is ' primed ' by gastric emptying 
due to a period of food deprivation prior to the induction of 
restraint stress (Pare and Glavin, 1986). 
The previous use of long periods of starvation (48-72 hours) often 
produced ulcers located only in the rumen of the rat stomach , 
indicative of starvation and not of exposure to stress (Pare and 
Temple, 1973). 
A total lack of ulceration was noted after both the starvation 
periods used in this experiment. No rumenal ulceration, indicative 
of starvation,was present . However , after the 12 hour time period , 
the presence of food in some stomachs was noted. Food - deprived rats 
require a shorter duration of exposure to stress before gastric 
ulcers are manifested (Buchel and Gallaire, cited in Pare and 
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Glavin , 1986) when compared to fed rats, indicating that the 
presence of food in the stomach inhibits the production of lesions 
to some extent. Thus a 24 hour starvation period was used in all 
experiments. 
It is well known that exposure to multiple stressors produces a 
high incidence of gastric ulceration within a short period of time 
(Dai and Chan, 1983) . The presence of many ulcers after two hours 
of exposure to restraint-immobilization and cold temperatures 
indicated that this was the minimum time required for exposure to 
the major stressors. 
Thus the optimum conditions that had to be used (which spared the 
animal any further discomfort) were a pre-stress starvation period 
of 24 hrs, followed by 2 hours exposure to restraint-immobilization 
and cold (4_7 °C). 
3.6 EXPERIMENTS 
3.6.l. EXPERIMENT 1: THE EFFECT OF STRESS ON PINEAL SNAT ACTMTY 
3.6.l.l. Introdnctlon 
A trans synaptic adrenergic mechanism controls the circadian rhythm 
in the activity of pineal SNAT , the enzyme regulating large changes 
in melatonin production. 
One of the responses to stress is the release of catecholamines 
from nerve endings. The pineal gland is an end organ of the 
sympathetic nervous system, and may thus exhibit changes in the 
secretion of melatonin in response to certain stressors.lt has been 
observed that catecholamines released into the circulation during 
acute exposure (2-2.5 hrs) to stress, can increase pineal SNAT 
activity (Lynch et ai, 1973). Exposure to certain stressors can 
elicit a four fo l d i ncrease in SNAT activity (Vaughan etal , 1978) . 
This experiment was undertaken to examine the effects of stress on 
pineal SNAT activity . 
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3.6.1.2 Materials and methods 
Groups of rats were either maintained on their normal diet or 
starved for 24 hours prior to experimentation. At 21hOO, one group 
of starved rats (n=4) was exposed to cold and restraint 
immobilization stress as described earlier (section 3.2.3) for 2 
hours. At 23hOO the stressed rats, as well as one group (n=S) of 
starved rats and one group of fed (n=S) rats were killed by neck 
fracture and then decapitated. The pineal glands were rapidly 
removed (see chapter2) and assayed for SNAT activity according to 
the method of Champney etal (1984) (see section 3.2.6). 
3.6.13 Results 
Fig 3.S describes the results obtained in this experiment . Starved 
rats show a slight but non-significant increase in SNAT activity as 
compared to control rats. Restraint immobilization and cold stress 
induced an almost four fold increase in SNAT activity. (F(df=12) -
4.32, p < O.OS). 
3.6.1.4 Discussion 
The results from this study support the possibility of an 
activation of the melatonin biosynthetic pathway on exposure to 
stress. 
Different stressors seem to elicit different responses as regards 
pineal SNAT activity and melatonin synthesis. 
During the light phase, insulin induced hypoglycaemia and restraint 
immobilization have been shown to increase pineal SNAT activity. In 
contrast, subjecting rats to hind leg saline injection at night 
(Joshi et ai, 1986) or forced swimming (Troiani et ai, 1988) results in 
a depression of melatonin synthesis . 
Histological studies (Miline, 1979) have suggested an increase in 
pinealocyte activity in response to stress, indicative of a 
possible increase in melatonin synthesis and release. 
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EFFECT OF STRESS ON PINEAL SNAT 
LEVELS IN FEMALE WISTAR RATS 
nmol SNAT formed/pineal gland hr-' 
1.2 ~-----~--.:=---------~ 
* 
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NON-STRESSED STARVED STARVED & STRESSED 
SNAT activity wa s measured in starved, starved and 
stressed, and unstressed rats. Stressed rats show an approximately 
four-fold increase in SNAT activity as compared to controls. 
* = significantly different to control. 
F(df=12) = 4.32, p < 0.05. 
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A wide variety of acute stressors increases melatonin synthesis in 
the rat, and it could be suggested that the general response of the 
pineal gland to stress results in an increase in pineal activity. 
3.6.2 EXPERIMENT 2: THE EFFECT OF MELATONIN ON THE PRODUCTION OF 
GASTRIC STRESS·INDUCED LESIONS IN RATS. 
3.6.2.1 Introduction 
Various stressful stimuli alter pineal melatonin production (Lynch 
et ai , 1973, Tannenbaum et ai , 1988, Vaughan et ai, 1978) . The exact role 
of the pineal hormone melatonin in stress is not clear. Studies 
have shown that exposure to stress can increase pineal SNAT 
activity, suggesting a possible activation of the melatonin 
biosynthetic pathway in response to certain aversive stimuli . 
(Vaughan et ai, 1978) . It is thus conceivable that melatonin ·could 
act as an anti-stress hormone . 
One of the peripheral consequences of stress exposure in rats is 
gastric ulceration (Ader, 1964) . The following study was undertaken 
to examine the effect of melatonin on stres s -induced gastric 
ulceration . 
3.6.2.2 Materials and Methods 
Rats (n ~ 5) were starved as previously described and lightly 
anaesthetised with ether. They were then injected with melatonin 
(100 ~g, 250 ~g, and 500 ~g/kg bw ip) or melatonin vehicle only 
( control) . 
The melatonin was freshly prepared by dissolving in a base 
containing 2% benzyl alcohol and 0.025% w/v citric acid to which 
10% tween (polysorbate 80) was added. The injection was then made 
up to volume using distilled water . 
The rats were then exposed to stressors (cold and restraint) for 
t wo hours, killed by neck fracture, and stomachs were examined for 
lesion production . (Section 3.2 . 3) 
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3.6.2.3 Results 
Figure 3.6 summarizes the gastric stress ulcer data obtained from 
this experiment . At the low doses used in this study, melatonin was 
observed to induce a dose dependent inhibition of gastric stress 
ulceration. (F(df=19) = 6.73, p < 0.01). A 500 ~g dose of melatonin 
was shown to induce an 88.79% ± 0 . 04% inhibition of lesion 
production . 
3.6.2.4 Discussiou 
The restraint-immobilization and cold stress technique have been 
used to evaluate the efficacy of anti-ulcer compounds, (Szelenyi 
el ai, 1986; Hanson and Brodie, 1960) as well as certain anti-
stress pharmacological agents (Doteuchi and Costa , 1975; Hanson and 
Brodie, 1960) . 
In this experiment melatonin significantly inhibits the production 
of gastric stress-induced lesions. Due to the nature of this study, 
the effect of melatonin could be indicative either of an anti -
stress effec t at a central (CNS) or peripheral (adrenal glands) 
level, or of a protective effect at the level of the gastro-
intestinal tract . 
The presence of melatonin in the gastro-intestinal tract has been 
noted (Bubenik el ai, 1976), with higher concentrations being found 
in the stomach and the duodenum than in other parts of the gut. 
These authors suggested that melatonin could participate in some 
aspect of intestinal physiology . Recent studies have shown that 
pre - incubation of rat stomachs with melatonin in vitro prevents 
ethanol induced gastric ulceration, possibly via a serotoninergic 
mechanism (Cho elal, 1988) . 
The effect of melatonin noted here, albeit an anti - stress effect or 
an anti - ulcerogenic effect, may reflect a physiological function of 
endogenous melatonin. 
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EFFECT OF SMALL DOSES OF MELATONIN 
ON GASTRIC STRESS ULCER FORMATION 
100r-------------------------------, 
80 
60 
40 
20 
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MEL 250 MEL 500 MEL 100 
Melatonin (100 fJ.g. 250 fJ.g. and 500 fJ.g/kg bw ip) was 
administered to rats iIIllIlediately before the induction of stress. 
Melatonin induces a dose-dependent reduction in lesion formation at 
low doses. 
F(df-19) 6.73. P < 0.01. 
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3.6.3 EXPERIMENT 3: INVESTIGATION INTO A POSSIBLE CIRCADIAN RESPONSE 
OF WISTAR RATS TO STRESS. 
3.6.3.1 Introduction 
Pineal melatonin synthesis is known to undergo a circadian rhythm, 
with highest concentrations being produced during the dark phase of 
the light dark cycle (Axelrod, 1974). The previous study showed 
that administration of exogenous melatonin produced a dose 
dependent reduction in ga s tric ulceration. The possibility thus 
exists that the high endogenous melatonin levels present during the 
dark phase of the LD cycle could facilitate a reduction in gastric 
stress ulceration as compared to daytime exposure to stress . 
The following experiment was carried 
exposure of rats to stress in the 
significantly different results when 
controls . 
3.6.3.2 Materials and Methods 
out to determine whether 
dark phase produced any 
compared to light phase 
Female Wistar rats (n=10) were starved for 24 hours as described 
above (3.2.3). At 21hOO they were subjected to the stress procedure 
as described (section 3.2.3) for a period of 2 hours. A dim red 
photo safe light source was used to facilitate handling of the 
animals during stress induction. 
Exposure of the rats to light during the dark phase iDllllediately 
suppresses melatonin synthesis, and as such care had to be taken to 
prevent stray light from entering the experimental area, which, 
except for the doorway, was totally sealed off. 
3.6.3.3 Results 
Interestingly, the results indicate that exposure to stress at 
night leads to a reduced incidence of gastric stress lesions (see 
fig 3.7). Daytime experiments (n=25) indicated the presence of many 
more ulcers as compared to rats stressed at night under exactly the 
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THE CIRCADIAN RESPONSE OF FEMALE 
WISTAR RATS TO STRESS 
* 
DAY NIGHT 
Expo sure of rats to stressful stimuli in the dark phase 
leads to a significant reduction in lesion formation as compared to 
light phase controls. 
t - 3.46, P < 0.001. 
* = significantly different to control 
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same conditions, in the absence of light. (t - 3.46, P < 0.001) 
3.6.3.4 Discussion 
The rats stressed at night show a reduced susceptibility to gastric 
ulceration when endogenous melatonin levels are high. It could be 
implied that this high level of melatonin present in the rat during 
the dark phase is probably responsible for the reduced effects of 
stress as manifested by gastric ulceration observed in these rats. 
However, various other rhythms persist in the body, and, although 
the possibility does exist, the results from this experiment cannot 
at this stage be directly attributed to the increased circulating 
levels of melatonin present at night. To clarify this, the 
following experiment was performed. 
3.6.4 EXPERIMENT 4: THE EFFECT OF PINEALECTOMY ON THE NIGHTTIME 
RESPONSE TO STRESS. 
3.6.4.1 Introduction 
The exact role of the pineal gland in stress is not clear. Research 
has indicated that stress induces an increase in activity in the 
pineal gland (Miline, 1980). 
It has been shown that certain progressive structural changes occur 
in the pineal gland on chronic exposure to low temperature (cold 
stress) and irradiation (800 r) stress (Miline 1980) . These include 
hypertrophy and hyperplasia of the pinealocytes, hypertrophy of the 
Golgi zone, and an abundance of free ribosomes. 
Miline (1980) thus proposed that the pineal gland plays a 
protective role in the maintenance and fundamental stabilization of 
homeostasis under stress induced conditions. 
From the previous experiments it could be suggested that melatonin, 
and possibly the pineal gland, are responsible for the amelioration 
of the effects of stress as manifested by gastric ulceration. 
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Melatonin levels during the light phase of the LD cycle are very 
low (Axelrod, 1974) . At night, the release of NA from the 
postganglionic neurons onto the pineal Il-receptor activates the 
mela tonin biosynthetic pathway and hence leads to an increase in 
melatonin production (Axelrod, 1974). 
This experiment was undertaken to observe the effects of 
pinealectomy on the nighttime response to stress . 
3.6.4.2 Materials and Methods 
Groups (n-6) of intact, sham-operated, and pinealectomized rats, 
were starved as previously described . They were exposed to stress 
for 2 hours at 21hOO (3 hours after lights off), sacrificed by neck 
fracture, and stomachs were examined for ulceration. (Section 
3.2.3) The rats were decapitated, and brains were examined to 
ensure the success of the pinealectomy procedure. 
3.6.4.3 Results 
Figure 3.8 describes the results obtained from this experiment 
graphically. 
Once again, a reduced incidence of gastric ulceration was observed 
in intact rats stressed in the dark phase . The total length of 
ulceration between the intact (3.42 ± 0.52) and sham operated (5.13 
± 1.17) rats did not vary significantly . Pinealectomised rats 
showed an increased incidence of ulceration, (F(df-17) - 6.07, P < 
0.01) and the total length of ulceration (14.03 ± 2.68) observed in 
these rats is comparable to previous daytime controls (See figure 
3.7) . 
All the pinealectomies were successful. On post mortem the rat 
brain appeared normal when compared to that of an unoperated rat, 
except for the absence of a pineal gland. No inflammation or 
presence of clotting was noted . 
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EFFECT OF PINEALECTOMY ON THE 
NIGHTTIME RESPONSE TO STRESS. 
* 
~ 
T 
.., 
control sham pmealectomlsed 
.. 
Fig 3.8: Intact , sham-opera ted and pinealectomized rats were exposed 
to stress in the dark phase. Pinealectomized rats present with a 
significant increase in gastric ulceration . 
F(df=l7), p < 0 . 01. 
* = s i gnificantly different to control . 
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3.6.4.4 Discussion 
Al though the exact role "f the pineal gland in the response to 
stress has not been elucidated, it has been suggested that the 
pineal gland is anti-stressogenic (Reiter, 1982) 
Miline (1979) conducted various histological studies on the effects 
of stress on the pineal gland, and concluded that the pineal has a 
protective role in stress . The author has also obtained results 
indicative of a functional antagonism between the pineal gland and 
the hypophysis, and suggests that the pineal gland actively 
participates in the general adaptation syndrome and reacts to 
protect the organism against stress induced effects. 
Rivest (cited in Romijn, 1978) suggested that the primary function 
of the pineal gland in stress is to control and regulate the 
physiological reactions of defence and adaptation in the general 
adaptation syndrome. 
The results of this study indicate that the pineal gland is 
necessary for the protection of the organism against stress-induced 
gastric ulceration. The presence of a pineal gland protected the 
control group of rats against ulceration at night, and pinealectomy 
reversed this effect. It could thus be suggested that the pineal 
gland is responsible for the circadian resistance to stress-induced 
ulceration seen earlier (see fig 3.7). 
The results from this experiment strengthen the hypothesis that the 
pineal gland plays a protective role in the response to stress. 
These observations are also suggestive of a possible anti-stress 
role for the pineal hormone melatonin. 
3.6.5 EXPERIMENT 5: THE EFFECT OF MELATONIN ON STRESS INDUCED GASTRIC 
ULCERATION IN PINEALECTOMISED RATS. 
3.6.5.1 Introduction 
The previous experiments have indicated that pinealectomy 
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exacerbates the production of stress induced gastric ulceration 
(see fig 3.8), and that melatonin administration to intact rats in 
the light phase of the LO cycle inhibits lesion formation to a 
great extent (see fig 3.6) 
The following experiment was undertaken to determine 
melatonin is one of the pineal substances responsible 
whether 
for the 
reduced incidence of lesion formation observed in intact rats in 
the dark phase of the LO cycle . 
3.6.5.2 Materials and Methods 
Groups (n=5) of pinealectomised rats were starved for 24 hours 
prior to experimentation. At 21hOO, they were lightly anaesthetized 
with ether and injected with melatonin 250 ~g, 500 ~g, or 1 mg/kg 
b.w. or with melatonin vehicle only (control group), via the 
intraperitoneal route. They were then subjected to the stress 
procedure as previously described (Section 3.2.3). The rats were 
handled in the dark, in the light of a single dim photosafe red 
light source. After sacrifice, brains were examined to confirm the 
pinealectomy. 
3.6.5.3 Results 
Fig 3.9 indicates that the 
melatonin to pinealectomised 
inhibition of gastric lesion 
0.005). 
administration of small doses of 
rats results in a dose dependent 
formation (F(df=19) 6.82, P < 
Once again, an increase in gastric ulceration, comparable to the 
daytime effects of stress on gastric lesion formation, is noted in 
pinealectomised rats . 
A 100% success rate of the pinealectomies was attained. Once again, 
the rat brain appeared normal, and there was no visual indication 
of damaged or inflamed tissue. 
3.6.5.4. Discussion 
Miline (1979) noted that an aqueous extract of the pineal gland 
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EFFECT OF MELATONIN ON STRESS 
INDUCED GASTRIC ULCERATION IN 
PINEALECTOMIZED RATS 
CONTROL MEL 0.25 MEL 0.5 MEL 1 
DRUG TREATMENT (mglkg BW) 
Pinealectomized rats were treated with melatonin vehicle, 
or with melatonin (0.25 mg, 0.5 mg, or 1mg/kg bw ip) prior to 
stress induction in the dark phase. Melatonin inhibits lesion 
formation in pinealectomized rats stressed in the scotophase, 
suggesting that it is probably the prime pineal substance 
responsible for the reduction in lesion formation noted in intact 
rats (see fig 3.8). 
F(df-19) ~ 6.82, P < 0.005. 
* ~ significantly different to control . 
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caused an inhibition in aggressiveness in the male species of the 
fish Betta splendens as well as an inhibition of aggressiveness and 
crowing in cocks of the Bantam breed. Changes in the morphodynamics 
of the thyroid gland, the adrenal gland, and the lymphatic gland 
after exposure to irradiation stress (800 r) were very mild in 
animals treated with this aqueous extract as compared to the strong 
reactions shown in animals not treated with this extract. 
It has been suggested that the pineal gland modulates adrenal 
steroidogenesis in normal as well as stress conditions (Romijn, 
1978). Mehdi and Sandor (1977) suggested that melatonin may be 
involved in a modulation of corticosteroidogenesis . Dickson and 
Hasty (1972) proposed that the pineal gland secretes a substance 
that acts at the level of the hypothalmo-pituitary axis to reduce 
the production and release of ACTH with a resultant inhibitory 
influence on the pineal gland. 
Although the other pineal substances have not been excluded, it is 
evident from this study that melatonin is one of the important 
pineal substances responsible for the reduction of gastric lesion 
production observed in rats at night. 
The exact mechanism of this action has yet to be elucidated. 
3.6.6 EXPERIMENT 6: THE EFFECT OF MELATONIN ON INDOMETHACIN INDUCED 
GASTRIC ULCERATION. 
3.6.3.1 Introduction 
Cardinali et al (1987) investigated the 
(PG' s) on the pineal gland. They 
effect of prostaglandins 
found that a-adrenergic 
stimulation of pineal explants results in PGE2 release in the rat 
pineal gland. Cardinali and Ritta (1983) also observed that the 
administration of PG synthesis inhibitors eg indomethacin, impaired 
the nocturnal rise in pineal melatonin synthesis and decreased NA-
stimulated melatonin release . In vitro addition of PGE2 increased rat 
pineal cAMP levels , SNAT activity, and melatonin release. 
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The high concentrations of PG's in the gastro-intestinal wall 
throughout the GIT suggest that these agents may play an important 
role in gastro-intestinal physiology. It has been shown that the E 
type PG's are capable of preventing the formation of gastric ulcers 
induced by cold stress (Kawarada et ai, 1975) and a wide variety of 
non-steroidal anti-inflammatory drugs (NSAID's) such as aspirin and 
indomethacin (Lippman, 1974). 
Melatonin is also found in the GIT, and although a reason for its 
presence here has not been elucidated, it has been suggested that 
the hormone may playa physiological role in the GIT. 
3.6.3.2 Materials and Methods 
An indomethacin suspension 
carboxymethylcellulose for oral 
was prepared 
administration. 
in 
Rats 
0.5% 
(n~5) 
w/v 
were 
starved for 24 hours as previously described (section 3.2.3) and 
then fed with either 1) vehicle only, 2) indomethacin suspension 
(200mg/kg/ml) only, 3) or indomethacin suspension (200mg/kg/ml) 
followed by an ip injection of melatonin (1 mg/kg bw). Groups 1 and 
2 were also injected ip with melatonin vehicle. 
The rats were killed after 4 hours by neck fracture . Stomachs were 
dissected out, and examined for ulceration as previously described 
(section 3.2 . 3). 
3.6.6.3 Results 
Rats treated with vehicle only (group 
ulceration. Group 2 and group 3 had 
distinguishable from stress lesions 
round and oval shaped ulcers, and 
Administration of mel (lmg/kg bw 
1) presented with no gastric 
gastric lesions. These were 
in that they were smaller, 
they were clearly defined. 
ip) did not affect lesion 
formation significantly (see fig 3.10). 
3.6.3.4 Discussion 
It is thought that the prostaglandins have "cytoprotective " 
properties that prevent mucosal injury (Roberts, 1979) . The results 
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THE EFFECT OF MELATONIN ON 
INDOMETHACIN INDUCED 
GASTRIC ULCERATION. 
o~--
Indomethacin 
alone 
Indomethacin 
after melatonin 
Rats were given an oral dose of indomethacin, and 
immediately injected with melatonin (1 mg/kg bw ip) or melatonin 
vehicle . Drug-induced gastric ulceration was measured 4 hours 
later. Melatonin could not reverse the effects of indomethacin on 
gastric ulceration. 
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of this experiment show that blockade of de novo synthesis of 
prostaglandins by the administration of a cyclo-oxygenase inhibitor 
(indomethacin) results in gastric ulceration. The inability of 
melatonin to counter this effect suggests that melatonin does not 
have a protective effect on drug-induced gastric ulceration, and 
does not act via the prostaglandin system. 
3.6.7 EXPERIMENT 7: THE EFFECT OF VARIOUS DOSES OF MORPHINE ON STRESS 
INDUCED GASTRIC ULCERATION. 
3.6.7.1 Introduction 
Endogenous opioids have been implicated in many of the biochemical, 
physiological, and behavioural responses to s t ress (Adams, 1987). 
In 1977, Guilleman et al showed that, in rats, l3-endorphin and ACTH 
are secreted simultaneously by the pineal gland in response to 
stress . This stirred much interest as to the role of the opiates in 
stress . Many studies have since examined the role of the opiates 
and opiate antagonists in gastric stress pathology, and 
contradiction exists as to their exact function . 
Much of the 
differences 
apparent 
in the 
conflict 
route of 
in the literature may be due to 
administration, the drug dose 
administered, the method of stress employed, and the chronicity of 
the challenge. 
Some investigators have found that the opiate antagonist, naloxone, 
decreases stress ulcer formation (Dai and Chan, 1983 ; Del Tacca et 
ai, 1987) . Others have found that intraperitoneal or 
intracerebroventricular administration of opiates reduces gastric 
stress ulceration . 
This experiment was undertaken to examine the effects of morphine 
on stress induced gastric lesions. 
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3.6.7:1. Materials and Methods 
Ra ts (n~5) were starved for 24 hours, anaesthetized with ether, 
injected with morphine HCI (1 mg, 5 mg, or 10 mg/kg bw ip) or 
control vehicle (normal saline). 
They were killed by neck fracture after 2 hours, and stomachs were 
examined for gastric ulceration (see section 3 . 2.3). 
3.6.7.3 Results 
Fig 3 . 11 shows that morphine induces a dose dependent inhibition of 
gastric ulceration at the doses used in this study. (f(df=19) = 
11.13, P < 0.0005) 
3.6.7.4 Discussion 
Arrigo-Reina and Ferri (1980) showed that exposure of rats to 
stressful stimuli (restraint, cold [4°C for 5 hours)) led to the 
production of gastric lesions. Treatment of rats with 10mg/ kg bw 
morphine inhibited stress lesion formation to an extent that it was 
practically non-existent. 
The results obtained in this study disagree with those of Ho et al 
(1984) who observed that morphine produced a naloxone reversible, 
dose dependent exacerbation of lesion production in pylorus ligated 
rats. Restraint stress ulceration and pylorus ligation induced 
ulceration have different etiologies, especially as pertains to the 
localisation of the gastric damage. Stress ulcers occur in the 
glandular region of the stomach, whereas pylorus ligation induced 
ulceration occur in the non-secreting portion of the stomach 
(rumen) - and the discrepancy in the results obtained could be 
indicative of a possibility that morphine and naloxone exert 
different effects when used with different ulcer inducing methods . 
In fact, it has been shown by other investigators (Tanaka et ai, 
1983) that morphine accelerates brain NA turnover and core 
temperature in non-stressed rats, and the reverse occurs in 
stressed rats (ie reduced NA turnover and hypothermia) . 
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EFFECT OF VARIOUS DOSES OF 
MORPHINE ON GASTRIC STRESS 
ULCER PRODUCTION 
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Rats were treated with morphine (1 mg, 10 mg, or 5 mg/kg 
bw ip) or saline vehicle prior to exposure to stress. Morphine 
induces a dose dependent inhibition of gastric stress lesion 
formation in rats, with the 10 mg/kg dose affording an almost 90% 
protection as compared to controls. 
F(df=19) - 11.13, p < 0 . 0005) 
The findings of this 
conditions of stress, 
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study show clearly that , under these 
morphine significantly inhibits gastric 
stress ulceration in a dose dependent manner. These results are 
supported by the reports of other investigators (Glavin, 1985; 
Arrigo-Reina and Ferri, 1980; Glavin et ai, 1986; Ferri et ai, 1983) 
who observed similar effects of morphine on stress induced gastric 
ulceration . 
These observations thus suggest a protective effect of morphine 
against gastric damage caused by exposure to stress. 
3.6.8 EXPERIMENT 8 : THE EFFECT OF VARIOUS DOSES OF NALOXONE ON 
STRESS INDUCED GASTRIC ULCER FORMATION. 
3.6.8.1 Introduction 
The pituitary and adrenal glands play an important role in 
regulating the physiological responses to stress (Selye, 1974). ~­
endorphin and ACTH are derived from a common precursor molecule 
(Mains et ai, 1977) and are released simultaneously in acute stress 
(Guilleman et ai, 1977). Enkephalin-like material may also be stored 
with catecholamines in adrenal medullary chromaffin cells, and may 
be released simultaneously in response to stress (Viveros et 
al,1979). These observations suggest a possible role for the 
opioids in stress. 
Contradictory evidence has been found on the effects of the opiate 
antagonist naloxone on gastric ulceration induced by stress. 
Dai and Chan (1983) observed a significant reduction in gastric 
stress ulceration using high doses of naloxone (25 mg and 50 mg/kg 
bw), and suggest that the endogenous opioids may playa role in the 
causation of gastric stress ulceration. Del Tacca et ~ (1987) also 
observed a reduction in severity of ulceration in pylorus ligated 
rats using smaller (4 mg/kg bw ip) doses of naloxone . 
Other workers have found evidence to the contrary (Glavin, 1985; 
Ferri et ai, 1983; Glavin et ai, 1986) showing an exacerbation of 
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gastric stress lesions by naloxone . 
The following study was thus undertaken to observe the effects of 
various doses of naloxone on gastric stress ulceration. 
3.6.8.2 Materials and Methods 
Rats were starved for 24 hours, injected with naloxone (10 mg, 20 
mg, or 30 mg/kg bw ip) or control vehicle (normal saline), and 
subjected to stress for 2 hours. (see section 3.2.3) 
They were killed by neck fracture, stomachs were removed, and 
examined for gastric ulceration. 
3.6.83 Results 
The results from this study indicate that naloxone induces a dose 
dependent exacerbation of gastric ulceration, evident from the 
smallest dose of naloxone used in this study. (F(df~19) - 30.21, 
P < 0.0001) - see figure 3.12. 
3.6.8.4 Discussion 
The results observed in this study are supported by the reports of 
various other investigators (Arrigo-Reina and Ferri, 1980; Glavin, 
1985; Fer!! elal, 1983; Glavin elal, 1986). 
Dai and Chan (1983), however, found that naloxone inhibits stress 
lesion formation. The experimental design used by these authors 
differs from this and other studies, in that the animals used in 
their study were allowed access to an 8% sucrose solution 
throughout the pre-stress starvation period and were exposed to 
restraint immobilization and cold for only 1 hour. 
Glavin (1980) suggests that both these factors tend to reduce the 
incidence of gastric ulceration. Thus, using this procedure, the 
method of Dai and Chan (1983) may have been inadequate to determine 
the effects of naloxone on gastric stress pathology . 
It has been suggested that the endogenous opioids may operate in a 
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EFFECT OF VARIOUS DOSES OF NALOXONE 
ON GASTRIC STRESS ULCER FORMATION 
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Fig 3.12: Naloxone (10 mg, 20 mg, and 30 mg/kg bw ip) or saline 
vehicle was administered to rats prior to exposure to stress . 
Naloxone induces a dose-dependent exacerbation of lesion formation . 
F(df-19) - 30.21, p < 0.0001 . 
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homeostatic system in the adaptive response of the organism to 
stressful stimuli (Arrigo-Reina and Ferri, 1980). 
The results obtained from this study support their argument to some 
extent. The effects of the stress-induced release of i3-endorphin 
(Guil1eman ef ai, 1977) were possibly blocked by the opiate 
antagonist naloxone, with a resultant exacerbation in lesion 
production, suggesting a role for the endorphins in stress. 
However, this finding is based on the assumption that naloxone only 
exerts an opiate-antagonizing effect, and cannot exclude the 
possibility that this exacerbation of stress induced ulceration is 
due to a yet unknown possible pharmacological action of naloxone. 
3.6.9 EXPERIMENT 9: THE EFFECT OF NALOXONE ON GASTRIC STRESS 
ULCERATION IN MORPHINE TREATED RATS. 
3.6.9.1 Introduction 
The previous experiments have shown that morphine induces a dose 
dependent inhibition in lesion formation (fig 3.11) and naloxone 
exacerbates lesion formation in a dose dependent manner (fig 3.12) . 
This experiment was undertaken to examine the effects of various 
doses of naloxone on stress ulceration induced in morphine treated 
rats. 
3.6.9.2 Materials and Methods 
Rats (n=5) were starved for 24 hours prior to experimentation. One 
group of rats was injected with control vehicle only (normal 
saline), another with morphine (5mg/kg bw ip) only, and the 
remaining groups with morphine 5mg/kg bw and naloxone (10 mg, 20 
mg, or 30 mg/kg bw) prior to stress induction. After exposure to 
stressors, they were sacrificed by neck fracture and stomachs were 
examined for ulceration (see section 3.2.3) 
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3.6.9.3 Results 
The results (fig 3.13) indicate that morphine reduces the incidence 
of lesion formation as compared to control rats. This effect of 
morphine was significantly antagonised by the 20 mg/kg and 30 mg/kg 
doses of naloxone. The administration of 10 mg/kg of naloxone had 
no significant exacerbating effect on morphine induced inhibition 
of lesion formation. Although naloxone exacerbated lesion formation 
at the higher doses. the total length of ulceration was reduced in 
the presence of morphine for both the 20 mg/kg (12.82 ± 3.62) and 
the 30 mg/kg (14.63 ± 3.26) doses when compared to the effect of 20 
mg/kg (16.92 ± 2.86) and 30 mg/kg (25.91 ± 2.33) naloxone in the 
absence of morphine (see fig 3.12 ). 
3.6.9.4 Discussion 
The results obtained from this study indicate. once again.· that 
morphine inhibits, and naloxone exacerbates. the production of 
stress induced gastric ulceration. 
These observations are supported by other investigators (Arrigo-
Reina and Ferri, 1980; Ferri et ai, 1983; Glavin, 1985; Glavin et ai, 
1986) who also observed a naloxone reversible inhibition of lesion 
formation by morphine. 
3.6.10 Experiment 10: THE EFFECf OF MORPHINE AND MELATONIN ON STRESS 
INDUCED GASTRIC ULCERATION. 
3.6.10.1 Introduction 
The production of the pineal hormone, melatonin is known to be , 
altered by various stressful stimuli (Lynch et ai, 1973; Vaughan et ai, 
1978; Tannenbaum et ai, 1988; Troiani et ai, 1988 ). Studies have shown 
an activation of the melatonin biosynthetic pathway on exposure to 
stressful stimuli in rats (exp 1, Vaughan et ai, 1978; Lynch et ai, 
1973) suggesting a possible role for the pineal gland in stress. 
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EFFECT OF NALOXONE ON GASTRIC 
STRESS ULCERATION IN MORPHINE 
TREATED RATS 
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Fig 3.13: Naloxone (10 mg, 20 mg and 30 mg/kg bw ip ) or saline was 
administered to morphine treated rats prior to stress - induction . 
Control rats were injected with saline only . Morphine inhibits 
lesion formation . Naloxone reverses the effect of morphine (5 mg/kg 
bw ip) on stress-induced gastric ulceration . 
* = significantly different to control and naloxone (20 mg and 30 mg) . 
** = significantly different to control as well as morphine and naloxone (10 
mg) . 
F(df~24) ~ 3 . 57 , P < 0 . 05 . 
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The opioidergic system is also known to attenuate the effects of 
stress in animals (Tanaka et ai, 1985; Dai and Chan, 1983; Del Tacca 
et ai, 1983; Selye, 1974; Glavin, 1985; Ferri et ai, 1983; Glavin et ai, 
1986). A direct physiological mechanism for this action has not yet 
been elucidated . 
It was recently observed that melatonin counteracts the effects of 
acute stress on thymus weight, acting via an opioidergic mechanism 
(Maestroni et ai, 1988) . This suggests a possible interaction 
between these two systems in the modulation of the stress response . 
The following experiment was undertaken to examine the effects of a 
combination treatment of morphine and melatonin on gastric stress 
ulceration. 
3.6.10.2 Materials and Methods 
Rats (n=5) were starved for 24 hours prior to experimentation and 
they were injected with vehicle, morphine HCl (10mg /kg bw), mel 
(lmg/kg bw) or morphine (10 mg/kg) plus melatonin (1 mg/kg) prior 
to stress induction. The animals were sacrificed 2 hours later, and 
stomachs were examined for the presence of ulceration as described 
earlier (section 3 . 2.3). 
3.6.10.3 Results 
The results (fig 3 . 14) indicate, once again, that melatonin and 
morphine individually reduce the incidence of gastric stress ulcer 
formation in rats. A combination of these two treatments shows 
neither antagonism nor potentiation of this effect (F(df=19) 
20.82, P < 0 . 0001) . 
3.6.10.4 Discussion 
Yet again, it is evident from this study that both morphine and 
melatonin have a protective action against gastric stress induced 
ulceration. 
The exact locus of this action, be it a centrally mediated or a 
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EFFECT OF MORPHINE AND MELATONIN ON 
GASTRIC STRESS ULCER PRODUCTION 
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Fig 3.14: Rats were treated with saline vehicle, melatonin (1 mg/kg 
bw ip) , morphine (10 mg/kg bw ip), or melatonin (1 mg/kg) plus 
morphine (10 mg/kg). Both morphine and melatonin significantly 
inhibit lesion formation and a combination treatment shows no 
antagonism of this effect. 
F(df=19) = 20.82, P < 0.0001. 
* = significantly different to control . 
, . 
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peripheral effect, has yet to be determined. 
3.6.11 Experiment 11: THE EFFECf OF NALOXONE ON MELATONIN INDUCED 
REDUCfION IN GASTRIC STRESS ULCERATION. 
3.6.11.1 Introduction 
The results from the previous experiment show that both morphine 
and melatonin reduce gastric stress ulceration. The question thus 
arises whether melatonin reduces gastric ulceration via an 
opioidergic mechanism . Alternatively, the noted effect could result 
from an action of morphine and melatonin via their own separate 
mechanisms. If melatonin is acting via an opioidergic mechanism, it 
would be expected that the opioid antagonist naloxone would 
counteract its stress-ulcer reducing activity. 
This experiment was undertaken to elucidate the probabiliti that 
melatonin was acting via an opioidergic mechanism to reduce gastric 
stress ulceration. 
3.6.11.2 Materials and Methods 
Rats (n=5) were starved for 24 hours as previously described 
(section 3.2.3). They were injected with control vehicle, melatonin 
10mg/kg bw, naloxone 12.5 mg/kg bw, or melatonin 10 mg/kg bw plus 
naloxone (12.5 mg/kg bw), prior to stress induction. 
2 hours later, they were killed by neck fracture, and stomachs were 
examined for ulceration. 
3.6.11.3 Results 
The results (fig 3 . 15) from this experiment indicate that: 
1) naloxone exacerbates lesion formation; and 
2) melatonin inhibits gastric stress lesion formation; 
3) naloxone shows no antagonism of the inhibition of gastric stress 
ulceration by melatonin. 
(F(df=18) 41.47, P < 0.0001) 
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EFFECT OF MELATONIN AND NALOXONE 
ON GASTRIC STRESS ULCER FORMATION 
** 
CONTROL NALOXONE MELATONIN MEL + NAL 
Fig 3.15: Rats were treated with saline, naloxone (12.5 mg/kg bw ip), 
melatonin (10 mg/kg bw ip), or melatonin (10 mg/kg) plus naloxone 
(10 mg/kg). Naloxone could not reverse the effects of melatonin on 
stress-induced gastric ulceration, suggesting that melatonin's 
action is not exerted via an opioidergic mechanism . 
* ~ significantly different to control and naloxone. 
** - significantly different to control and other treatment groups. 
F(df-19) - 41 . 47, p < 0.0001. 
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3.6.11.4 Discussion 
Recent observations have suggested a possible interaction between 
the pineal gland and the opioid system (Lakin et ai, 1981; Esposti 
etai, 1986; Reiter, 1988; Lissoni etal, 1988) 
Thymus involution, as well as gastric ulceration, is used as a 
marker for exposure to stress (Pare and Glavin, 1986). Maestroni et 
al (1988) recently observed that melatonin counteracts the effects 
of stress on thymus weight . This protective effect could be 
indicative of a possible anti-stress effect of melatonin. 
These investigators, however, also observed that this effect of 
melatonin was exerted via an opioidergic mechanism. The results of 
the present study (fig 3 . 15) show that it is unlikely that 
melatonin does acts via an opioidergic mechanism to counter the 
effects of stress on gastric ulceration. 
The study of Maestroni et al (1988) differs from the present study in 
that 1) thymus involution was used as a measure of exposure to 
stress; and 2) animals were restrained in 50 ml plastic tubes for 4 
days from 10hOO in the morning. This method produced anxiety but 
not complete immobilization . 
The application of stress in this manner could 
immunosuppressive effect in the animals used in 
resulting in thymus involution. Selye (1976) and 
Solomon (1974) have concluded that excessive stress 
have had an 
their study, 
Amkraut and 
can exert a 
generalized immunosuppressive effect 
involution. 
characterized by thymus 
It has been shown that ~-endorphin modulates immune functions 
(Fischer and Falke, 1984). Maestroni et al have previously shown that 
inhibition of melatonin synthesis leads to a significant depression 
of humoral and cell-mediated immune responses in mice; and evening 
administration of melatonin antagonizes the immunosuppressive 
effect of corticosterone in mice (Maestroni et ai, 1986). They also 
observed that this immunoaugmenting effect of melatonin was 
antagonized by naloxone (Maestroni etal, 1986) . 
164 
It could perhaps therefore be suggested that the antagonism of 
thymus involution by melatonin noted by these workers is probably 
mediated via an immunological, and not an anti-stress mechanism. 
From the above study (fig 3.15) it is clear that at the doses used 
here, naloxone does not antagonize the effect of melatonin on 
gastric ulceration, ruling out the possibility of an opiate 
mediation of melatonin's anti-stress effect. 
The exact mechanism!s of action of melatonin and the pineal gland 
in stress have not yet been elucidated; and as such the clinical 
significance of these studies, as well as those of Maestroni el ai, 
(1986) have yet to be clearly evaluated. 
Taking into consideration that the opioid system is not responsible 
for melatonin's action in stress, the presence of GABA-ergic and 
benzodiazepine binding sites in the pineal gland suggests· that 
GABA-ergic mechanisms may be involved in some aspect of pineal 
physiology (Cardinali, 1988) and melatonin could exert some 
benzodiazepine-like psychopharmacological effects (Niles, 1988). 
3.6.12 Experiment U: EFFECT OF DIAZEPAM ON STRESS INDUCED GASTRIC LESIONS 
IN PINEALECTOMIZED RATS. 
3.6.12.1 Introduction 
The previous experiments carried out in this study have indicated 
that melatonin does not exert an anti-stress effect via an 
opioidergic mechanism. This experiment was undertaken to observe 
the effects of diazepam on gastric stress ulceration in 
pinealectomized rats. 
Diazepam is an anxiolytic agent able to inhibit the nocturnal 
increase in SNAT activity (Zatz and Browenstein, 1979) possibly by 
an effect on the hypothalamus resulting in a reduced adrenergic 
stimulation of the pineal gland. 
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3.6.12.2 Materials and Methods 
Intact and pinealectomized rats (n=5) were starved for 24 hours 
prior to experimentation. Intact rats were then injected with 
control vehicle, or diazepam 5 mg/kg bw, via the intraperitoneal 
route. The same procedure was undertaken using pinealectomized 
rats . They were stressed at 21hOO for two hours, killed by neck 
fracture, and examined for gastric ulceration (section 3.2.3). 
3.6.12.3 Results 
The results show that pinealectomized rats exhibit an increased 
incidence of lesion formation when compared to untreated controls . 
The inhibitory effect of diazepam on gastric stress ulceration is 
more prevalent in intact rats. Pinealectomized rats treated with 
diazepam show no significant difference in lesion production when 
compared to intact rats (see fig 3.16). 
3.6.12.4 Discussion 
Niles (1988) has suggested that the pineal 
the psychopharmacological 
hormone melatonin 
exhibits some of effects of the 
that 
brain 
benzodiazepines. Pyridoxal phosphokinase is an 
catalyzes the formation of pyridoxal phosphate 
(McCormick and Snell, 1959). Pyridoxal phosphate is 
enzyme 
in the 
essential for 
the synthesis of DA, 5- HT, and GABA (Lovenberg et ai, 1962). Anton-
Tay el al (1970) observed that ip administration of small doses of 
melatonin (0.25 mg/kg 4 mg/kg) caused a significant dose 
dependent increase in pyridoxal phosphate activity in the brain. 
This action could affect various brain functions, especially 
serotoninergic and GABA-ergic mechanisms. Melatonin could thus 
alter the metabolic activity of the brain by increasing pyridoxal 
phosphate content. 
Studies on rat pineal glands have indicated the presence of an 
exclusive population of peripheral-type benzodiazepine (BZP) 
receptors (Lowenstein et al, 1984), and pineal BZP binding 
decreased by 30-60% in SCGx rats. This suggests that intact 
sympathetic nerves are required for the benzodiazepines to manifest 
~ 
z 
H 
z 
0 
H 
E-< 
;2 
'" u ...,
::> 
r.. 
0 
'" E-< 
" Z 
'" 
..., 
..., 
<>: 
E-< 
0 
... 
166 
EFFECT OF DIAZEPAM ON THE FORMATION 
OF STRESS-INDUCED GASTRIC LESIONS 
TOTAL LENGTH OF ULCERATION IN mm 
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Fig 3.16: Intact and pinealectomized rats were treated with vehicle 
or diazepam (5 mg/kg bw) prior to the induction of stress in the 
dark phase. The inhibitory effect of diazepam on gastric stress 
ulceration in intact rats (***) is significantly different to that 
in pinealectomized rats (**). 
8.35, P < 0.01 . 
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a total effect on the pineal gland. 
The results obtained in this study indicate that an intact pineal 
gland is necessary to modulate the protective effect of diazepam on 
gastric stress ulcer production . 
It could thus be suggested that the pineal gland modulates the 
stress response via a GABA-ergic mechanism. 
Further research in this direction did not fall within the scope of 
this study. 
3.6.13 Experiment 13: THE EFFECT OF ACTMTY CYCLE ON STRESS 
INDUCED GASTRIC LESIONS IN RATS. 
3.6.13.1 Introduction 
It has been suggested by other investigators (Ader,1964; also cited 
in Pare and Glavin , 1986) that the relationship between the applied 
stressor and the animals activity level has to be considered when 
evaluating the response to stress. 
An experiment carried out by Ader (1964) showed that restraining 
rats at the peak of their ac tivity cycle is associated with lesion 
production, whereas restraint in the inactive period produced no 
ulceration . The investigator proposed that the perception of the 
restraint stress by the rat would be more intense if it were 
stressed as it was approaching its period of greatest activi ty, 
than it would be during relatively inactive periods . 
The night-time experiments in this study were carried out at 21hOO, 
3 hrs after lights off (when SNAT activity is maximal). Results 
from these experiments showed a reduction in ulceration in rats 
stressed at this time than rats stressed during the day (see fig 
3 . 7). 
Rats are nocturnal animals , and an increase in activity would thus 
be expected in the scotophase . This experiment was thus undertaken 
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to compare the activity level of rats subjected to stress at 21hOO 
to the activity level at other time points. 
3.6.13.2 Materials and Methods 
Groups of rats (n-6, using 6 groups of 3 rats each ~ 18 rats) were 
placed in an activity monitor (described later) linked to a data 
processor for 48 hours. They were allowed access to food and water 
ad libitum so as to prevent any disturbances in activity due to 
starvation. Food boxes and water bottles were replenished at 06hOO 
daily. Activity levels were monitored every 20 minutes for 48 
hours. Animals were maintained under the normal LD 12:12 cycle by 
manual regulation of the light switch. 
3.6.13.3 Results 
The results show a cyclic pattern of activity over a two day 
period; with peak activity during the dark phase of the LD cycle, 
and rats most active between 20hOO and 23hOO (see fig 3.17). 
3.6.13.4 Discussion 
From the above it has been ascertained that rats stressed at 21hOO 
were at the peak of their activity cycle, and yet showed a lower 
incidence of ulceration when compared to rats stressed at 09hOO. 
These results differ from those of Ader (1964). The method of 
experimentation used by Ader has important differences when 
compared to this method:-
1) Lights were kept on throughout the experiment (2 
weeks); and 
2) Rats were stressed without a pre -restraint starvation 
period. Food was present in the stomachs of 8 out of 13 rats 
stressed at the time of low activity, and two out of 17 rats 
stressed during peak activity. 
The presence of light could have altered many endogenous rhythms in 
the rat, and most definitely abolished the melatonin rhythm 
(Axelrod, 1964). It has been shown that an intact pineal gland (fig 
a: 
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SPONTANEOUS 
LOCOMOTOR ACTIVITY 
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Fig 3.17: Rats show a cyclic pattern of activity over a two day 
period, with peak activity in the scotophase (---) when melatonin 
synthesis is high. 
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3 . 8), actively secreting melatonin (fig 3.9), protects against 
stress induced gastric ulceration. Rats stressed in the dark phase 
of a normal LD 12 : 12 cycle would therefore most probably present 
with less ulcers when compared to rats kept in a continuous 
lighting cycle. In the absence of the nocturnal increase in 
melatonin synthesis (as induced by constant lighting), it could 
possibly be suggested that the increase in gastric ulceration 
noted by Ader, (1964) could be a function of the state of activity 
of the rat. 
The presence of food in the stomach protects against lesion 
formation (Pare and Glavin, 1986). 70 . 15 % of the rats stressed at 
the low activity period had food in their stomachs, and there is no 
indication of the level of protection afforded to rats by food that 
may have been present during the restraint period. 
It could thus be suggested that the method used by Ader for 
determining the effect of activity level on gastric stress 
ulceration was not adequate . 
It could be concluded from this study that the application of 
stress at the peak of the activity cycle is associated with a 
reduction in lesion formation . 
CONCLUSION 
The mind and body are so closely interwoven that it is difficult to 
perceive a physiological stressful event that does not initiate a 
somatic stressful one and vice versa. 
Intense stress is associated with a variety of central and 
peripheral changes . These include gastric ulcers, hypertrophy of 
the adrenal glands, increased plasma levels of corticosterone, 
fatty acids and glucose, atrophy of the thymus and the spleen, 
hypothermia, and accelerated NA and DA turnover in the brain 
(review, Pare and Glavin, 1986) . 
The novel experimental work undertaken in this study indicates that 
the pineal gland is responsible for the circadian variation in 
171 
lesion formation observed in stressed Wistar rats at night and low 
doses (100 ~g 500 ~g) of melatonin reduce gastric stress 
ulceration . This effect is not mediated via an 
mechanism and peliminary evidence exists for 
modulation of this effect by a GABA-ergic mechanism. 
opioidergic 
a possible 
The mode of action of melatonin in the prevention of lesion 
formation could be a cytoprotective one at the level of the GIT or 
a peripheral (adrenal glands) or central (eNS) anti-stress effect. 
Further research could be carried out to determine the effect of 
melatonin on the stomach. Evidence already exists to show that 
melatonin pre-treatment protects against ethanol induced gastric 
ulcera tion in vitro (Cho et a/, 1988), and work carried out in this 
study indicates that melatonin affords no protection against . 
indomethacin induced gastric ulceration in vivo. Studies on the effect 
of melatonin on acid and mucus production, or the inhibition 
thereof, would be valuable in determining a possible cytoprotective 
action of this hormone . 
Farrel (1960) was the first investigator to suggest that the pineal 
gland secretes a factor that is capable of inhibiting adrenal 
steroidogenesis . Earlier, other workers (Wurtman et a/1959) noticed 
an increase in adrenal weight in female rats following 
pinealectomy. Dickson and Hasty (1972) suggested that the pineal 
gland secretes a substance which blocks the synthesis and release 
of ACTH at the hypothalamo-pitui tary level, thus resulting in an 
inhibitory action upon the adrenal glands . Ogle and Kitay (1976) 
concluded that the pineal gland, together with the ovaries, plays a 
role in the modulation of adrenal steroidogenesis. 
Anton-Tay (1970) observed that melatonin administration increases 
brain pyridoxal phosphate activity, a precursor necessary for the 
production of NA, DA and GABA (Lovenberg et a/ , 1962). He also found 
that melatonin increases brain serotonin concentrations. 
It could thus be suggested that the pineal gland and melatonin 
modulate some aspect of the response to stress. 
The search for new , safe and efficient drugs to improve the quality 
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of our lives and its expectancy is unending . The many side effects 
of prol onged stress, such as tension headaches, lower back pains, 
gastric ulceration, and the life-threatening hypertension, could 
very well lead to a decrease in productivity and joidevivre. 
Modern day therapy for the treatment of stress related disorders 
include the barbiturates and the benzodiazepines. Neither of these 
drugs is ideal. 
Clinical investigations into the extent and 
melatonin IS action in stress could be invaluable . 
mechanism of 
This substance 
could be a possible stress-reducing compound, and may very well 
provide us with a lead product for the development of a safer 
alternative for stress therapy. 
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CHAPTER FOUR 
ANALGESIC TESTING 
5.1 INTRODUCTION 
Medical science is still involved in a relentless quest for newer 
drugs that alleviate pain; a syndrome with which every human being 
inevitably becomes familiar. 
Pain is such a subjective and intimate experience that it is 
difficul t to find a suitable definition for it. Lednicer (1982) 
described pain as being the 'sensory phenomenon that may occur in 
response to noxious stimuli. This phenomenon has a physiological 
(magnitude of tissue damage, size, area) as well as a psychological 
(past experience, environmental setting, ethnic background) 
component (Lednicer, 1983) 
The use of opium as an analgesic goes back in antiquity. The 
Sumerians may have used it more than 5500 years ago - and it is 
mentioned in the 'Eber's Papyrus' (1500 B.C) - (deStevens, 1965). 
Some of the alkaloids derived from opium (eg morphine) are used 
clinically for the treatment of pain. 
The pineal hormone, melatonin, has been shown to exhibit analgesic 
activity in mice (Lakin, 1981; Sugden, 1983) whereas pinealectomy 
interferes with the nocturnal response of mice to morphine-induced 
analgesia. These findings suggested a role for the pineal gland in 
the mechanisms of analgesia. 
This study was undertaken to observe the effects of the opiates and 
the opiate antagonist, naloxone, on pain sensitivity; as well as to 
ascertain a possible role for the pineal gland in the opiate-
modulated analgesic response. 
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4.2 MATERIALS AND METHODS 
4.2.1 Animals 
Inbred female rats of the Wistar strain were used in all 
experiments . Rats were housed five per cage in an animal room under 
an automatically regulated lighting cycle of LD 12:12, with access 
to a standard diet and tap water ad libitum. It has been observed that 
ageing affects opioid analgesia (Kavaliers et al 1983) thus, per 
experiment , rats of similar age groups were always used. 
4.2.2 Pinealectomy 
Pinealectomies and sham operations were carried out as described 
earlier (chapter 3). Animals were used after a minimum of two weeks 
post-operation . Rats were killed by neck fracture after being used 
in experiments, and brains were examined for the absence of the 
pineal gland so as to confirm the success of the operation. 
4.2.3 Analgesic Testing 
Testing for analgesic activity in animals involves the presentation 
of a painful stimulus followed by an appropriate measurement of the 
animal's response to it . 
Various stimuli 
mechanical) may 
(chemical, 
be used to 
thermal, 
determine 
electrical, ultrasonic, 
analgesic activity. The 
thermal method of analgesic testing is widely used, and a tail-
immersion method was adopted for this study. 
Animals were weighed and marked 3 days prior to testing; so as to 
diminish the effects of stress due to handling . The tail of each 
rat was marked annularly, 3 cm from the tip . 
On the day of the experiment, the rat was injected with the test 
drug or vehicle as required. After the necessary lag time, the 
animal was placed in a plastic cylindrical tube, with tail emerging 
from one end. The tail was then quickly lowered to the 3cm mark 
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into a water bath set at 55°C (± O.SOC). The time that elapsed 
before the tail jerked or twitched was then recorded as the 
response time by an observer unaware of treatment conditions. The 
response time was measured in seconds, to the nearest one hundredth 
of a second, using a stopwatch. The animal was removed from the 
restraining tube immediately after each test. 
A cut-off time of 15 seconds was used to terminate the experiment 
so as to prevent tissue damage to the tail. Rats reaching the cut-
off time were assumed to display total analgesia. 
Experiments carried out in the dark phase were undertaken using a 
dim photosafe red light bulb to aid visibility. 
4.2.4 Statistics 
All data was statistically analysed using oneway analysis of 
variance followed by Scheffe' s post hoc test for multiple range 
comparisons; or the Students-t-test. 
43 EXPERIMENTS 
43.1 EXPERIMENT 1 : DETERMINATION OF THE ANALGESIC EFFECT OF 
VARIOUS DOSES OF MORPHINE IN RATS. 
43.1.1 Introduction 
Opium contains more than 20 distinct alkaloids, one of which is 
morphine. Morphine was first isolated in 1806 by Serturner (Goodman 
et al , 1981) - and he named it after the Greek god of dreams, 
Morpheus. 
Morphine is a potent analgesic agent, and although many new 
compounds producing analgesia have been synthesized, none of them 
have been found to be clinically superior to this opiate (Goodman 
et ai, 1981). Morphine thus remains the standard drug against which 
new drugs with analgesic activity are tested. 
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The following experiment was undertaken to examine the analgesic 
effect of various doses of morphine in rats. 
4.3.1.2 Materials and Methods 
Rats (n=5) were injected with saline or morphine (10, 20, 30 mg/kg 
bw ip) . They were then subjected to the tail immersion test at t = 
0, 20, 40, 60, and 80 minutes ; and tail flick responses were noted 
by an observer unaware of treatment conditions. Rats were removed 
from the restraining tube immediately after each determination. 
4.3.1.3 Results 
Results (fig 4.1) indicate that morphine exhibits good analgesic 
activity at all the doses used in this experiment. The reponse time 
for reaction to the noxious stimuli was significantly different 
from that of the control with all the doses of morphine used in 
this study, and at all time points excluding t ~ 0. The analgesic 
activity of morphine was dose-dependent. Rats treated with 30mg/kg 
bw morphine showed total analgesia at t = 40 minutes, and still 
exhibited significant analgesia at the last time point of testing 
(t = 80 minutes). 
4.3.1.4 Discussion 
The sensation of pain is a very necessary one for the prevention of 
damage to tissue and acts as a tell-tale sign of possible injury 
that may otherwise go unnoticed . Chronic pain, however, is 
debilitating . Morphine and its congeners are clinically useful 
drugs to counter chronic and intense pain. 
This experiment shows that morphine exhibits good analgesia in rats 
at the doses used. 
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Rats (n ~ 5) were injected with morphine (10 mg, 20 mg, 
and 30 mg/kg bw ip) or saline vehicle and tested for response to 
noxious stimuli. Morphine exhibits a significant dose-dependent 
antinociceptive effect in rats . 
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4.2 EXPERIMENT 2: DETERMINATION OF THE ENDOGENOUS RHYTHM OF 
ANALGESIA IN RATS 
4.3.2.1 Introduction 
Reynolds (1969) was the first investigator to report the presence 
of a potent analgesia following focal and electrical stimulation of 
the rat mid-brain. The presence of an endogenous pain modulating 
system was thus suggested. 
Research in the early 1970's lead to the characterisation of opiate 
receptors (Pert and Snyder, 1973; Simon et ai, 1973; Terenius et ai, 
1973), and spurred on the search for an endogenous opioid ligand, 
leading to the isolation of ~-endorphin (Li and Ching, 1976). 
The endogenous opiate system in mice and rats undergoes diurnal 
changes. Wesche and Frederickson (1979) have shown that the content 
of endorphin-enkephalin in mouse brain is greater in the afternoon 
than in the la te morning. Intracere broventicular inj ec tion of [3-
endorphin led to a dose related inhibition of the tail-flick and 
hot plate responses of mice to nociceptive stimuli (Loh, 1976). 
Many physiological and biochemical parameters vary in a circadian 
manner in rodents (Turke and Campbell, 1979). This experiment was 
undertaken to observe the response of rats to noxious thermal 
stimuli in the mid-dark and mid-light phases of the LD cycle. 
4.3.2.2 Materials and Methods 
Rats (n~12) were tested for the response to painful stimuli as 
described earlier (section 4.2.3) at t ~ 12hOO (mid-light) and t ~ 
24hOO (mid-dark). 
4.3.2.3 Results 
Figure 4.2 describes the results obtained from this experiment . An 
increase in the response time to painful stimuli is noted in the 
dark phase of the LD cycle as compared to that in the mid-light 
period. 
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Rats were sub j ected to the tail i nnnersion test at 12HOO 
and 24hOO. An increased latency in the response to nociceptive 
stimuli was noted in the dark phase . 
n = 12, t = 5 . 74, P < 0 . 001 
* = significantly diffe r ent to control 
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4.3.2.4 Discussion 
Chronobiological studies in man and other mammals have shown that 
the metabolism of neurotransmitters such as NA (Perlow et ai, 1978; 
Ziegler et ai, 1976) and DA (Schering et ai, 1978; Simon and George, 
1975) undergo diurnal rhythmic changes. 
Kerdelhue et al (1983) monitored j3-endorphin concentrations in the 
anterior and intermediate lobes of the pituitary gland and some 
brain regions in the male rat over a 24 hr time period. They 
observed a circadian variation in the concentration of this 
peptide, with the highest levels present in the dark phase of the 
LD cycle . 
Frederickson et ai, also observed a circadian rhythm in the response 
of mice to noxious stimuli (hot plate), with highest jump latencies 
being present in the dark phase of the LD cycle. 
The results of this study would thus support the existence of a 
time-dependent variation in analgesic activity, possibly due to a 
variation in the activity of j3-endorphin with time. 
4.3.3 EXPERIMENT 3: EFFECT OF NALOXONE ON THE NOCTURNAL RESPONSE TO 
NOXIOUS STIMULI IN RATS 
4.3.3.1 Introduction 
Naloxone is a competitive antagonist at mu, sigma, kappa and delta 
opioid receptors (Goodman et ai, 1981). Evidence for a physiological 
role of the endorphins and enkephalins as potential hormones and 
neurotransmitters is increasing (Frederickson , 1977) and it has 
been suggested that these peptides may function in nociception, 
neuroendocrine regulation, and may even influence mood and 
behaviour (Rodgers and Cooper, 1988) . 
The suggestion of a physiological role for these hormones would 
indicate that naloxone would have some direct pharmacological 
activity in naive animals, resulting from an antagonism of the 
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endogenous opioid system . 
This experiment was undertaken to observe the effects of naloxone 
on the nocturnal response of rats to painful stimuli. 
4.3.3.2 Materials and Methods 
Rats (n~6) were injected with naloxone (10 mg/kg bw ip) or saline 
vehicle at 24hOO. Fifteen minutes later, they were subjected to the 
tail immersion test described earlier (section 4.2 . 3). 
4.3.3.3 Results 
Figure 4.3 describes the results obtained from this experiment. 
Naloxone pre-treatment results in a reduced latency (response time) 
to painful stimuli as measured by the tail flick test. 
4.3.3.4 Discussion 
The results obtained from this experiment suggest that the 
endogenous opioids are responsible for the increased pain threshold 
noted in the dark phase (24hOO). This is indicated by naloxone's 
antagonism of the delayed response to noxious stimuli (heat) noted 
during the dark phase of the LD cycle. 
These observations support the suggestion of a role for the 
endogenous opioid peptides in the modulation of nociception. 
4.3.4 EXPERIMENT 4: DETERMINATION OF A POSSIBLE RHYfHM OF 
MORPHINE·INDUCED ANALGESIA IN RATS. 
4.3.4.1 lntroduction 
It is now widely recognized that opiates and opioid peptides 
produce analgesia through an activation of opioid receptors located 
at both spinal and supra-spinal levels (Dubner et ai, Basbaum and 
Fields, 1984). 
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EFFECT OF NALOXONE ON THE 
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Naloxone (10 mg/kg bw ip) or saline vehicle was 
administered to rats in the dark phase prior to analgesic testing. 
The opioid antagonist was observed to reduce the response time of 
rats to noxious stimuli. 
n - 6, t = 2.91, P < 0.01 
* = significantly different to control 
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Loh et at (1976) observed that the administration of the opioid 
peptide ~-endorphin directly into certain brain areas resulted in a 
potent analgesia . They found that ~-endorphin, when compared to 
morphine sulphate on a molar basis, was 18-33 times more active as 
an analgesic agent . 
The previous experiments suggest that the variation in the response 
to noxious stimuli observed in rats at the mid-dark and mid-light 
phases of the LD cycle is possibly due to a circadian variation in 
the the activity of ~-endorphin. This experiment was undertaken to 
determine whether rats exhibited a variation in the susceptibility 
to morphine-induced analgesia at different time points (12hOO and 
24hOO) in the LD cycle. 
43.4.2 Materials and Methods 
Rats were treated with morphine HCl (10mg/kg bw ip) or saline 
vehicle at 12hOO (n=8) and 24hOO (n=10). Twenty minutes after drug 
administration, the rats were tested for analgesic response as 
described above (section 4.2 . 3). 
43.43 Results 
Figure 4 . 4 describes the results obtained in this experiment . Rats 
show an increased nocturnal analgesic response to noxious stimuli, 
as well as an increase in morphine-induced analgesia. (F(df=35) = 
62.46, P < 0.001) 
43.4.4 Discussion 
Naber et at (1980) demonstrated that neurotransmitters as well as 
their specific receptors exhibit circadian rhythms. Although the 
receptor affinity remains unchanged, the number of binding sites of 
these receptors change significantly throughout the day. 
Opioid peptide levels and pain sensitivity have been shown to 
undergo diurnal rhythms in mouse brain (Wesche and Frederickson, 
1979), with higher levels and jump latencies observed at 15hOO than 
at 08hOO. 
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DAY!NIGHT RHYTHM OF MORPHINE 
ANALGESIA IN RATS 
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Fig 4.4: Rats were treated with morphine (10 mg/kg bw ip) or 
saline vehicle in the light (n = 8) and dark (n = 10) phase . An 
increase in the endogenous as well as morphine-induced response to 
the noxious thermal stimulus was noted in the dark phase . 
62 . 45, P < 0 . 001 
* = significantly different to all treatment groups 
** A significantly different to all treatment groups 
*** significantly different to all treatment groups 
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Naber et ai, (1980) investigated opioid receptor binding (using [3Hl-
naloxone) in rat brain and found that these receptors undergo a 
circadian rhythm, with maximal binding in the first half of the 
dark phase. 
The possible circadian activation of the endorphin system could 
thus be responsible for the increased analgesic effect of morphine 
noted in the dark phase (fig 5.4). Similar effects have been noted 
in mice (Lutsch and Morris, 1971; 1972) and other rodents (Pilcher 
et ai, 1982; McGivern and Bernston, 1980; Rosenfeld and Rice, 
1979), thus supporting these findings. 
It has been suggested that a component of morphine-induced 
analgesia may be contributed via the release of endogenous opioids. 
4.3.5 EXPERIMENT 5: INVESTIGATION INTO THE CIRCADIAN RHYfHMS IN 
SUSCEPTIBILITY TO NOXIOUS STIMULI 
4.3.5.1 Introduction 
In 1967, Morris and Lutsch observed a quantitative variation in 
morphine-induced analgesia over a 24 hr time scale. These 
variations were evident in the heightened analgesia observed in the 
12 hr dark period and the reduced levels in the 12 hr light period. 
Pilcher et ai, (1982) observed that the aversiveness (taste-
conditioning) of naloxone during the dark phase was significantly 
different from that of the light phase; and that the analgesic 
potency of morphine varied within these phases. 
Frederickson et ai, . (1977) observed diurnal rhythms in naloxone-
induced hyperalgesia in mice. Similar effects were noted in rats by 
other investigators (Rosenfeld and Rice, 1979). 
The previous experiments have indicated an increased sensitivity to 
morphine induced analgesia in the dark phase (fig 5.4). Naloxone 
was observed to reduce the increase in the response to painful 
stimuli noted in the scotophase. 
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This experiment was undertaken to observe the response of rats to 
noxious stimuli at various points in a 24 hr LD 12:12 cycle. 
4.3.5.2 Materials and Methods 
Groups of rats (n=5) were subjected to the analgesic test described 
above (section 4.2.3) at one of seven 4 hr intervals over a 24 hr 
time period, commencing at 16hOO on day 1 and ending at 16hOO on 
day 2. Animals were injected with saline, morphine HCI (10 mg/kg bw 
ip) or naloxone HCI (10mg/kg bw ip) 20 minutes and 15 minutes (in 
the case of naloxone) prior to analgesic testing. A total of 105 
rats was used in this experiment. 
4.3.5.3 Results 
Fig 4.5 illustrates the results obtained from this experiment. A 
circadian rhythm in the analgesic activity of morphine and the 
hyperalgesic activity of naloxone, with peak analgesic activity in 
the scotophase is prevalent. A circadian rhythm of response to 
noxious stimuli is noted for saline treated controls, with peak 
response times in the dark phase, and lower reponses in the light 
phase. 
4.3.5.4 Discussion 
The results obtained from this study agree with those of other 
workers (Lutsch and Morris, 1971; 1972), who observed that morphine 
displays a quantitative variation in susceptibilty, characterized 
by peak analgesia in the . scotophase in mice. 
These investigators suggested that the i/lcrease in sensitivity to 
morphine in the scotophase could be due to a variability in the 
pain threshold or even to a variability in the quantity of morphine 
arriving at and reacting with the receptor site. 
Wirz-Justice et ai, (1982) and Naber et al (1981) have demonstrated a 
nocturnal increase in the binding of naloxone to opiate receptors 
in the brain, consistent with an increase in the number of binding 
sites. 
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24 HR SUSCEPTIBILITY PATTERN OF 
SALINE AND DRUG TREATED RATS 
TO NOXIOUS STIMULI 
16hOO 20hOO 24hOO 04hOO 08hOO 12hOO 16hOO 
A rhythm in endogenous and morphine induced analgesia, 
as well as naloxone-induced hyperalgesia is observed. 
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Various workers have observed rhythms in analgesic responses over a 
time period. Frederickson et al (1979) demonstrated that the opiate 
antagonist naloxone was capable of blocking the endogenous increase 
in the analgesic response in the dark phase. These investigators 
suggested that the circadian rhythm of morphine-induced analgesia 
appears to be the result of an interaction between the endogenous 
fluctuation in pain sensitivity and the exogenously administered 
morphine. 
Pilcher et ai, (1982) also observed a rhythmic fluctuation in the 
sensitivity to pain in rats, and suggested that these changes arise 
as a result of rhythms in the activation of the endorphinergic 
system. These investigators, however, noted two peaks of reduced 
sensitivity to noxious thermal stimuli in rats over a single 24 hr 
LD cycle. One peak occurred in the light phase and the other more 
pronounced peak occurred in the dark phase. A rhythm with with one 
peak in the dark phase was noted when using the paw pinch method of 
analgesic testing. They thus concluded that the nociception of 
qualitatively different stimuli may be mediated by different 
endorphinergic systems. Another explanation for these findings 
could be that the thermal method of assaying analgesia is possibly 
more sensitive than the paw pinch procedure. 
The observations from this study indicate that a circadian rhythm 
in the susceptibilty to pain as well as morphine-induced analgesia 
occurs in rats, and this endogenous rhythm can be blocked by the 
opiate antagonist naloxone. 
4.3.6 EXPERIMENT 6 : EVALUATION OF MELATONIN AS A POSSIBLE 
ANALGESIC AGENT IN RATS 
4.3.6.1 Introduction 
It has been suggested that the pineal gland and melatonin have 
significant effects on opioid functions (Kavaliers et ai, 1983; 
Reiter, 1987; Esposti et al,1988b). In the goldfish, it has been 
suggested that the thermoregulatory and behaviourial activating 
effects of ~-endorphin may be mediated by the pineal gland 
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(Kavaliers etal, 1983a). 
Electrophysiological studies carried out by Dafny and Burks (1977) 
suggested that the pineal gland may be involved in determining the 
actions of morphine on the hypothalamus. 
A circadian variation in the sensitivity and response 
(Frederickson et ai, 1977; Rosenfeld and Rice, 1979), 
to pain 
and the 
susceptibility to morphine-induced analgesia (Morris and Lutsch, 
1969; Lutsch and Morris,1971; 1972) and melatonin synthesis by the 
pineal gland (Axelrod, 1974; Ozaki and Lynch, 1976), have been 
reported. 
This experiment was undertaken to determine whether the pineal 
hormone melatonin displays analgesic activity in rats. 
4.3.6.2 Materials and Methods 
Rats (n-S) were injected with melatonin (30 mg, 60mg, or 90mg/kg bw 
ip) or melatonin vehicle (see section 3.2.1.) at 12hOO. Tail-flick 
response time was measured at t = 0, 20, 40, 60, and 80 minutes as 
described earlier (section 4.2.3). 
4.3.6.3 Results 
The results of this 
significant analgesic 
experiment indicate that melatonin 
activity noted at 40 minutes after 
has 
drug 
administration (fig 4.6) (F(df=19) 6.61, P < 0.01. This 
analgesic effect of melatonin was not dose dependent at the doses 
used in this study. 
4.3.6.4 Discussion 
Melatonin is considered to be the major indoleamine hormone 
produced by the pineal gland. It has been implicated in the 
functional activities of many organs (Minneman and Wurtman, 1984). 
The results from this study indicate that melatonin (30 - 90 mg/kg 
bw ip) administration to rats results in time-related changes in 
analgesic activity . 
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Rats were treated with melatonin (30 mg. 60 mg and 90 
mg/kg bw 1p) or melatonin vehicle and subjected to the tail 
immersion test. Although melatonin displays some analgesic 
activity. this effect is not dose-dependent. 
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Similar observations were made by Lakin el ai, (1981) who showed that 
melatonin (30 90 mg/kg bw) administration produces a dose-
dependent time-related analgesic effect in mice tested on the hot 
plate (55 ± 0.50 C). 
Other investigators (Winters el ai, 1981) suggested an analgesic role 
for melatonin in chicks. 
Sugden (1983) carried out analgesic tests (hot plate and writhing 
tests) 30 minutes after melatonin administration to mice. Large 
doses of melatonin (200 mg/kg and 400 mg/kg bw) inhibited 
acetylcholine-(5 mg/kg bw) induced writhing and increased the 
reaction time on the hot plate (50 ± 0.5 °C) in mice, in a dose 
related manner. 
These observations would thus suggest that melatonin has potential 
as an analgesic agent. 
4.3.7 EXPERIMENT 7: EFFECT OF CONSTANT LIGHTING ON THE 
NOCTURNAL SENSITMTY TO MORPHINE INDUCED 
ANALGESIA IN RATS 
4.3.7.1 Introdnction 
Melatonin synthesis undergoes a circadian rhythm in the pineal 
gland (Axelrod, 1974), with peak levels during the dark phase of a 
LD cycle. Data from the above experiments have shown that the 
analgesic response of rats treated with morphine is greater in the 
dark phase, when melatonin levels are high. 
It has been suggested that the pineal release of melatonin is 
responsible for the diurnal cycle of analgesia induced by melatonin 
in chicks (Winters el ai, 1980. Exposure to a continuous lighting 
regimen is known to suppress pineal melatonin synthesis (Wurtman el 
ai, 1982). This experiment was thus carried out to observe the 
effects of "an abolished melatonin rhythm on the nocturnal analgesic 
response in morphine-treated rats. 
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4.3.7.2 Materials and Methods 
Rats (n~S) were either exposed to a continuous lighting regimen for 
three days or left under the normal constant lighting cycle of LD 
12:12 . On the day of the experiment, rats were injected with 
morphine Hel (10 mg/kg bw ip), 20 minutes prior to analgesic 
testing at 12hOO or 24hOO. For the night-time experiments, rats 
were removed from the constant lighting cycle at 23h3S. 
4.3.7.3 Results 
The findings of this experiment are illustrated in figure 4.7. The 
enhanced nocturnal analgesic response to morphine noticed in rats 
kept under the normal lighting cycle (LD 12: 12) is abolished by 
exposure of rats to a constant lighting cycle. 
5.3.7.4 Discussion 
Information about environmental lighting is conveyed to the pineal 
gland via neuronal pathways from the retina (Klein and Moore, 
1979). Lutsch and Morris (1972) have suggested that photic 
information is a dominant exogenous force synchronizing the 
morphine susceptibility pattern in mice. Their findings suggest 
that the analgesic pattern of morphine in the LD cycle was 
dependent on the lighting regimen. Alternating a 12 hr LD cycle, or 
reversal of a normal 12 hr LD cycle, always produced peak analgesia 
in the dark phase (when melatonin levels are high). In continuous 
light (when melatonin production is abolished), these workers 
showed no statistically significant differences in analgesic 
responses to morphine at various time points. It could be suggested 
that physiological doses of melatonin might be able to potentiate 
the analgesic activity of morphine. 
The results of the present study are in agreement with these 
findings . Al though other possibilities have not been excluded , it 
could be suggested that melatonin may enhance the morphine-induced 
analgesic response in rats. 
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EFFECT OF CONTINUOUS LIGHTING 
ON MORPHINE SUSCEPTIBILITY 
IN RATS 
* 
_ continuous lighting _ normal LD cycle 
Rats were maintained in an normal LD 12:12 cycle, or 
under a continuous lighting cycle (LL) and subjected to the tail 
immersion test at 12HOO and 24HOO. Only rats maintained under the 
normal lighting cycle showed an enhanced morphine (10 mg/kg bw ip)-
induced nocturnal analgesic activity. 
* = significantly different to all treatment groups. 
F(df=l9) - 9.75, p < 0.001. 
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4.3.8 EXPERIMENT 8 : EFFECT OF PINEALECTOMY ON MORPHINE-INDUCED 
ANALGESIA IN RATS 
4.3.8.1 Introduction 
The previous experiments have shown that a circadian rhythm in the 
response to noxious stimuli exists in naive and morphine - treated 
rats, with higher response times being noted in the dark phase of 
the LD cycle (fig 4.5). Also, the pineal hormone , melatonin, has 
some analgesic activity in rats (fig 4.6). 
These findings initiated the following experiment, which was 
undertaken to determine whether the pineal gland played a role in 
the manifestation of the circadian changes in pain sensitivity and 
susceptibility to morphine. 
4.3.8.2 Materials and Methods 
Intact, sham operated and pinealectomized rats (n- 5) were treated 
with morphine Hel (lOmg/kg bw ip) at 12hOO and 24hOO and analgesic 
activity was determined twenty minutes later as described (section 
4 . 2 . 3) . 
4.3.8.3 Results 
The results (fig 4 . 8 and fig 4 . 9) from this study show that both 
intact and sham operated rats exhibit an increase in the endogenous 
and morphine-induced analgesic reponse in the dark phase (24hOO). 
Pinealectomized rats, however, show a significant lowering of the 
response "time to noxious thermal stimuli in the dark phase (24hOO) 
when compared to intact and sham operated rats. 
This effect was not noted in the photophase . 
Fig 4.8: 
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EFFECT OF PINEALECTOMY ON 
THE DAY !NIGHT RESPONSE 
TO PAINFUL STIMULI 
2.5 ,--------------------------------, 
OLL __ L-L--L-L __ L-____ _ 
INTACT SHAM PINx INTACT SHAM PINx 
DAY NIGHT 
Intact, sham-operated and pinealectomized rats were 
subjected to the tail immersion test at 12HOO and 24HOO. 
Pinealectomy causes a significant reduction in the endogenous 
response to noxious thermal stimuli in the dark phase. The response 
time in the dark phase remains unchanged. 
F(dfQ 29) a 49.50, p < 0.01 
* - significantly different to nighttime controls and all daytime 
treatment groups. 
** - significantly different to all other treatment groups. 
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EFFECT OF PINEALECTOMY ON 
THE DAY!NIGHT RHYTHM OF 
MORPHINE ANALGESIA 
5,-----------------------------------, 
4 
3 
2 
1 
OU-__ ~ __ _L~ __ L_ __ ___ 
INTACT SHAM PINx INTACT SHAM PINx 
DAY NIGHT 
Intact, sham-operated and pinealectomized rats were 
treated with morphine (10 mg/kg bw ip) and subjected to the tail 
immersion test at 12HOO and 24HOO. Pinealectomy cause a partial but 
significant reduction in morphine analgesia in the dark phase. 
F(df=29) = 49.56, P < 0.001 
* - significantly different to all other treatment groups. 
** = significantly different to all other treatment groups. 
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43.8.4 Discussion 
In most rodent species studied, melatonin synthesis in the pineal 
gland and plasma levels of melatonin are greatest during darkness 
(Ozaki and Lynch, 1976), when animals have been reported to be most 
sensitive to morphine-induced analgesia (Lutsch and Morris ,1971; 
1972) and least sensitive to pain (Frederickson et ai, 1977; 
Rosenfeld and Rice, 1979) . 
Kavaliers et al (1983), have proposed that the pineal gland is 
involved in the "fine-tuning" and integration of neural and 
endocrine activities that may affect opioid activity. 
Kumar et al (1982) have observed that pinealectomy abolishes the 
daily fluctuations in met-enkephalin levels in the hypothalamus 
pre-optic area. 
The findings of this experiment suggest that the pineal gland is an 
integral link in the expression of the circadian changes in the 
endogenous and morphine-induced response to noxious thermal 
stimuli. Removal of the pineal gland resulted in a loss of the dark 
phase augmentation of morphine analgesia, suggesting that this 
gland is involved in the manifestation of the circadian response to 
morphine in rats. 
Lakin et al (1981) observed that pinealectomy completely abolished 
the rhythm of morphine analgesia in mice. The results of this 
study, however, indicate that pinealectomy induces only a partial 
but significant reduction in the nocturnal sensitivity to morphine-
induced analgesia in rats. 
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4.3.9 EXPERIMENT 9: EFFECT OF MELATONIN ON THE SENSITIVITY TO 
MORPHINE-INDUCED ANALGESIA IN 
PINEALECTOMIZED RATS. 
4.3.9.1 Introduction 
The results obtained from the previous experiments indicated that 
the pineal gland was necessary for the modulation of the increased 
nocturnal pain sensitivity noted in rats, as well as for the 
variation in morphine susceptibility. 
Melatonin is considered to be the principal pineal hormone; and has 
many effects on the eNS (Quay et ai, 1974; Reiter, 1977). This 
experiment was undertaken to examine whether the administration of 
melatonin to pinealectomized rats altered the morphine 
susceptibility in rats. 
4.3.9.2 Materials and Methods 
Two groups each of intact, sham-operated and pinealectomized rats 
were injected either with morphine (10 mg/kg bw ip) and melatonin 
vehicle, or morphine (10 mg/kg bw ip) and melatonin (5 mg/kg bw ip) 
twenty minutes prior to analgesic testing. At 24hOO, rats were 
subjected to the tail immersion test described earlier. 
4.3.9.2 Results 
The results of this experiment indicate that melatonin 
administration results in a small but significant increase in the 
analgesic activity of morphine in pinealectomized rats (see figure 
4.10) . 
4.3.9.3 Discussion 
At the doses used in this study, melatonin was unable to fully 
reverse the effects of pinealectomy on the nocturnal susceptibility 
to morphine as measured using analgesic testing. A small but 
significant increase in response time was noted in melatonin-
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EFFECT OF MELATONIN ON THE 
NOCTURNAL SENSITIVITY TO MORPHINE-
INDUCED ANALGESIA IN PINx RATS 
** 
, 
§." 
INTACT SHAM PINx INTACT SHAM PINx 
_ morphine only morphine + melatonin 
Intact, sham-operated and pinealectomized rats were 
treated with morphine (10 mg/kg bw ip) or melatonin (5 mg/kg bw ip) 
+ morphine (10 mg/kg bw ip) and subjected to the tail immersion 
test at 24HOO . Melatonin induced a slight but significant increase 
in the nocturnal analgesic activity of morphine . This dose of 
melatonin, however, could not fully reverse the effects of 
pinealectomy on the nocturnal analgesic activity of morphine. 
F(df=29) 6.005, P < 0 , 001 
* - significantly different to all other treatment groups. 
** - significantly different to all other treatment groups. 
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treated rats as compared to control rats. 
Winters et al (1983) found an analgesic effect of melatonin in chicks 
which, they suggested, appeared to be based on a melatonin 
triggered release of endogenous analgesic pituitary peptides. They 
suggested that pineal melatonin could be the basis for the diurnal 
rhythm of analgesia noted for morphine and ketamine. These 
investigators also observed that morphine, ketamine and melatonin 
analgesia is reversed by naloxone, and suggest a link between the 
pineal/pituitary glands and opioid receptors. 
Lakin et ai, (1981) also observed that melatonin-induced analgesia 
was blocked by naloxone; and suggested an opioid linked role for 
melatonin analgesia. 
Sugden (1983) however, noted that the analgesic activity of 
melatonin was not reversed by naloxone, contrary to the findirigs of 
the above reports. 
A problem arises in the design of these studies. Lakin et al (1981) 
and Sugden (1983) administered naloxone subsequent to melatonin 
injection. Naloxone has been shown to exert a hyperalgesic effect 
(Frederickson et ai, 1977; Rosenfeld and Rice, 1979; Pilcher et ai, 
1982) and the reduction in the analgesic response to melatonin 
could be attributed to this effect. 
From this study, it is clear that at the higher than physiological 
dose used in this experiment, melatonin is unable to fully reverse 
the effects of pinealectomy on the susceptibility to morphine. 
Various other peptides are released by the pineal gland (Cardinali 
and Vacas, 1988), and the possibility exists that one of these 
peptides may modulate the enhanced nocturnal analgesic activity in 
rats. 
Although an activation of the endogenous opioid system by melatonin 
could be sugge sted, further research (including biochemical and 
physiological studies) would have to be initiated to determine the 
exact mode and site of action of this hormone. 
201 
4.3.10 EXPERIMENT 10: EFFECT OF MELATONIN ON STRESS·INDUCED 
ANALGESIA. 
4.3.10.1 Introduction 
The endogenous opioid system plays an important role in analgesia 
(Akil ef ai, 1984). This system can be activated by a broad range of 
environmental stimuli, including stress (Guilleman ~al, 1977). 
One of the most common stressors used in animal experiments, 
restraint, involves both somatic and emotional components (Axelrod 
and Reisine, 1984) and is also associated with analgesia (Amir and 
Amit, 1978). 
Immobilization in a plexiglass chamber has been found to increase 
the plasma concentration of ~-endorphin in the rat (DeSouza and van 
Loon, 1985) and increases hot plate latencies in the mouse (Amir 
and Amit, 1978). 
Winters ef al (1983) have suggested that melatonin triggers the 
release of endogenous opioid peptides and thus exhibits analgesic 
activity . This experiment was undertaken to observe the effect of 
melatonin on immobilization-induced analgesia in rats. 
4.3.10.2 Materials and Methods 
Rats (n=5) were injected with melatonin vehicle, melatonin (5 mg/kg 
bw ip) or naloxone (lOmg /kg bw ip) 20 minutes and 10 minutes (in 
the case of naloxone) prior to immobilization. Animals were 
restrained in the cylindrical tubes used for analgesic testing (see 
section 4.2.3) for fifteen minutes. At the end of the restraint 
period, they were subjected to the tail-flick test as described 
earlier (section 4 . 2 . 3) . 
4.3.10.3 Results 
Resul ts (fig 4 . 11) indicate that saline-treated rats exposed to 
immobilization for fifteen minutes show significant analgesia when 
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compared to unrestrained controls . Naloxone abolished this effect. 
Melatonin was observed to significantly increase the tail flick 
response time when compared to saline treated controls. 
4.3.10.4 Discussion 
Many studies have reported the presence of analgesic activity after 
restraint (Amir and Amit, 1978 ; 1979; Appelbaum and Holtzman, 1984; 
1985). Activation of the opioid system occurs in the course of 
immobilization stress (Guilleman et ai, 1977) , and is activation 
may also be characterized by the opioid-like alterations in animal 
behaviour (Porro and Carli, 1988) . 
Restraint has also been observed to potentiate morphine -induced 
analgesia in rats. Acute immobilization increases the pain 
threshold in the tail flick test, and increases the duration and 
potency of the analgesic effects of morphine and methadone. 
Various systems, including DA-ergic, serotoninergic and NA-ergic 
mechanisms have been proposed to explain the increase in analgesic 
activity due to stress exposure (Porro and Carli, 1988) . Kelly and 
Franklin (1985) have proposed that an increase in brain tryptophan 
may be a general mechanism for the effect of stress on sensitivity 
to pain. 
The results from this study indicate that restraint induces an 
increase in analgesic activity, and that this effect is blocked by 
naloxone. Exposure to stress is known to increase pineal 
biosynthetic activity (See chapter 3).Melatonin administration was 
observed to potentiate the restraint-induced analgesia . This 
ob servation could indicate a possible activation of the opioid 
system in restraint by melatonin . 
However , this is an indirect method of noting the effect of 
melatonin on the opioid system; and as such it cannot be 
conclusively assumed that melatonin exerts its stress-induced 
potentiation of the analgesic response via an opioid mechanism. 
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EFFECT OF MELATONIN AND 
NALOXONE ON STRESS-INDUCED 
ANALGESIA 
60 r--------------------------------, 
50 * 
40 
30 
20 
10 
0 
MELATONIN CONTROL NALOXONE 
Melatonin potentiates the stress-induced increase in 
analgesic activity. Naloxone induces a reduction in the response 
time of rats subjected to noxious stimuli. 
F(df~14) - 14.35, P < 0.001. 
* ~ significantly different to control and naloxone 
** significantly different to control and melatonin . 
, 
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No research in this field has yet been undertaken. Investigations 
into the actual mode of action of melatonin on the endogenous 
opioid system may help to explain a possible analgesic role for 
this hormone . 
4.4 CONCLUSION 
The pineal gland is a neuroendocrine transducer. capable of 
converting neural signals received from the retina in response to 
environmental lighting into a hormonal output (Axelrod. 1974). 
The analgesic effect of morphine was shown to undergo a diurnal 
variation depending on the lighting regimen. suggesting that 
photoperiodicity has an important effect on morphine susceptibility 
in rats. 
This study has also provided interesting results. suggesting that 
the pineal gland plays an important role in the endogenous as well 
as morphine-induced analgesic responses in rats. 
Although some of the observations noted in this study suggest that 
melatonin may exert an effect in rats via an activation of the 
opioid system. these findings are inconclusive . 
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CHAPTER FIVE 
CONCLUSION 
This study investigated existing as well as new possible areas of 
interaction between the pineal gland and the opioid system. 
Organ culture studies showed that the opioid agents do not affect 
[14C]-serotonin metabolism by the pineal gland in vitro. This 
suggests that the opioids do not exert a direct action on the 
pineal gland. An indirect-acting opioid synapse may thus be 
responsible for the effects of opioids on the pineal gland observed 
by other investigators. 
The opioid system was shown to play a possible role in stress . 
Using the restraint-immobilization stress technique, it was 
observed that morphine inhibits stress-induced gastric ulceration. 
Naloxone exacerbated this effect, as well as reversed the 
protective effects of morphine on stress-induced gastric 
ulceration . The pineal gland was shown to be necessary for the 
modulation of some aspect of stress-induced gastric pathology in 
rats. Its principal hormone, melatonin, could counter the effects 
of stress on gastric ulceration very effectively. This effect, 
however, was not exerted via an opioid mechanism. The pineal gland 
and melatonin thus possibly exert their effects via a different 
mechanism that has yet to be elucidated. 
Pinealectomy was shown to abolish the diurnal rhythm of morphine-
induced analgesia, suggesting that an intact pineal gland is 
necessary for this different diurnal sensitivity to the analgesic 
effects of morphine . Melatonin could only partly reverse this 
effect, and it could thus be suggested that other pineal factors 
may be involved in the mediation of this effect. 
It would thus appear that the pineal gland may be necessary for the 
modulation of some of the effects of the opioid system. However, no 
clear cut evidence has been provided to infer that these effects of 
melatonin are exerted via the opioid system. 
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Melatonin could have many sites of 
stress-induced ulceration. These 
action 
include 
in its inhibition of 
possible peripheral 
effects such as local microcirculatory vasodilation, maintenance of 
an acid balance in the stomach, and maintenance of gastric mucosal 
integrity. Recent observations (Szabo, 1989) however, indirectly 
revoke this possibilty . Szabo (1989) has observed a circadian 
variation in chemically-induced gastric erosions in rats, with 
maximal lesions being present in the dark cycle. Melatonin levels 
are higher at night than during the day (Axelrod, 1974); and a 
possible cytoprotective effect of endogenous melatonin could be 
excluded. 
A central effect of melatonin in stress could also be postulated . 
This pineal factor could possibly reduce emotionality in rats, or 
influence the stress-triggered activity of the hypothalamo-
pituitary-adrenal axis to exert its protective effect on the 
gastric mucosa in stress. 
Melatonin is known to influence brain concentrations of GABA, NA, 
DA, and serotonin (see chapter1) , and anyone of these 
neurotransmitters may be implicated in the actions of melatonin 
observed in this study. 
During the past few decades, many investigators have studied the 
role of GABA in a variety of behavioural systems, and recent 
observations suggest that GABA exerts an analgesic effect that may 
differ from that of the opioids. Potent GABA agonists (e.g. 
muscimol) potentiate morphine-induced analgesia in the mouse and 
the rat (Biggio et ai, 1977). It has been suggested that the 
elevation of cerebral GABA content has an anti-nociceptive effect 
in rats and mice, and that this effect is not opioid-like in nature 
(DeFeudis, 1982). 
An explanation for some of the effects noted in this study could be 
surmised from the above discussion. Melatonin could possibly exert 
some of its effects via the GABA-ergic system. Administration of 
melatonin possibly increases brain GABA concentrations, and this 
effect could lead to an attenuation of the effects of stress on 
gastric ulceration (chapter 3) and an enhancement of the 
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antinociceptive response of rats subjected to stress (chapter 4) . 
It could be concluded that although a link between the pineal gland 
and the opioid system as observed in this study (chapter 4) may 
exist, a modulation of the noted effects by other systems (GABA-
ergic, dopaminergic, noradrenergic, serotoninergic) cannot be 
excluded. 
208 
SUMMARY 
CHAPTER! 
A general review on the pineal gland, the opioid system, and 
possible interactions between these two systems has been presented, 
including an overview on stress and analgesia. 
CHAPTER 2 
The influence of opioids (methadone, morphine) and 
antagonist naloxone on [14C )- serotonin metabolism by 
gland has been investigated, using an organ culture 
the opioid 
the pineal 
technique . 
Neither the opioids nor the opioid antagonist naloxone have any 
effect on [14C)-serotonin metabolism by the pineal gland. The organ 
culture system described may be used to study melatonin production 
in tissue other than the pineal gland. 
CHAPTER 3 
The effects of melatonin, morphine and naloxone on stress-induced 
gastric ulceration has been studied. Melatonin and morphine 
significantly inhibit stress lesion formation in rats, whereas 
naloxone exacerbates this effect. Pinealectomized rats show a 
higher incidence of gastric lesions when compared to control rats, 
suggesting that the pineal gland is necessary for the modulation of 
some aspect of the stress response. This effect of melatonin is not 
exerted via an opiatergic mechanism. 
CHAPTER 4 
The response of rats to noxious stimuli after various manipulations 
(drug administration, pinealectomy, altered lighting cycle) has 
been investigated. A diurnal variation in the response of rats 
(treated with saline, morphine or naloxone) to noxious stimuli has 
been observed. Pinealectomy abolishes the nocturnal increase in 
morphine-induced analgesia, and melatonin only partly reverses this 
effect . Melatonin potentiates stress-induced analgesia in rats. 
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CHAPTERS 
The pineal gland and melatonin may be responsible for some of the 
actions of the opioid system. The principal pineal factor, 
melatonin, may have therapeutic use in the management of stress, 
and could serve as a lead product in the development of safer 
alternatives for stress therapy . 
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